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Abstract
Engineered systems provide a means of deconstructing the microenvironmental cues which guide cell fate
and function. These cues can include biochemical elements, as in ligand–receptor binding for cell–cell or
cell–extracellular matrix (ECM) interactions, or responses to biophysical parameters, as in cell sensing of
substrate material properties. One category of engineered system, high-throughput cell microarrays, are
useful not only for the efficient identification of roles for new cues in specific biological processes but also for
mapping combinatorial interactions between known cues. In this dissertation, I describe a cell microarray
platform with several additional capabilities: the integration of multiple readout modalities, including direct
readout of mRNA expression using in situ hybridization and, crucially, cell-generated forces using traction
force microscopy (TFM); and the deconvolution of signaling via cell–cell (ligand–receptor) interactions by
combining cell-extrinsic ligand presentation with cell-intrinsic ligand knockdown. I delineate the use of this
platform towards investigations of microenvironmental regulation in the context of liver progenitor differen-
tiation and lung tumor cell drug responses. Liver progenitor differentiation was found to be combinatorially
regulated by Notch, TGFβ signaling as well as interactions with ECM proteins. The Notch ligands Jag1
and Dll1 were further found to found play distinct cell-intrinsic and cell-extrinsic roles in differentiation to-
wards a biliary epithelial cell fate. Parallel TFM measurements in arrayed microenvironments indicated that
progenitor cell differentiation towards biliary fates is a coordinated function of ECM composition, substrate
stiffness, and cell contractility. Additional analysis of spatially-localized differentiation within array patterns
showed that cooperative interactions between Notch and cell mechanotransduction signaling pathways are
necessary for biliary differentiation. Similarly, the responses of tumor cells to drug treatment is known to
depend on interactions with their matrix microenvironment. Lung tumor cell drug responses were mapped
using a combinatorial ECM array design and shown to be a function not only of matrix composition but
also genotype, specifically the presence or absence of the lineage oncogene ASCL1. Thus, this dissertation
presents an advanced array platform which not only improves our understanding of biochemical and bio-
physical regulation of liver progenitor fate specification and lung tumor cell drug responses but also enables
similar studies of other tissue contexts and organ systems.
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Chapter 1
Introduction∗
1.1 Abstract
From early development through pathogenesis, cell fate and function are regulated not only by cell-intrinsic
genetic programs but also cues from the local microenvironment. These cues include cell–cell, cell–soluble
factor, and cell–extracellular matric (ECM) interactions as well as physical and chemical properties such as
pH, gas or metabolite concentration, and mechanical forces. Engineered systems have contributed to both
improved understanding of the role of microenvironmental regulation in fundamental biological processes,
such as morphogenesis, and scaling of biomaterial constructs for clinically-relevant applications. This chapter
introduces and reviews the use of different types of engineered systems (Section 1.2), select mechanisms of
liver development (Section 1.3), and the role of the matrix regulation of lung tumor cell drug resistance
(Section 1.4). Last, I provide a concise synthesis of the elements of these literatures most relevant to the
studies described here and present the principal aims of this dissertation mapped by chapter (Section 1.5).
1.2 Engineered systems for analyzing cell fate and function
Cells are exposed to a variety of regulatory cues through their in situ microenvironment, or niche (Figure 1.1).
These microenvironmental cues include cell–cell, cell–soluble factor, and cell–ECM interactions and have
been shown to influence cytoskeletal architecture, polarity, and motility, and are further known to stimulate
intracellular signaling pathway activity. In addition to these biochemical cues, it is increasingly recognized
that physical and chemical properties such as pH, gas or metabolite concentration, mechanical forces, and
electrical potential play key roles in processes such as stem cell fate determination. The particular set
of cues presented to a cell in situ depends on the details of that cell’s niche in the tissue or organ of
interest as well as the local physiological or pathophysiological state. Engineered systems have been used
∗Parts of this chapter were adapted from a book chapter published by World Scientific Publishing Company (Hackensack,
New Jersey) in the second volume of the Gels Handbook (Kaylan and Underhill 2016) and are reproduced here with the
permission of the publisher.
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toward both deconstructing the cues necessary to guide cell fate decisions and recapitulating specific in vivo
microenvironmental contexts for scaling of tissue constructs and cell-based therapies. These systems can be
broadly indexed into a number of different categories depending on the methods utilized and aims achieved
(Figure 1.1). The remainder of this section, however, will focus specifically on the use of micropatterning,
hydrogel biomaterials, and high-throughput arrays as these techniques are of direct relevance to the studies
described in later chapters of this dissertation.
1.2.1 Micropatterning
One of the first micropatterning techniques to attain widespread use was microcontact printing, which was
initially described by the group of Whitesides (Lopez et al. 1993) and is an adaption of tools used in the
semiconductor industry. In this method, an elastomeric stamp (typically composed of polydimethylsiloxane)
with bas-relief features is “inked” with a material of interest. This inked material is selected such that
subsequent transfer to a pre-functionalized substrate enables spatially-controlled, selective adhesion of cells.
While the group of Whitesides originally patterned self-assembling monolayers of thiols, the technique has
since been adapted to directly pattern DNA (Lange et al. 2004; Thibault et al. 2005), proteins (Bernard et al.
1998; James et al. 1998), and cells (Mrksich et al. 1997; Singhvi et al. 1994). Microcontact printing is limited
by the requirement of an initial etching step to fabricate the stamp and, most importantly, variable quality
of protein transfer. To address some of these limitations, others have since developed non-etching methods
including photopatterning (Balakirev et al. 2005; Fink et al. 2007), laser patterning (Bélisle et al. 2009;
Doyle et al. 2009), and electropatterning (Albrecht, Underhill, Mendelson, et al. 2007; Albrecht, Underhill,
Wassermann, et al. 2006).
Collectively, these micropatterning techniques have contributed considerably to our knowledge of the
role of the microenvironment in cell physiology, especially with respect to the processes of cell adhesion to
ECM proteins and subsequent assembly and reorganization of cytoskeletal networks. For instance, Lehnert
et al. (2004) used regular patterns of micropatterned dots with varying areas (0.1–9 µm2) and center-to-
center spacings (1–30 µm) to determine the geometric ranges supportive of cell spreading via focal adhesion
formation. Using similar sub-micrometer patterns to present single integrin-binding sites, Arnold et al. (2004)
determined that the maximum length scale for integrin clustering is 58–73 nm, above which cell spreading
does not occur due to restricted integrin clustering and activation. Others have examined the role of cell
shape and geometry in cytoskeletal dynamics and have observed localization of focal adhesions in patterned
geometries with straight edges and corners, resulting in increased cell contractility at those locations (Chen
et al. 2003; Théry et al. 2006). Further, changes in cell geometry have been shown to regulate mesenchymal
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stem cell fate through differential expression of the cytoskeletal regulators RhoA and ROCK (Bhadriraju
et al. 2007; Kilian et al. 2010; McBeath et al. 2004).
Variations on micropatterning have been employed toward improved understanding of cell–cell interac-
tions. Of particular interest is a series of studies by the group of Chen in which bowtie-shaped agarose
microwells were used to isolate the effects of direct cell–cell contact from paracrine signaling and cell shape
(Nelson and Chen 2002, 2003; Nelson, Pirone, et al. 2004). In these studies, the proliferation of vascular
endothelial cells was found to increase with cell–cell contacts via a PI3K-dependent mechanism. This mech-
anism was further linked to engagement with VE-cadherin, which was shown to inhibit cell spreading and
initiate RhoA-dependent changes in cytoskeletal tension. At multicellular scale, Bhatia et al. (1999) used mi-
cropatterned islands to control heterotypic cell–cell interactions between hepatocytes and non-parenchymal
cells, finding that micropatterned co-cultures exhibited elevated hepatic function as measured by urea syn-
thesis and albumin secretion. Similar multicellular patterns of mesenchymal stem cells have revealed spatial
localization of differentiation toward adipogenic or osteogenic lineages within multicellular circular geome-
tries (Ruiz and Chen 2008).
In summary, micropatterning systems provide a versatile means of controlling cellular geometry and
associated interactions with the surrounding microenvironment. These systems are therefore key for inves-
tigating the role of cell–cell and cell–ECM interactions at both single-cell and multicellular scales and have
enabled studies of cell behavior in response to highly-specific sets of microenvironmental cues.
1.2.2 Hydrogel biomaterials
Hydrogels are composed of insoluble networks of cross-linked hydrophilic polymers which swell to several
times their dry weight with the addition of water. Applications for hydrogels range from “smart” biomaterials
(Kopeček and Yang 2007; Seliktar 2012) to scaffolds for tissue engineering (K. Y. Lee and D. J. Mooney
2001; Peppas et al. 2006; Rosso et al. 2005). Hydrogel-based biomaterials are increasingly utilized in tissue
engineering and regenerative medicine due to the tunability of their physical, mechanical, chemical, and
functional properties to the demands of each application. Considerable effort in tissue engineering has focused
on utilizing the myriad capabilities of hydrogels to create biocompatible, modular hydrogel platforms for
culturing cells and tissues. These capabilities are crucial for hepatic tissue engineering in particular as it has
long been known that hepatocytes experience loss of function and phenotype in traditional 2D cultures on
plastic or glass and that different ECM compositions result in disparate effects on hepatic morphology and
function (D. M. Bissell, Arenson, et al. 1987; D. M. Bissell and Guzelian 1980; Dunn et al. 1989; Flaim et al.
2005). Furthermore, an ensemble of other factors dictate the fate and behavior of hepatic cells, such as the
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extent and nature of cell–cell (i.e., homotypic vs. heterotypic) and cell–ECM (e.g., collagen vs. fibronectin)
interactions, concentration of metabolites or nutrients, and presentation of growth factors (see Section 1.3).
In facilitating control of the factors listed above, hydrogels enhance hepatic function and phenotype in vitro
and establish cultures which better resemble native liver tissue, enabling studies of fundamental biology and
translation of therapeutic approaches to the clinic.
Hydrogels are highly biocompatible and structurally similar to many tissues and the ECM (Drury and
D. J. Mooney 2003). Moreover, they possess low interfacial tension and minimal mechanical and frictional
irritation, further promoting biocompatibility (Baroli 2007). Their capacity for in situ polymerization eases
seeding and encapsulation of cells for both in vitro and in vivo studies. Combinations of different chemical
moieties, crosslinking methods, copolymer blends, and other properties and parameters enable precision
engineering of the cellular microenvironment presented by the hydrogel to further match that of the tissue
or organ of interest. In addition to the physical and chemical properties of the scaffold, hydrogels offer
tailored cell–ECM interactions and functionality, viz., adhesion, biodegradation, or growth factor delivery,
through the addition of various biofunctional groups (Zhu 2010). Hydrogels can also incorporate dynamically-
controlled physicochemical stimuli and time-dependent factor release to recapitulate cell–chemical and cell–
protein signaling (C.-C. Lin and Anseth 2009). Methods such as photopatterning and microfluidics enable
additional spatiotemporal control of hydrogel architecture and related environmental cues (DeForest and
Anseth 2012; Kloxin et al. 2010). As with most other tissue engineering scaffolds, the mass transport of gases,
metabolites, nutrients, and waste in hydrogels are important determinants of biocompatibility. Cell function
and morphology are further dependent on the concentration of oxygen, hormones, and nutrients, thus the
transport properties of hydrogel-based culture systems must be carefully weighed for each application. These
considerations must also be balanced with the mechanical properties of the hydrogel, as both are a function
of the crosslinking density and other physical and chemical properties.
With respect to studies of stem cell fate, one of the most important properties of a cell’s substrate is
stiffness (A. J. Engler et al. 2006; A. Engler et al. 2004; Wen et al. 2014). For hydrogels, this parameter is
controlled through the percentage of the polymer or crosslinking agent used—higher degrees of crosslinking
lead to stiffer gels. Values of the storage modulus of healthy liver tissue range from 150–2,000 Pa using
both standard rheometry and elastography (Georges et al. 2007; Yeh et al. 2002). Stiffness has been shown
to modulate a number of different aspects of hepatic cells and increases in diseased states such as fibrosis
(Venkatesh and Ehman 2014; Yeh et al. 2002; Yin et al. 2007). Mechanical signaling via matrix stiffness
can also act in concert with other forms of cellular communication. For example, both tension and sig-
naling initiated by TGFβ are required for portal fibroblast differentiation to myofibroblasts (Z. Li et al.
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2007). Studies of stiffness have also been combined with substrate-bound ligand presentation. Primary
rat hepatocytes exhibited dedifferentiation, reduced hepatic function, and increased proliferation on rigid
rather than compliant polyacrylamide hydrogel substrates (Semler et al. 2005). The authors additionally
observed that the extent of cell spreading on the rigid surface was sensitive to different concentrations of
polyacrylamide-conjugated fibronectin; the same was not true for cells on a compliant surface. Last, hydro-
gels are compatible with traction force microscopy, a technique by which cell-generated forces are measured
directly through observation of fluorescent beads embedded in the substrate (Butler et al. 2002; J. H.-C.
Wang and J.-S. Lin 2007). This capability permits detailed studies of cell contractility and downstream
mechanotransduction using hydrogel substrates and scaffolds (Balaban et al. 2001; Trepat et al. 2009; Wen
et al. 2014).
In summary, hydrogel biomaterials make possible the design of tailored cell microenvironments with
specified physicochemical and biofunctional properties. These systems are therefore central for efforts toward
the establishment of cultures which better recapitulate key cues presented to cells in their tissues of origin.
1.2.3 High-throughput arrays
High-throughput arrays represent a parallelized means of systematically evaluating the impact of combi-
nations of microenvironmental signals, typically in the form of matrix proteins, growth factors, or cell–cell
ligands. Different microtechnological approaches can be used to generate both 2D and 3D arrays of hun-
dreds or thousands of individually-addressable features to rapidly identify those arrayed cues which act as
key regulators of the biological process of interest. These microtechnologies include ECM arrays (Brafman,
Minicis, et al. 2009; Brafman, K. D. Shah, et al. 2009; Flaim et al. 2005), microwell arrays (Gobaa et al.
2011; Kurth et al. 2009; Lutolf et al. 2009), spheroid arrays (Hsiao et al. 2012; X. Li et al. 2014; Tung et al.
2011), and 3D gel-based arrays (Fernandes et al. 2010; M.-Y. Lee et al. 2008; Ranga et al. 2014), among
others. Here, I present a succinct account focused on 2D cell microarrays of mammalian cells and refer the
reader to Jonczyk et al. (2016) for a current review of other types of living cell microarrays.
Cell microarrays have been used to transfect or transduce cells with libraries of genetic constructs, thus
allowing for systematic perturbation (i.e., inhibition or induction) of specific intracellular signaling path-
ways. Ziauddin and Sabatini (2001) described the first 2D cell microarray in which cDNA encoding for
GFP was printed on a gelatin-coated glass slide using a standard microarraying robot. Cells were subse-
quently seeded and cultured on the arrayed substrate in media supplemented with a lipid-based transfection
reagent, generating localized spots of GFP-transfected cells and enabling further screening of a library of
192 cDNAs for gene products that increase the activity of kinase signaling pathways. Wood et al. (2012)
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arrayed a library of lentiviral constructs containing open reading frames on polyacrylamide-coated slides
to identify the kinases which desensitize BRAF-mutated melanoma cells to inhibitors of MAP3K signaling.
Others have demonstrated array platforms for identification of orphaned GPCRs (Mishina et al. 2004) and
reverse transfection of shRNA for selective knockdown of cells on arrayed patterns (Silva et al. 2004). Thus,
microarrays are broadly useful for the study of intracellular signaling in diverse contexts.
Flaim et al. (2005) demonstrated microarrays of ECM proteins, identifying combinations that impacted
primary rat hepatocyte function and differentiation of mouse embryonic stem (ES) cells. Other groups
utilized similar ECM microarray platforms toward the study of human ES cells (Brafman, K. D. Shah, et al.
2009), hepatic stellate cells (Brafman, Minicis, et al. 2009), mammary progenitors (LaBarge et al. 2009), and
lung adenocarcinoma cells (Reticker-Flynn, Malta, et al. 2012). Moreover, arrays including combinations
of both ECM proteins and growth factors have been employed by multiple groups to study regulation of
stem cell fate (Brafman, K. D. Shah, et al. 2009; Braga Malta et al. 2016). In particular, Soen et al.
(2006) fabricated arrays on aldehyde-functionalized glass slides containing the ECM proteins laminin and
fibronectin as well as members of several signaling pathways. On these arrays, they seeded human neural
progenitors capable of differentiation toward cortical neurons and glia, finding that co-stimulation of Wnt
and Notch signaling maintains cells in an undifferentiated, proliferative state.
In summary, high-throughput arrays provide a rapid, combinatorial means of presenting microenviron-
mental cues to cells. These systems are therefore integral to attaining a systematic understanding of processes
related to cell fate and function, one for which potential cooperative effects between large numbers of different
cues is fully accounted.
1.3 Mechanisms of liver development
Like other organs of the gastrointestinal tract, the liver derives from embryonic endoderm. During late
gastrulation (embryonic day 7.5 in mouse), a subset of epiblast cells in the anterior primitive streak separate
from the bipotential mesendoderm to form the definitive endoderm (Gordillo et al. 2015). The nearby
visceral endoderm is then progressively displaced by the cells of the definitive endoderm (Tam et al. 1993),
which are subsequently patterned into three sets of endodermal precursor domains constituting the foregut,
midgut, and hindgut. Of these three domains, the foregut gives rise to not only the liver but also the ventral
pancreas, stomach, lungs, and thyroid (Tremblay and Zaret 2005). Following foregut patterning, liver bud
organogenesis begins with the thickening of the ventral anterior foregut to form the liver diverticulum by
embryonic day 9 in mouse. The first liver progenitor cells, or hepatoblasts, are observed at this point as
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a pseudostratified epithelium which eventually delaminates to form the liver bud (Bort et al. 2006; J. W.
Wilson et al. 1963).
The continued hepatic specification and expansion of these liver progenitor cells during embryonic days
10–12.5 in mouse is regulated not only by interactions with surrounding cells—namely the endothelial and
mesenchymal cells of the septum transversum (Shin and Monga 2013)—but also a set of soluble factors
including Wnt, HGF, and FGF (Berg et al. 2007; Micsenyi et al. 2004; Schmidt et al. 1995). Liver progenitors
are considered bipotential and therefore thought to be the precursor to both hepatocytes and bile duct cells,
or cholangiocytes—both cell fates are generated by progenitor differentiation from embryonic day 13.5 to
18.5 in mouse (Figure 1.2). Maturation and differentiation of liver progenitors to hepatocytes is primarily
regulated by BMP, FGF, and Wnt signaling, the details of which are reviewed in detail by Zaret (2001) and
Lade and Monga (2010). Further, the spatial distribution of ECM proteins is known to shift considerably
throughout liver development (Martinez-Hernandez and Amenta 1993) and several works have demonstrated
effects of these proteins on early hepatic specification and hepatocyte differentiation (Braga Malta et al. 2016;
Flaim et al. 2005; D. Mooney et al. 1992; Rana et al. 1994).
Several lines of evidence implicate TGFβ and Notch signaling as key regulators of biliary differentiation
of progenitor cells and attendant duct morphogenesis. A gradient of TGFβ activity caused in part by
expression of TGFβR2 and TGFβR3 in the periportal region leads to differentiation of progenitors toward
a biliary epithelial fate (Antoniou et al. 2009; Clotman et al. 2005). Mutations in the receptor NOTCH2
or ligand JAG1 are associated with bile duct paucity and cholestasis in patients with Alagille syndrome
(L. Li et al. 1997; McDaniell et al. 2006; Oda et al. 1997). By deletion of the Notch effector Rbpj, Zong
et al. (2009) showed that Notch is necessary for both biliary cell fate and tubulogenesis after embryonic
day 16.5 in mouse. Using tamoxifen-induced overexpression of the NOTCH1 intracellular domain linked to
the promoter for albumin, they additionally activated Notch signaling in mature hepatocytes and observed
ectopic biliary differentiation of these cells. Further, Jeliazkova et al. (2013) implemented distinct gain- and
loss-of-function mouse models specific for the embryonic and adult liver compartments, showing that biliary
differentiation and morphogenesis are both dependent on signaling through RBPJ but not HES1.
In summary, the mechanisms of liver development include not only execution of morphogenetic programs
via soluble growth factors but also interactions between embryonic stem and progenitor cells and their
microenvironment. Engineered systems provide a strategy for investigating these combinatorial interactions
through controlled presentation of these microenvironmental cues.
7
1.4 Matrix regulation of lung tumor cell drug resistance
It is known that ECM proteins can mediate drug resistance in tumor cells through interactions with cell-
surface receptors such as integrins (M. J. Bissell et al. 2005; Pickup et al. 2014). Meads et al. (2009)
refers to this as cell-adhesion mediated drug resistance, or CAM-DR, a process which enables tumor cell
persistance during later therapy and eventually leads to acquired resistance and relapse (Figure 1.3). For
lung cancer progression in particular, cell–ECM interactions are known to play a role in several distinct
mechanisms of tumor progression, including fibrosis (Mackinnon et al. 2012), metastasis (Reticker-Flynn
and Bhatia 2015; Reticker-Flynn, Malta, et al. 2012), resistance to chemotherapeutic treatment (Hodkinson
et al. 2007; Sethi et al. 1999), and epithelial–mesenchymal transition (Gibbons et al. 2009; Gill et al. 2012;
P. P. Shah et al. 2012). With respect to drug resistance in particular, Sethi et al. (1999) showed that
attachment of lung tumor cells to the ECM proteins fibronectin, laminin, and collagen IV was sufficient to
induce resistance to chemotherapeutic agents through regulation of survival signaling by β1 integrin. Other
groups have observed decreased survival of lung cancer patients with tumors overexpressing the ECM protein
osteopontin (Chambers et al. 1996; Donati et al. 2005).
In summary, resistance of lung tumor cells to drugs is a function of cues provided by ECM proteins
present in the local microenvironment. Yet the full set of ECM proteins which mediate drug resistance in
this manner remains undefined, as do any potential combinatorial interactions between these cues.
1.5 Synthesis
In this dissertation, I describe the implementation of a multi-modal cell microarray platform for combinatorial
investigation of cell fate and function (see Figure 1.4). In addition to increased throughput and decreased
material usage, this cell microarray platform incorporates aspects of each of the categories of engineered
systems described in Section 1.2, chiefly the defined geometries of micropatterning and tightly-controlled
material properties of hydrogel biomaterial systems. Below, I delineate the three categories of contributions
in this dissertation and their associated chapters:
Advancing cell microarray platforms. Building on the capabilities listed above, I further describe
the integration of these arrays with multiple readout modes, including not only standard immunoflu-
orescence but also in situ hybridization (Chapter 4) and, critically, traction force microscopy (Chap-
ters 3 and 4). I also combine presentation of ECM proteins and cell–cell signaling ligands with ligand
knockdown to establish a means of deconvolving signaling via cell–cell (ligand–receptor) interactions
(Chapter 2).
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Identifying combinatorial mechanisms of liver progenitor differentiation. I report combinatorial
interactions between Notch, TGFβ, and ECM proteins, and additionally delineate distinct cell-intrinsic
and cell-extrinsic roles in cholangiocytic differentiation for the Notch ligands Jag1 and Dll1 (Chap-
ter 2). Moreover, parallel immunofluorescence and traction force microscopy measurements of liver
progenitors differentiating toward a biliary epithelial fate indicated that these cells are sensitive to
both the ECM protein composition and elastic modulus of their substrate (Chapter 3). Last, I ob-
served cooperative interactions between Notch and cell mechanotransduction signaling pathways and
show that both are necessary for the spatially-localized differentiation of progenitors in arrayed patterns
(Chapter 4).
Mapping lung tumor cell drug responses. I describe a combinatorial ECM array platform to investi-
gate lung tumor cell drug responses as a function of both matrix composition and genotype (Chapter 5).
Interestingly, the presence of a lineage oncogene, ASCL1, is sufficient to reshape ECM-dependence of
drug responses, suggestive of interactions between cell-intrinsic genetic programs and responsiveness
to microenvironmental cues.
In Chapter 6, I enumerate and contextualize the specific contributions of previous chapters and provide
future perspectives.
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1.6 Figures
Figure 1.1: Engineered systems for studying stem cell microenvironments. Stem cells integrate both
biochemical and biophysical cues during renewal or fate specification. Several categories of engineered
systems have been used to both deconstruct the mechanistic roles of these cues and recapitulate them in
artificial contexts. This figure was reproduced from Underhill (2012) with the permission of John Wiley &
Sons, Inc. (Hoboken, New Jersey).
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Figure 1.2: Bile duct development. Hepatoblasts (light green) are the epithelial progenitor cells of the
fetal liver and are capable of differentiating into both hepatocytes (red) and biliary epithelium (dark green).
This figure was adapted from Gordillo et al. (2015) with the permission of The Company of Biologists, Ltd.
(Cambridge, United Kingdom).
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Figure 1.3: Matrix-mediated drug resistance of tumor cells. Interactions between tumor cells and local
soluble factors and ECM proteins leads to acquired drug resistance (left). Without these supportive signals,
tumor cells are sensitive to therapy and undergo apoptosis (right). This figure was adapted from Meads
et al. (2009) with the permission of Nature Publishing Group (London, United Kingdom).
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Figure 1.4: Overview of multi-modal arraying platform. In Section 1, glass substrates are cleaned and
silanized to facilitate the fabrication of polyacrylamide hydrogels. In Section 2, the biomolecule combinations
of interest are prepared in a 384-well source microplate. A robotic arrayer is then loaded with clean pins,
the source microplate, and the polyacrylamide hydrogels and initialized, fabricating arrays on the hydrogels.
In Section 3, cells are seeded onto the arrayed domains and allowed to adhere, after which the culture
protocol of interest is performed. At the endpoint, cells are either fixed for immunofluorescence, analyzed
using traction force microscopy, or processed for other readouts methods. Scale bars are 75 µm. This figure
was adapted from Kaylan, Kourouklis, et al. (2017) under the terms of the Creative Commons Attribution-
NonCommercial-NoDerivs 3.0 Unported License.†
†https://creativecommons.org/licenses/by-nc-nd/3.0/
13
1.7 References
Albrecht, D. R., G. H. Underhill, A. Mendelson, et al. (2007). “Multiphase electropatterning of cells and
biomaterials”. In: Lab Chip 7.6, pp. 702–709. doi: 10.1039/b701306j.
Albrecht, D. R., G. H. Underhill, T. B. Wassermann, et al. (2006). “Probing the role of multicellular organiza-
tion in three-dimensional microenvironments”. In: Nat Methods 3.5, pp. 369–375. doi: 10.1038/nmeth873.
Antoniou, A. et al. (2009). “Intrahepatic bile ducts develop according to a new mode of tubulogenesis
regulated by the transcription factor SOX9”. In: Gastroenterology 136.7, pp. 2325–33. doi: 10.1053/j.
gastro.2009.02.051.
Arnold, M. et al. (2004). “Activation of Integrin Function by Nanopatterned Adhesive Interfaces”. In:
ChemPhysChem 5.3, pp. 383–388. doi: 10.1002/cphc.200301014.
Balaban, N. Q. et al. (2001). “Force and focal adhesion assembly: a close relationship studied using elastic
micropatterned substrates”. In: Nat Cell Biol 3.5, pp. 466–472. doi: 10.1038/35074532.
Balakirev, M. Y. et al. (2005). “Photochemical patterning of biological molecules inside a glass capillary”.
In: Anal Chem 77.17, pp. 5474–5479. doi: 10.1021/ac0504619.
Baroli, B. (2007). “Hydrogels for tissue engineering and delivery of tissue-inducing substances”. In: J Pharm
Sci 96.9, pp. 2197–2223. doi: 10.1002/jps.20873.
Bélisle, J. M., D. Kunik, and S. Costantino (2009). “Rapid multicomponent optical protein patterning”. In:
Lab Chip 9.24, pp. 3580–3585. doi: 10.1039/b911967a.
Berg, T. et al. (2007). “Fibroblast growth factor 10 is critical for liver growth during embryogenesis and
controls hepatoblast survival via β-catenin activation”. In: Hepatology 46.4, pp. 1187–1197. doi: 10.
1002/hep.21814.
Bernard, A. et al. (1998). “Printing patterns of proteins”. In: Langmuir 14.9, pp. 2225–2229. doi: 10.1021/
la980037l.
Bhadriraju, K. et al. (2007). “Activation of ROCK by RhoA is regulated by cell adhesion, shape, and
cytoskeletal tension”. In: Exp Cell Res 313.16, pp. 3616–3623. doi: 10.1016/j.yexcr.2007.07.002.
Bhatia, S. N. et al. (1999). “Effect of cell–cell interactions in preservation of cellular phenotype: cocultivation
of hepatocytes and nonparenchymal cells”. In: FASEB J 13.14, pp. 1883–1900.
Bissell, D. M., D. M. Arenson, et al. (1987). “Support of cultured hepatocytes by a laminin-rich gel. Evidence
for a functionally significant subendothelial matrix in normal rat liver”. In: J Clin Invest 79.3, pp. 801–12.
doi: 10.1172/jci112887.
Bissell, D. M. and P. S. Guzelian (1980). “Phenotypic stability of adult rat hepatocytes in primary monolayer
culture”. In: Ann N Y Acad Sci 349, pp. 85–98. doi: 10.1111/j.1749-6632.1980.tb29518.x.
14
Bissell, M. J., P. A. Kenny, and D. C. Radisky (2005). “Microenvironmental regulators of tissue structure
and function also regulate tumor induction and progression: The role of extracellular matrix and its
degrading enzymes”. In: Molecular Approaches to Controlling Cancer 70, pp. 343–356. doi: 10.1101/
sqb.2005.70.013.
Bort, R. et al. (2006). “Hex homeobox gene controls the transition of the endoderm to a pseudostratified,
cell emergent epithelium for liver bud development”. In: Dev Biol 290.1, pp. 44–56. doi: 10.1016/j.
ydbio.2005.11.006.
Brafman, D. A., S. de Minicis, et al. (2009). “Investigating the role of the extracellular environment in
modulating hepatic stellate cell biology with arrayed combinatorial microenvironments”. In: Integr Biol
(Camb) 1.8-9, pp. 513–24. doi: 10.1039/b912926j.
Brafman, D. A., K. D. Shah, et al. (2009). “Defining long-term maintenance conditions of human embryonic
stem cells with arrayed cellular microenvironment technology”. In: Stem Cells Dev 18.8, pp. 1141–54.
doi: 10.1089/scd.2008.0410.
Braga Malta, D. F. et al. (2016). “Extracellular matrix microarrays to study inductive signaling for endoderm
specification”. In: Acta Biomater 34, pp. 30–40. doi: 10.1016/j.actbio.2016.02.014.
Butler, J. P. et al. (2002). “Traction fields, moments, and strain energy that cells exert on their surroundings”.
In: Am J Physiol Cell Physiol 282.3, pp. C595–C605. doi: 10.1152/ajpcell.00270.2001.
Chambers, A. F. et al. (1996). “Osteopontin expression in lung cancer”. In: Lung Cancer 15.3, pp. 311–23.
doi: 10.1016/0169-5002(95)00595-1.
Chen, C. S. et al. (2003). “Cell shape provides global control of focal adhesion assembly”. In: Biochem Biophys
Res Commun 307.2, pp. 355–361. doi: 10.1016/S0006-291X(03)01165-3.
Clotman, F. et al. (2005). “Control of liver cell fate decision by a gradient of TGFβ signaling modulated by
Onecut transcription factors”. In: Genes Dev 19.16, pp. 1849–54. doi: 10.1101/gad.340305.
DeForest, C. A. and K. S. Anseth (2012). “Photoreversible Patterning of Biomolecules within Click-Based
Hydrogels”. In: Angewandte Chemie 124.8, pp. 1852–1855. doi: 10.1002/ange.201106463.
Donati, V. et al. (2005). “Osteopontin expression and prognostic significance in non-small cell lung cancer”.
In: Clin Cancer Res 11.18, pp. 6459–65. doi: 10.1158/1078-0432.CCR-05-0541.
Doyle, A. D. et al. (2009). “One-dimensional topography underlies three-dimensional fibrillar cell migration”.
In: The Journal of cell biology 184.4, pp. 481–490. doi: 10.1083/jcb.200810041.
Drury, J. L. and D. J. Mooney (2003). “Hydrogels for tissue engineering: scaffold design variables and
applications”. In: Biomaterials 24.24, pp. 4337–4351. doi: 10.1016/s0142-9612(03)00340-5.
15
Dunn, J. C. et al. (1989). “Hepatocyte function and extracellular matrix geometry: long-term culture in a
sandwich configuration”. In: FASEB J 3.2, pp. 174–7.
Engler, A. J. et al. (2006). “Matrix Elasticity Directs Stem Cell Lineage Specification”. In: Cell 126.4,
pp. 677–89. doi: 10.1016/j.cell.2006.06.044.
Engler, A. et al. (2004). “Substrate Compliance versus Ligand Density in Cell on Gel Responses”. In: Biophys
J 86.1 Pt 1, pp. 617–28. doi: 10.1016/s0006-3495(04)74140-5.
Fernandes, T. G. et al. (2010). “Three-dimensional cell culture microarray for high-throughput studies of
stem cell fate”. In: Biotechnol Bioeng 106.1, pp. 106–118. doi: 10.1002/bit.22661.
Fink, J. et al. (2007). “Comparative study and improvement of current cell micro-patterning techniques”. In:
Lab Chip 7.6, pp. 672–680. doi: 10.1039/b618545b.
Flaim, C. J., S. Chien, and S. N. Bhatia (2005). “An extracellular matrix microarray for probing cellular
differentiation”. In: Nat Methods 2.2, pp. 119–125. doi: 10.1038/nmeth736.
Georges, P. C. et al. (2007). “Increased stiffness of the rat liver precedes matrix deposition: implications for
fibrosis”. In: Am J Physiol Gastrointest Liver Physiol 293.6, G1147–54. doi: 10.1152/ajpgi.00032.2007.
Gibbons, D. L. et al. (2009). “Contextual extracellular cues promote tumor cell EMT and metastasis by
regulating miR-200 family expression”. In: Genes Dev 23.18, pp. 2140–51. doi: 10.1101/gad.1820209.
Gill, B. J. et al. (2012). “A synthetic matrix with independently tunable biochemistry and mechanical
properties to study epithelial morphogenesis and EMT in a lung adenocarcinoma model”. In: Cancer Res
72.22, pp. 6013–23. doi: 10.1158/0008-5472.CAN-12-0895.
Gobaa, S. et al. (2011). “Artificial niche microarrays for probing single stem cell fate in high throughput”.
In: Nat Methods 8.11, pp. 949–955. doi: 10.1038/nmeth.1732.
Gordillo, M., T. Evans, and V. Gouon-Evans (2015). “Orchestrating liver development”. In: Development
142.12, pp. 2094–2108. doi: 10.1242/dev.114215.
Hodkinson, P. S., A. C. Mackinnon, and T. Sethi (2007). “Extracellular matrix regulation of drug resistance
in small-cell lung cancer”. In: Int J Radiat Biol 83.11-12, pp. 733–41. doi: 10.1080/09553000701570204.
Hsiao, A. Y. et al. (2012). “384 hanging drop arrays give excellent Z-factors and allow versatile formation of
co-culture spheroids”. In: Biotechnol Bioeng 109.5, pp. 1293–1304. doi: 10.1002/bit.24399.
James, C. et al. (1998). “Patterned protein layers on solid substrates by thin stamp microcontact printing”.
In: Langmuir 14.4, pp. 741–744. doi: 10.1021/la9710482.
Jeliazkova, P. et al. (2013). “Canonical Notch2 signaling determines biliary cell fates of embryonic hepato-
blasts and adult hepatocytes independent of Hes1”. In: Hepatology 57.6, pp. 2469–79. doi: 10.1002/hep.
26254.
16
Jonczyk, R. et al. (2016). “Living Cell Microarrays: An Overview of Concepts”. In: Microarrays (Basel) 5.2.
doi: 10.3390/microarrays5020011.
Kaylan, K. B., A. P. Kourouklis, and G. H. Underhill (2017). “A high-throughput cell microarray platform
for correlative analysis of cell differentiation and traction forces”. In: Journal of visualized experiments:
JoVE 121. doi: 10.3791/55362.
Kaylan, K. B. and G. H. Underhill (2016). “Hydrogels for Hepatic Tissue Engineering”. In: Gels Hand-
book: Fundamentals, Properties and Applications, Volume 2: Applications of Hydrogels in Regenerative
Medicine. Ed. by M. Abidian, U. Gurkan, and F. Edalat. doi: 10.1142/9789813140394_0015.
Kilian, K. A. et al. (2010). “Geometric cues for directing the differentiation of mesenchymal stem cells”. In:
Proc Natl Acad Sci U S A 107.11, p. 4872. doi: 10.1073/pnas.0903269107.
Kloxin, A. M. et al. (2010). “Tunable hydrogels for external manipulation of cellular microenvironments
through controlled photodegradation”. In: Adv Mater 22.1, pp. 61–66. doi: 10.1002/adma.200900917.
Kopeček, J. and J. Yang (2007). “Hydrogels as smart biomaterials”. In: Polym Int 56.9, pp. 1078–1098. doi:
10.1002/pi.2253.
Kurth, I. et al. (2009). “Hematopoietic stem and progenitor cells in adhesive microcavities”. In: Integr Biol
1.5-6, pp. 427–434. doi: 10.1039/b903711j.
LaBarge, M. A. et al. (2009). “Human mammary progenitor cell fate decisions are products of interactions
with combinatorial microenvironments”. In: Integr Biol (Camb) 1.1, pp. 70–9. doi: 10.1039/b816472j.
Lade, A. G. and S. P. S. Monga (2010). “β-catenin signaling in hepatic development and progenitors: Which
way does the WNT blow?” In: Dev Dyn 240.3, pp. 486–500. doi: 10.1002/dvdy.22522.
Lange, S. A. et al. (2004). “Microcontact printing of DNA molecules”. In: Anal Chem 76.6, pp. 1641–1647.
doi: 10.1021/ac035127w.
Lee, K. Y. and D. J. Mooney (2001). “Hydrogels for Tissue Engineering”. In: Chem Rev 101.7, pp. 1869–1880.
doi: 10.1021/cr000108x.
Lee, M.-Y. et al. (2008). “Three-dimensional cellular microarray for high-throughput toxicology assays”. In:
Proc Natl Acad Sci U S A 105.1, pp. 59–63. doi: 10.1073/pnas.0708756105.
Lehnert, D. et al. (2004). “Cell behaviour on micropatterned substrata: limits of extracellular matrix geom-
etry for spreading and adhesion”. In: J Cell Sci 117.1, pp. 41–52. doi: 10.1242/jcs.00836.
Li, L. et al. (1997). “Alagille syndrome is caused by mutations in human Jagged1, which encodes a ligand
for Notch1”. In: Nat Genet 16.3, pp. 243–51. doi: 10.1038/ng0797-243.
Li, X. et al. (2014). “Micro-scaffold array chip for upgrading cell-based high-throughput drug testing to 3D
using benchtop equipment”. In: Lab Chip 14.3, pp. 471–481. doi: 10.1039/c3lc51103k.
17
Li, Z. et al. (2007). “Transforming growth factor-β and substrate stiffness regulate portal fibroblast activation
in culture”. In: Hepatology 46.4, pp. 1246–1256. doi: 10.1002/hep.21792.
Lin, C.-C. and K. S. Anseth (2009). “PEG hydrogels for the controlled release of biomolecules in regenerative
medicine”. In: Pharm Res 26.3, pp. 631–643. doi: 10.1007/s11095-008-9801-2.
Lopez, G. P. et al. (1993). “Convenient methods for patterning the adhesion of mammalian cells to surfaces
using self-assembled monolayers of alkanethiolates on gold”. In: J Am Chem Soc 115.13, pp. 5877–5878.
doi: 10.1021/ja00066a087.
Lutolf, M. P. et al. (2009). “Perturbation of single hematopoietic stem cell fates in artificial niches”. In: Integr
Biol 1 (1), pp. 59–69. doi: 10.1039/B815718A.
Mackinnon, A. C. et al. (2012). “Regulation of transforming growth factor-β1-driven lung fibrosis by galectin-
3”. In: Am J Respir Crit Care Med 185.5, pp. 537–546. doi: 10.1164/rccm.201106-0965OC.
Martinez-Hernandez, A. and P. S. Amenta (1993). “The hepatic extracellular matrix. II. Ontogenesis, re-
generation and cirrhosis”. In: Virchows Arch A Pathol Anat Histopathol 423.2, pp. 77–84. doi: 10.1007/
bf01606580.
McBeath, R. et al. (2004). “Cell shape, cytoskeletal tension, and RhoA regulate stem cell lineage commit-
ment”. In: Dev Cell 6.4, pp. 483–95. doi: 10.1016/s1534-5807(04)00075-9.
McDaniell, R. et al. (2006). “NOTCH2 mutations cause Alagille syndrome, a heterogeneous disorder of the
notch signaling pathway”. In: Am J Hum Genet 79.1, pp. 169–73. doi: 10.1086/505332.
Meads, M. B., R. A. Gatenby, and W. S. Dalton (2009). “Environment-mediated drug resistance: a major
contributor to minimal residual disease”. In: Nat Rev Cancer 9.9, pp. 665–674. doi: 10.1038/nrc2714.
Micsenyi, A. et al. (2004). “β-Catenin is temporally regulated during normal liver developmentI”. In: Gas-
troenterology 126.4, pp. 1134–1146. doi: 10.1053/j.gastro.2003.12.047.
Mishina, Y. M. et al. (2004). “Multiplex GPCR assay in reverse transfection cell microarrays”. In: J Biomol
Screening 9.3, pp. 196–207. doi: 10.1177/1087057103261880.
Mooney, D. et al. (1992). “Switching from differentiation to growth in hepatocytes: Control by extracellular
matrix”. In: J Cell Physiol 151.3, pp. 497–505. doi: 10.1002/jcp.1041510308.
Mrksich, M. et al. (1997). “Using microcontact printing to pattern the attachment of mammalian cells to
self-assembled monolayers of alkanethiolates on transparent films of gold and silver”. In: Exp Cell Res
235.2, pp. 305–313. doi: 10.1006/excr.1997.3668.
Nelson, C. M. and C. S. Chen (2002). “Cell-cell signaling by direct contact increases cell proliferation via a
PI3K-dependent signal”. In: FEBS Lett 514.2-3, pp. 238–242. doi: 10.1016/s0014-5793(02)02370-0.
18
Nelson, C. M. and C. S. Chen (2003). “VE-cadherin simultaneously stimulates and inhibits cell proliferation
by altering cytoskeletal structure and tension”. In: J Cell Sci 116.Pt 17, pp. 3571–81. doi: 10.1242/jcs.
00680.
Nelson, C. M., D. M. Pirone, et al. (2004). “Vascular endothelial-cadherin regulates cytoskeletal tension,
cell spreading, and focal adhesions by stimulating RhoA”. In: Mol Biol Cell 15.6, pp. 2943–53. doi:
10.1091/mbc.e03-10-0745.
Oda, T. et al. (1997). “Mutations in the human Jagged1 gene are responsible for Alagille syndrome”. In: Nat
Genet 16.3, pp. 235–42. doi: 10.1038/ng0797-235.
Peppas, N. et al. (2006). “Hydrogels in Biology and Medicine: From Molecular Principles to Bionanotech-
nology”. In: Adv Mater 18.11, pp. 1345–1360. doi: 10.1002/adma.200501612.
Pickup, M. W., J. K. Mouw, and V. M. Weaver (2014). “The extracellular matrix modulates the hallmarks
of cancer”. In: EMBO Rep 15.12, pp. 1243–53. doi: 10.15252/embr.201439246.
Rana, B. et al. (1994). “Cell-extracellular matrix interactions can regulate the switch between growth and
differentiation in rat hepatocytes: reciprocal expression of C/EBP alpha and immediate-early growth
response transcription factors.” In: Mol Cell Biol 14.9, pp. 5858–5869. doi: 10.1128/mcb.14.9.5858.
Ranga, A. et al. (2014). “3D niche microarrays for systems-level analyses of cell fate”. In: Nat Commun 5.
doi: 10.1038/ncomms5324.
Reticker-Flynn, N. E. and S. N. Bhatia (2015). “Aberrant glycosylation promotes lung cancer metastasis
through adhesion to galectins in the metastatic niche”. In: Cancer Discov 5.2, pp. 168–81. doi: 10.1158/
2159-8290.CD-13-0760.
Reticker-Flynn, N. E., D. F. B. Malta, et al. (2012). “A combinatorial extracellular matrix platform identifies
cell-extracellular matrix interactions that correlate with metastasis”. In: Nat Commun 3, p. 1122. doi:
10.1038/ncomms2128.
Rosso, F. et al. (2005). “Smart materials as scaffolds for tissue engineering”. In: J Cell Physiol 203.3, pp. 465–
470. doi: 10.1002/jcp.20270.
Ruiz, S. A. and C. S. Chen (2008). “Emergence of patterned stem cell differentiation within multicellular
structures”. In: Stem Cells 26.11, pp. 2921–7. doi: 10.1634/stemcells.2008-0432.
Schmidt, C. et al. (1995). “Scatter factor/hepatocyte growth factor is essential for liver development”. In:
Nature 373.6516, pp. 699–702. doi: 10.1038/373699a0.
Seliktar, D. (2012). “Designing cell-compatible hydrogels for biomedical applications.” In: Science 336 (6085),
pp. 1124–1128. doi: 10.1126/science.1214804.
19
Semler, E. J. et al. (2005). “Engineering hepatocellular morphogenesis and function via ligand-presenting
hydrogels with graded mechanical compliance”. In: Biotechnol Bioeng 89.3, pp. 296–307.
Sethi, T. et al. (1999). “Extracellular matrix proteins protect small cell lung cancer cells against apoptosis:
a mechanism for small cell lung cancer growth and drug resistance in vivo”. In: Nat Med 5.6, pp. 662–8.
doi: 10.1038/9511.
Shah, P. P., M. Y. Fong, and S. S. Kakar (2012). “PTTG induces EMT through integrin ανβ3-focal adhesion
kinase signaling in lung cancer cells”. In: Oncogene 31.26, pp. 3124–35. doi: 10.1038/onc.2011.488.
Shin, D. and S. P. S. Monga (2013). “Cellular and molecular basis of liver development”. In: Comprehensive
Physiology. doi: 10.1002/cphy.c120022.
Silva, J. M. et al. (2004). “RNA interference microarrays: High-throughput loss-of-function genetics in mam-
malian cells”. In: Proc Natl Acad Sci U S A 101.17, pp. 6548–6552. doi: 10.1073/pnas.0400165101.
Singhvi, R. et al. (1994). “Engineering cell shape and function”. In: Science, pp. 696–696. doi: 10.1126/
science.8171320.
Soen, Y. et al. (2006). “Exploring the regulation of human neural precursor cell differentiation using arrays
of signaling microenvironments”. In: Mol Syst Biol 2, p. 37. doi: 10.1038/msb4100076.
Tam, P. P. L., E. A. Williams, and W. Y. Chan (1993). “Gastrulation in the mouse embryo: Ultrastructural
and molecular aspects of germ layer morphogenesis”. In: Microsc Res Tech 26.4, pp. 301–328. doi: 10.
1002/jemt.1070260405.
Théry, M. et al. (2006). “Cell distribution of stress fibres in response to the geometry of the adhesive
environment”. In: Cell Motil Cytoskeleton 63.6, pp. 341–355. doi: 10.1002/cm.20126.
Thibault, C. et al. (2005). “Direct microcontact printing of oligonucleotides for biochip applications”. In:
Journal of nanobiotechnology 3.1, p. 7. doi: 10.1186/1477-3155-3-7.
Tremblay, K. D. and K. S. Zaret (2005). “Distinct populations of endoderm cells converge to generate the
embryonic liver bud and ventral foregut tissues”. In: Dev Biol 280.1, pp. 87–99. doi: 10.1016/j.ydbio.
2005.01.003.
Trepat, X. et al. (2009). “Physical forces during collective cell migration”. In: Nat Phys 5.6, pp. 426–430.
doi: 10.1038/Nphys1269.
Tung, Y.-C. et al. (2011). “High-throughput 3D spheroid culture and drug testing using a 384 hanging drop
array”. In: Analyst 136.3, pp. 473–478. doi: 10.1039/c0an00609b.
Underhill, G. H. (2012). “Stem cell bioengineering at the interface of systems-based models and high-
throughput platforms”. In: Wiley Interdiscip Rev Syst Biol Med 4.6, pp. 525–45. doi: 10.1002/wsbm.
1189.
20
Venkatesh, S. K. and R. L. Ehman (2014). “Magnetic resonance elastography of liver”. In: Magn Reson
Imaging Clin N Am 22.3, pp. 433–46. doi: 10.1016/j.mric.2014.05.001.
Wang, J. H.-C. and J.-S. Lin (2007). “Cell traction force and measurement methods”. In: Biomech Model
Mechanobiol 6.6, pp. 361–71. doi: 10.1007/s10237-006-0068-4.
Wen, J. H. et al. (2014). “Interplay of matrix stiffness and protein tethering in stem cell differentiation”. In:
Nat Mater 13.10, pp. 979–87. doi: 10.1038/nmat4051.
Wilson, J. W., C. S. Groat, and E. H. Leduc (1963). “Histogenesis of the liver”. In: Ann N Y Acad Sci 111.1,
pp. 8–24. doi: 10.1111/j.1749-6632.1963.tb36945.x.
Wood, K. C. et al. (2012). “MicroSCALE screening reveals genetic modifiers of therapeutic response in
melanoma”. In: Sci Signal 5.224, rs4. doi: 10.1126/scisignal.2002612.
Yeh, W. C. et al. (2002). “Elastic modulus measurements of human liver and correlation with pathology”.
In: Ultrasound Med Biol 28.4, pp. 467–74. doi: 10.1016/s0301-5629(02)00489-1.
Yin, M. et al. (2007). “Assessment of hepatic fibrosis with magnetic resonance elastography”. In: Clin Gas-
troenterol Hepatol 5.10, 1207–1213.e2.
Zaret, K. S. (2001). “Hepatocyte differentiation: from the endoderm and beyond”. In: Curr Opin Genet Dev
11.5, pp. 568–574. doi: 10.1016/s0959-437x(00)00234-3.
Zhu, J. (2010). “Bioactive modification of poly (ethylene glycol) hydrogels for tissue engineering”. In: Bio-
materials 31.17, pp. 4639–4656. doi: 10.1016/j.biomaterials.2010.02.044.
Ziauddin, J. and D. M. Sabatini (2001). “Microarrays of cells expressing defined cDNAs”. In: Nature 411.6833,
pp. 107–10. doi: 10.1038/35075114.
Zong, Y. et al. (2009). “Notch signaling controls liver development by regulating biliary differentiation”. In:
Development 136.10, pp. 1727–39. doi: 10.1242/dev.029140.
21
Chapter 2
Combinatorial microenvironmental
regulation of liver progenitor
differentiation by Notch ligands, TGFβ,
and extracellular matrix∗
2.1 Abstract
The bipotential differentiation of liver progenitor cells underlies liver development and bile duct formation
as well as liver regeneration and disease. TGFβ and Notch signaling are known to play important roles in
the liver progenitor specification process and tissue morphogenesis. However, the complexity of these sig-
naling pathways and their currently undefined interactions with other microenvironmental factors, including
extracellular matrix (ECM), remain barriers to complete mechanistic understanding. Utilizing a series of
strategies, including co-cultures and cellular microarrays, we identified distinct contributions of different
Notch ligands and ECM proteins in the fate decisions of bipotential mouse embryonic liver (BMEL) progen-
itor cells. In particular, we demonstrated a cooperative influence of Jagged-1 and TGFβ1 on cholangiocytic
differentiation. We established ECM-specific effects using cellular microarrays consisting of 32 distinct com-
binations of collagen I, collagen III, collagen IV, fibronectin, and laminin. In addition, we demonstrated that
exogenous Jagged-1, Delta-like 1, and Delta-like 4 within the cellular microarray format was sufficient for en-
hancing cholangiocytic differentiation. Further, by combining Notch ligand microarrays with shRNA-based
knockdown of Notch ligands, we systematically examined the effects of both cell-extrinsic and cell-intrinsic
ligand. Our results highlight the importance of divergent Notch ligand function and combinatorial microen-
vironmental regulation in liver progenitor fate specification.
2.2 Introduction
Microenvironmental regulation plays a key role in stem and progenitor cell fate in development. Within
the liver, progenitor cell differentiation and bile duct morphogenesis are driven by spatially-dependent and
∗This work was previously published by Nature Publishing Group (London, United Kingdom) in the journal Scientific
Reports (Kaylan et al. 2016) and is reproduced here under the terms of the Creative Commons Attribution 4.0 International
License (https://creativecommons.org/licenses/by/4.0/).
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temporally-sequenced cell–cell and cell–factor interactions coordinated by several signaling pathways, namely
Notch and TGFβ (Clotman, Jacquemin, et al. 2005; Kodama et al. 2004; Tanimizu and Miyajima 2004; Zong
et al. 2009). During fetal liver development, a decreasing spatial gradient of TGFβ from the portal vein
delineates cholangiocytic versus hepatocytic differentiation of bipotential liver progenitors (Clotman and
Lemaigre 2006). NOTCH2 and JAG1 activity is required for both cholangiocytic fate specification and
formation of mature intrahepatic bile ducts (Hofmann et al. 2010; Jeliazkova et al. 2013; Loomes et al.
2007; Lozier et al. 2008; Tchorz et al. 2009). The importance of Notch in bile duct morphogenesis is further
highlighted by Alagille syndrome, an autosomal dominant genetic disorder caused by mutations in NOTCH2
or JAG1 and associated with paucity of intrahepatic bile ducts, neonatal jaundice, cholestasis, and other
abnormalities (Alagille et al. 1987; Li et al. 1997; McDaniell et al. 2006; Oda et al. 1997). Moreover,
extracellular matrix (ECM) proteins are known to regulate both fate specification and morphogenesis, as
demonstrated by enhanced induction of bile duct epithelium by collagen I and Matrigel (Tanimizu, Miyajima,
and Mostov 2007; Yanai et al. 2008), β1 integrin-mediated regulation of apicobasal polarity and subsequent
morphogenesis by α1- and α5-containing laminin (Tanimizu, Kikkawa, et al. 2012), and activation of genes
encoding ECM proteins by Sox9, a specific early marker of biliary epithelial cells, and Sox4 (Hanley et al.
2008; Poncy et al. 2015).
In addition to normal tissue development, duct morphogenesis also occurs in the adult liver in response
to severe and chronic injury (Roskams et al. 2004). These so-called ductular reactions exhibit highly variable
differentiation patterns and have been demonstrated to significantly contribute to proliferative response in the
liver (Gouw et al. 2011). Notably, Notch signaling activation has been shown to be an important component
of biliary regeneration in ductular reactions associated with chronic disease (Boulter et al. 2012). Changes
in ECM have also been suggested to be involved as ECM remodeling occurs during ductular reactions in
rodent models (Lorenzini et al. 2010; Van Hul et al. 2009). In particular, proliferating progenitor cells
within these ductular reactions have been associated with the turnover of collagen I and the deposition
of basement membrane structures containing laminin (Williams et al. 2014). Collectively, despite many
insights gained into the pathways involved in liver progenitor specification, the complete mechanistic details
of the link between liver progenitor cell fate and liver duct morphogenesis as well as the combined impact
of feedback between Notch, TGFβ, and ECM proteins remain unclear. Thus, an approach capable of
simultaneously probing combinatorial microenvironmental regulation by cell–cell, cell–soluble factor, and
cell–matrix interactions is required in order to define the functional overlap of these distinct pathways.
Mechanistic studies of Notch are difficult due not only to partially redundant function of receptors and
ligands but also highly context-dependent pathway activity and function (Andersson et al. 2011; Artavanis-
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Tsakonas et al. 1999; Bray 2006). Cell–cell contact and binding of receptor (NOTCH1–4) to ligand (JAG1,
JAG2, DLL1, DLL3, and DLL4) triggers cleavage of the receptor by ADAM metalloproteases and the γ-
secretase complex, freeing the Notch intracellular domain to localize to the nucleus and mediate gene tran-
scription through interactions with the DNA-binding protein RBPJ-κ. Even in contexts for which key Notch
ligand–receptor pairs have been identified, such as NOTCH2–JAG1 for Alagille syndrome, function remains
highly dependent on cell type and microenvironmental context. In particular, the degree of Notch signaling
activation can be substantially influenced by interactions with other pathways. For hepatocyte regeneration
in the setting of chronic liver injury, for example, activation of the Wnt pathway in liver progenitor cells
causes an inhibition of Notch signaling, preventing cholangiocyte differentiation and promoting hepatocyte
differentiation (Boulter et al. 2012). Relevant in vitro methods for studying regulation by specific Notch
receptors or ligands include ligand immobilization (Varnum-Finney, Purton, et al. 1998; Varnum-Finney,
L. Z. Wu, et al. 2000) antibody-mediated functional blocking of specific receptors (Tran et al. 2013; Y. Wu
et al. 2010) and treatment with soluble Notch ligand peptide (Nickoloff et al. 2002). Here, we exploited
a cellular microarray platform, which exhibits well-defined material properties and unique capabilities for
simultaneously examining multiple types of microenvironmental regulation (Brafman et al. 2012; Flaim et
al. 2005; Underhill et al. 2009). Using this approach, we investigated liver progenitor differentiation within
defined microenvironments consisting of systematically introduced soluble factors, ECM components, and
cell–cell signaling ligands.
In this study, we demonstrate a cooperative role of Notch and TGFβ in liver progenitor fate specifica-
tion, including unique effects of the Notch ligands Jag1 and Dll1 on the differentiation process. Utilizing a
co-culture format together with shRNA-mediated knockdown of Jag1 or Dll1, we explored the cell-extrinsic
versus cell-intrinsic influence of these ligands. In addition, a cellular microarray platform was used to quan-
tify microenvironmental regulation by five ECM proteins (collagen I, collagen III, collagen IV, fibronectin,
and laminin) for all 32 (25) possible combinations. We further adapted this microarray platform to include
highly-functional Protein A/G-conjugated Notch ligands, showing induction of cholangiocytic differentiation
by exogenous (cell-extrinsic) presentation of JAG1, DLL1, and DLL4 dependent on ECM and cell-intrinsic
expression of Jag1 and Dll1. In summary, our study of liver progenitor fate specification implicates combi-
natorial interactions between Notch, TGFβ and ECM proteins and further suggests that the Notch ligand
Dll1 may exhibit effects distinct from Jag1 in hepatocytic and cholangiocytic differentiation.
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2.3 Methods
2.3.1 Cell culture, differentiation experiments, and treatments
BMEL 9A1 cells used in this study were between passages 26 and 35 and were cultured as previously
described (Strick-Marchand and Weiss 2002). Briefly, cells were seeded on tissue culture plastic coated
with collagen I (0.5 mg/ml) and cultured in an incubator under controlled conditions (37°C and 5% CO2).
Trypsin-EDTA (0.25% v/v) was used to detach cells for passaging. Basal (growth) media consisted of
RPMI 1640 + GlutaMAX (Life Technologies, 61870-127) supplemented with fetal bovine serum (10% v/v,
FBS), penicillin/streptomycin (1% v/v, P/S), and freshly-added human recombinant insulin (10 µg/ml, Life
Technologies, 12585-014), IGF-2 (30 ng/ml, PeproTech, 100-12), and EGF (50 ng/ml, PeproTech, AF-100-
15). Differentiation media consisted of Advanced RPMI 1640 (Life Technologies, 12633-012) supplemented
with FBS (2% v/v), P/S (0.5% v/v), L-glutamine (1% v/v), and minimum non-essential amino acids (1%
v/v, Life Technologies, 11140-050). During differentiation experiments, cells were seeded at 104E3 cells/cm2
and cultured for 72 h with a media change at 48 h unless otherwise noted. Differentiation experiments
included the following treatments: TGFβ1 (1.5 ng/ml unless otherwise noted, R&D Systems, 240-B-002),
GSI X (5 µM, EMD Millipore, 565771), and SB-431542 (10 µM, Sigma-Aldrich, S4317). For microarray
experiments, cells were seeded at 2E6 cells/slide (106E3 cells/cm2) and allowed to adhere to patterned ECM
domains for 2 h before washing 2× with media and adding experiment-specific treatments.
2.3.2 shRNA lentivirus-mediated knockdown of Notch ligands
MISSION TRC shRNA lentiviral particles (Sigma-Aldrich) were used to transduce BMEL cells with a non-
mammalian control sequence, Jag1 -targeting sequence, and Dll1 -targeting sequence per the manufacturer’s
instructions at a multiplicity of infection (MOI) of 20–30 (see Appendix A.1 for TRC clone IDs and se-
quences). Cells were selected using puromycin (1.25 µg/ml) for 29–34 h after transduction (at which point
untransduced cells were no longer viable) and subsequently cultured under reduced puromycin (0.625 µg/ml)
for at least 1–2 passages to avoid toxicity before banking in liquid nitrogen. qRT-PCR analysis indicated
67% knockdown for Jag1 and 78% knockdown for Dll1 while immunoblot further confirmed 73% knock-
down for Jag1 (Figure A.3). Puromycin selection was removed from the cells starting the passage before an
experiment through endpoint.
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2.3.3 Immunoblot
Cell lysates were collected using ice-cold RIPA lysis buffer (Thermo Scientific, 89900) with an EDTA-free
protease inhibitor cocktail (Thermo Scientific, 78425) per the manufacturer’s instructions. Samples were
immediately pulse sonicated 3× and centrifuged at 14,000×g for 15 min at 4°C to remove cell debris. A
BCA protein assay (Thermo Scientific, 23225) was performed in 96-well microplates per the manufacturer’s
instructions to determine total protein concentrations. Isodiluted samples were further diluted in 4× Laemmli
sample buffer and 2-mercaptoethanol (50 mM), denatured at 95°C for 5 min, and loaded into a pre-cast 4–
20% polyacrylamide gel (Bio-Rad, 567-1093) at 50 µg/well. The gel was run in 1× tris/glycine/SDS at 200
V and 33-43 mA for 43-45 min. Transfer to a 0.45 µm PVDF membrane (EMD Millipore, IPVH00010)
occurred in 1× tris/glycine and methanol (20% v/v) at 100 V using plate electrodes for 30 min, after
which the membrane was placed in a blocking solution of non-fat dry milk (5% w/v) in wash buffer (1×
tris-buffered saline and Tween-20 [0.05% w/v]) for 1 h with agitation. The membrane was subsequently
incubated overnight on an orbital shaker at 4°C in wash buffer with bovine serum albumin (5% w/v, BSA)
and rabbit anti-JAG1 monoclonal antibody (56 ng/ml, 1/10,000 dilution from stock, Abcam, ab109536).
After 3×10 min rinses with wash buffer, the membrane was incubated with a solution of HRP-linked anti-
rabbit IgG (1/3,000 dilution from stock, Cell Signaling, 7074S) in wash buffer with non-fat dry milk (5%
w/v) for 1 h at room temperature. The membrane was subsequently rinsed 6×5 min with wash buffer,
incubated for 5 min with chemiluminescent substrate (Thermo Scientific, 34080), and imaged (ChemiDoc
XRS Imaging System, Bio-Rad). To confirm equal protein loading, membranes were treated with stripping
buffer (Thermo Scientific, 21059) and labeled with monoclonal rabbit anti-β-actin (1/1,000 from stock, Cell
Signaling, 4970S) using the same protocol. Protein content was quantified with Quantity One software
(Bio-Rad); background was automatically subtracted.
2.3.4 RNA isolation and qRT-PCR analysis
Cell lysates were collected in TRIzol solution (Life Technologies, 15596-026) from which RNA was isolated
using phenol-chloroform extraction per the manufacturer’s instructions. Samples were subsequently digested
with DNAse (New England Biolabs, M0303S) at 37°C for 30 min and cleaned using an RNeasy Mini Kit
(Qiagen, 74104) per the manufacturer’s instructions. RNA concentration was obtained by UV spectroscopy
using a NanoDrop ND-1000 (Thermo Scientific); samples with a 260 nm/280 nm absorbance ratio <1.8 were
discarded. cDNA from isolated RNA (500 ng unless otherwise specified) was generated using the iScript
cDNA synthesis kit (Bio-Rad, 170-8891) and mixed with SsoAdvanced Universal SYBR Green Supermix
(Bio-Rad, 1725264) with pre-added primer pairs at a final concentration of 100 nM/primer, again per the
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manufacturer’s instructions. Primer pairs for each gene of interest were designed using the NCBI’s Primer-
BLAST (Ye et al. 2012) with a target Tm of 60°C (see Supplemental Methods for GenBank accession numbers
and sequences). Thermal cycling and measurement of amplification curves were performed on a CFX Connect
Real-Time PCR Detection System (Bio-Rad). Expression (i.e., 2−∆∆Ct) analysis was performed in R using
a custom script (R Core Team 2014). mRNA expression was calculated relative to Hprt1 and control samples
as indicated.
2.3.5 Immunofluorescence
Before double immunofluorescence for ALB and OPN, cells were treated with brefeldin A (10 µg/ml,
R&D Systems, 1231/5), an inhibitor of protein translocation to Golgi, for 2 h. Cells were then fixed in
paraformaldehyde (4% v/v in 1× phosphate buffered saline [PBS]) for 15 min and permeabilized in Tri-
ton X-100 (0.25% v/v in 1× PBS). After 1 h at room temperature in blocking buffer (donkey serum [5%
v/v] in 1× PBS), samples were incubated at room temperature with mouse anti-ALB (1/50 from stock,
R&D Systems, MAB1455) and goat anti-OPN (1/60 from stock, R&D Systems, AF808) diluted in blocking
buffer. After 3×5 min washes with 1× PBS, samples were incubated at room temperature with DyLight
550-conjugated donkey anti-mouse IgG (1/50 from stock, Abcam, ab98767) and DyLight 488-conjugated
donkey anti-goat IgG (1/50 from stock, Abcam, ab96935). After another set of 3×5 min washes with 1×
PBS, samples were mounted in Fluoromount G with DAPI (Southern Biotech, 0100-20). Immunofluoresence
for arrayed proteins (namely JAG1 and DLL1) was performed as described above without the permeabiliza-
tion and mounting steps; rabbit anti-JAG1 (1/50 from stock, Abcam, ab109536), rabbit anti-DLL1 (1/200
from stock, Santa Cruz Biotechnology, sc-9202), and donkey anti-rabbit IgG (1/200 from stock, Abcam,
ab96919) were used for these experiments. Samples were imaged with an Axiovert 200M microscope (Carl
Zeiss, Inc.) and associated Zen Pro software. The tiling feature of Zen Pro was used to compile images of
entire microarrays.
2.3.6 GFP+/GFP− co-cultures
Cells were infected with a CMV-driven hr-GFP adenovirus (University of Iowa Viral Vector Core Facility,
Ad5CMVhr-GFP) at an MOI of 2,500 in differentiation media with polybrene (4 µg/ml) for 6 h, after which
cells were cultured in growth media overnight. Both GFP+ and GFP− cells were passaged the next day and
immediately co-cultured under differentiation conditions (TGFβ1±) at 96E3 GFP+ cells per 4.704E6 GFP−
cells (a 1:50 ratio) in 3×100 mm petri dishes per combination of cell type (GFP+ or GFP−). Additional
bulk monocultures of GFP− and GFP+ cell types were cultured in parallel to confirm initial basal state,
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differentiation capacity at mRNA transcript level, and expression of and sorting for GFP. After 72 h of
culture, ≤100E3 GFP+ cells were collected using a FACSAria III sorter (BD Biosciences). RNA isolation
and qRT-PCR analysis was then performed as described above with the amount of RNA varying between
150–300 ng depending on experimental yield.
2.3.7 Microarray fabrication and characterization
Microarrays were fabricated as described previously (Brafman et al. 2012; Flaim et al. 2005; Underhill et
al. 2009). Briefly, pre-cleaned microscope slides were silanized by treatment with 3-(trimethoxysilyl)propyl
methacrylate (2% v/v) in ethanol for 30 min on an orbital shaker, after which slides were washed with
ethanol for 5 min and baked on a hot plate at 110°C. Our polyacrylamide pre-polymer solution consisted of
acrylamide (10.55% w/v), bis-acrylamide (0.55% w/v), and Irgacure 2959 (2% w/v, BASF, 55047962) and
was 0.2 µm-filtered and degassed as needed. Silanized slides were coated with 100 µl pre-polymer solution,
covered with a 22×60 mm cover glass, and crosslinked using 365 nm UV A for 10 min (240E3 µJ). Fabricated
hydrogels were stored in excess dH2O with daily changes for three days and dehydrated on a hot plate at 50°C
for 15 min. Biomolecules for arraying were diluted in 2× ECM protein buffer (38% v/v glycerol in dH2O,
16.4 mg/ml sodium acetate, 3.72 mg/ml EDTA, 0.5% v/v Triton X-100, 80 ul glacial acetic acid, pH=4.8) or
2× growth factor buffer (38% v/v glycerol in 1× PBS, 10.55 mg/ml sodium acetate, 3.72 mg/ml EDTA, 10
mg/ml CHAPS) and loaded in a 384-well V-bottom microplate. ECM proteins were prepared at a final total
concentration of 250 µg/ml in 2× ECM protein buffer and included: collagen I (rat tail, EMD Millipore, 08-
115), collagen III (human, EMDMillipore, CC054), collagen IV (human, EMDMillipore, CC076), fibronectin
(human plasma, EMD Millipore, 341635), and laminin (mouse, EMD Millipore, CC095). Fc-recombinant
Notch ligand solutions were prepared in 2× growth factor buffer and included: Fc-JAG1 (150 µg/ml final,
R&D Systems, 599-JG-100), Fc-DLL1 (250 µg/ml final, R&D Systems, 5026-DL-050), and Fc-DLL4 (250
µg/ml final, Adipogen, AG-40A-0145-C050). All Notch ligand conditions were pre-conjugated with Protein
A/G (Life Technologies, 21186) at a 1:6 molar ratio (A/G:ligand) before arraying. Human IgG (970.6 µg/ml
final, R&D Systems, 1-001-A) was arrayed as a control in experiments involving Notch ligands. A robotic
benchtop microarrayer (OmniGrid Micro, Digilab) loaded with SMP3 Stealth microarray pins (ArrayIt) was
used to transfer biomolecules from source plate to polyacrylamide hydrogel substrate, producing 150 µm
arrayed domains. Fabricated arrays were stored at room temperature and 65% RH overnight and sterilized
the next morning with 30 min UVC while immersed in 1× PBS supplemented with 1% (v/v) P/S, after
which cells were seeded on arrays as described above.
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2.3.8 Quantification and analysis of microarrays
Array images were pre-processed in ImageJ and Fiji, producing 8-bit TIFF files (Schindelin et al. 2012;
Schneider et al. 2012). Image size was reduced to ≤100 MB by binning to reduce memory requirements
during computational analysis. CellProfiler was used to identify all cells on the arrays and associated
intensities in each channel for each cell (Kamentsky et al. 2011). Array locations were manually recorded
for each image using dextran-rhodamine markers included in each array and used to automatically assign a
grid location and arrayed condition for each identified cell. Each biological replicate included 2–3 technical
replicates (i.e., individual arrays). Channel intensities and other single-cell measures were normalized using
quantile normalization by biological replicate and propagated throughout the remaining analysis. R and
the ggplot2 package were used to visualize results while the plyr package performed analytical calculations
using a customized set of scripts (Wickham 2009, 2011). The percentage of cells positive for ALB or OPN in
each arrayed condition was calculated by defining a cutoff 2 s.d. above the mean of the treatment negative for
that marker, i.e., TGFβ1− for OPN and TGFβ1+ for ALB. For the Notch ligand arrays, this comparison
was performed against arrayed IgG.
2.3.9 Statistical analyses
At least three biological replicates were performed for each experiment. Data are presented as mean ± s.e.m.
Where noted, Student’s t-tests were performed in R comparing the groups of interest using options denoting
a two-tailed, two-sample comparison with unequal variance. Multiple regression analyses were performed in
R (see Appendix A.1).
2.4 Results
2.4.1 Cooperative effects of Notch and TGFβ on liver progenitor
differentiation
In order to systematically examine the microenvironmental regulatory mechanisms underlying liver progeni-
tor differentiation, we used bipotential mouse embryonic liver (BMEL) 9A1 cells as a model liver progenitor
cell type. These cells were derived from embryonic day 14 mouse embryos, can be induced to differentiate
into hepatocytes or cholangiocytes in vitro, and have further been demonstrated to exhibit bipotential differ-
entiation in vivo (Strick-Marchand, Morosan, et al. 2004; Strick-Marchand and Weiss 2002). Previous efforts
have utilized three-dimensional cell aggregate culture to induce hepatocytic differentiation of BMEL cells. To
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enable the series of studies implemented here, we first tested the capability of inducing BMEL cell differen-
tiation within high-density two-dimensional monolayer culture. Under these differentiation conditions (i.e.,
high cell seeding density and reduced serum without insulin, IGF-2, and EGF), the BMEL cells committed
to a hepatocytic fate, exhibiting an upregulation of albumin (ALB) protein (Figure 2.1A). Consistent with
the previously recognized role of TGFβ1 in cholangiocyte differentiation (Clotman, Jacquemin, et al. 2005;
Clotman and Lemaigre 2006), addition of TGFβ1 at the initiation of the differentiation cultures resulted
instead in a commitment to a cholangiocytic fate, indicated by reduced expression of ALB and upregulation
of osteopontin (OPN), a matricellular protein associated with ductular cholangiocytes but not hepatocytes
(Carpentier et al. 2011). We further examined the differentiation of BMEL cells in the presence of varied
concentrations of TGFβ1. These experiments demonstrated a dose-dependent effect of TGFβ1 on inducing
Opn mRNA expression and repressing Alb mRNA expression (Figure 2.1B). In addition, TGFβ1 treatment
increased mRNA expression of Sox9, a transcription factor known to be expressed during cholangiocyte dif-
ferentiation in vivo, and at doses of 1.5 ng/ml and greater, TGFβ1 repressed the hepatocytic transcription
factor Hnf4a (Figure A.1). Taken together, these results are consistent with the role of TGFβ1 in driving
cholangiocytic fate and suppressing hepatocytic fate. Next, we sought to determine if other pathways, in
particular Notch signaling, act together with TGFβ1 to regulate the differentiation trajectory.
Treatment with an inhibitor of Notch signaling (γ-secretase inhibitor X, GSI X) partially suppressed
cholangiocytic differentiation (Opn and Sox9 mRNA expression) in a manner dependent on TGFβ1 dose
(Figure 2.1C). Specifically, at 1.5 ng/ml of TGFβ1, GSI X partially blocked Opn mRNA transcript expres-
sion (40.2±7.74% of DMSO, P<0.001), compared to a more substantial relative repression of Opn expression
at 0.19 ng/ml (18.6±0.74% of DMSO, P<0.001). In comparison, treatment with SB-431542, an inhibitor
of TGFβ signaling, resulted in the near complete inhibition of Opn upregulation in response to TGFβ1
(2.75±0.535% of DMSO, P<0.001). In addition, SB-431542 unexpectedly downregulated Alb mRNA tran-
script expression at low TGFβ1 concentrations, which could potentially result from either off-target effects
of this inhibitor (Inman et al. 2002) or from a currently unidentified effect on autocrine signaling pathways.
We also observed upregulation of mRNA transcripts of the Notch-related transcription factors Hes1 and
Hey2 as well as the cholangiocytic marker Ggt1 by treatment with 5.0 ng/ml of TGFβ1; both GSI X and
SB-431542 downregulated all three mRNA transcripts (Figure A.2). Expression of the hepatocytic tran-
scription factor Cebpa was reduced by TGFβ1 treatment; SB-431542 (but not GSI X) served to upregulate
mRNA transcript expression to levels similar to the condition without TGFβ1 (Figure A.2).
Based on the chemical inhibition data implying potential cooperation between TGFβ and Notch signal-
ing, our next series of experiments explored the expression and the functional relevance of Notch ligands
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in BMEL cells. BMEL cells upregulated mRNA transcripts for the Notch ligands Dll1, Dll4, and Jag1
under differentiation conditions (TGFβ1±), particularly in TGFβ1+ (Figure 2.2A). Notably, Dll1 and Dll4
were upregulated under hepatocytic (TGFβ1−) and cholangiocytic (TGFβ1+) differentiation conditions,
although the upregulation was more pronounced in the presence of TGFβ1. In contrast, Jag1 was exclu-
sively upregulated in cholangiocytic (TGFβ1+) conditions. Jag2 was not induced by either differentiation
conditions or TGFβ1. As Jag1 has been implicated in previous studies of liver progenitor fate specification,
we assayed regulation of its protein product JAG1 by TGFβ1 (Figure 2.2B) and confirmed upregulation
by densitometry (Figure 2.2C). Furthermore, both GSI X and SB-431542 blocked upregulation of JAG1 by
TGFβ1, confirming positive feedback by both Notch and TGFβ signaling. Expression of β-actin remained
unchanged by treatment with GSI X and SB-431542 (Figures 2.2B and A.2). To assess the functional role
of Notch ligands in TGFβ1-mediated cholangiocytic fate specification, we employed lentiviral vectors con-
taining shRNA sequences against a non-target sequence (control), Dll1 (shDll1), and Jag1 (shJag1), and
confirmed knockdown at both mRNA transcript (Dll1 and Jag1 ) and protein levels (JAG1) by qRT-PCR
analysis and immunoblot, respectively (Figure A.3). Following differentiation induction, we observed mor-
phological differences in shJag1 and shDll1 cells that suggested an altered response to TGFβ1 (Figure A.3).
Thus, we evaluated the effects of Jag1 and Dll1 knockdown on Alb and Opn mRNA expression in response
to TGFβ1 (Figure 2.2D). Although Alb expression was not significantly affected by the knockdown of Jag1,
Dll1 knockdown appeared to have a distinct effect on Alb expression. In particular, Dll1 knockdown de-
creased Alb expression in TGFβ1− and increased Alb expression in TGFβ1+ relative to control cells. The
most substantial effect on Opn expression was measured following treatment with TGFβ1. Upon differenti-
ation in these conditions, Opn expression was reduced in Jag1 knockdown cells but remained unaffected by
knockdown of Dll1, further confirming the role of Jag1 in cholangiocytic fate specification.
2.4.2 “Knockdown co-cultures” demonstrate distinct roles for Jag1 and Dll1
ligands
Experiments assessing bulk mRNA transcript and protein levels in response to chemical inhibition or genetic
manipulation are unable to clarify whether Notch ligands work by cell-intrinsic (cell-autonomous) or cell-
extrinsic (non-cell-autonomous) mechanisms. We designed a GFP+/GFP− co-culture platform to address
these gaps in knowledge and methodology (Figure 2.3A). GFP+ BMEL cells were generated by adenoviral
transduction and mixed at a 1:50 ratio with GFP− cells. This ratio was selected to balance the need to
collect sufficient numbers of cells for endpoint analysis with the requirement that GFP+ cells not be in
contact with one another during the differentiation protocol, a cell–cell interaction that would dilute the
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results of the assay. After 72 h under differentiation conditions (±1.5 ng/ml TGFβ1), GFP+ cells were
spatially separated and primarily in contact only with GFP− cells (Figure A.4). Approximately 100,000
GFP+ cells were then collected from co-cultures by flow sorting, from which 150–300 ng of RNA was isolated
for downstream qRT-PCR analysis. Introduction of control-, shDll1-, or shJag1-infected BMEL cells into
this co-culture platform allowed for the assessment of the impact of both cell-intrinsic (i.e., GFP+) and
cell-extrinsic (i.e., GFP−) knockdown of Notch ligand.
qRT-PCR analysis of Alb, Opn, and Sox9 mRNA transcripts in RNA isolated from GFP+ cells showed
distinct roles for Jag1 and Dll1 (Figure 2.3B). In agreement with the results from bulk cell cultures,
shJag1GFP+ (shJag1GFP−) resulted in downregulation of Opn while shDll1GFP+ (shDll1GFP−) had mini-
mal impact. In addition, shDll1GFP+ (shJag1GFP−) resulted in downregulation of Opn to a level similar
to shJag1GFP+ (shJag1GFP−). These results imply that Opn upregulation results from the combined effect
of cell-intrinsic and cell-extrinsic Jag1 expression, and that Dll1 may cooperate with Jag1 to mediate this
upregulation. Interestingly, shDll1GFP+ (controlGFP−) and shDll1GFP+ (shDll1GFP−) conditions indepen-
dently exhibited elevated Alb, which is consistent with the relative increase in Alb expression in TGFβ1−
for Dll1 knockdown cells (Figure 2.2D). These data suggest that Dll1 may act in a cell-intrinsic manner
to repress Alb expression in response to TGFβ1−induced differentiation. The relative expression levels of
Sox9 were generally consistent with Opn, with a few exceptions. In particular, Sox9 was not upregulated in
the controlGFP+ (shDll1GFP−) and shDll1GFP+ (shDll1GFP−) conditions following TGFβ1 treatment, sug-
gesting that Sox9 upregulation is most significantly dependent on cell-extrinsic Dll1 signaling. Divergence
from expected expression profiles was further visualized through control-normalized Alb/Opn and Opn/Sox9
ratios (Figure A.4).
2.4.3 Cellular microarrays establish influence of ECM on progenitor fate
Both Notch and TGFβ signaling can be influenced by other microenvironmental signals, including the
composition of the ECM. For example, ECM proteins can bind and sequester TGFβ, potentially contributing
to the known gradient of TGFβ in situ (Clotman and Lemaigre 2006; Hynes 2009). In addition, integrin
receptor crosstalk with both TGFβ and Notch signaling has been demonstrated in numerous cell contexts
(Boulter et al. 2012; Estrach et al. 2011; Leong et al. 2002). Thus, in order to further deconstruct the
effects of these distinct microenvironmental signals, we utilized a cellular microarray approach (Figure 2.4A).
This platform enables a complete suite of capabilities to simultaneously assess the functional impact of
both microenvironmental regulation (cell–cell, cell–ECM, cell–soluble factor) and genetic factors via shRNA
knockdown. Further, here we have developed an analytical pipeline that facilitates both single-cell and
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summary quantifications through automated image analysis (Figure 2.4B). Using identical differentiation
protocols, BMEL cell fates on cellular microarrays were consistently similar to previous bulk observations
(Figure 2.4C).
To specifically examine cell–ECM interactions, we adapted a previously-published array design and fab-
ricated cellular microarrays incorporating all 25 combinations of collagen I, collagen III, collagen IV, fi-
bronectin, and laminin (Flaim et al. 2005). These ECM proteins were selected for their variable expression
and function during hepatogenesis in the fetal and neonatal liver (Martinez-Hernandez and Amenta 1993).
Following differentiation induction in the array format, staining and quantification of cell nuclei and differ-
entiation markers was performed to evaluate cell number and degree of differentiation per ECM condition.
Consistent with cell density observations in bulk cultures (Figure A.3), treatment with TGFβ1 led to a
relative decrease in cell numbers compared to untreated differentiation conditions (Figure A.5). Quantifica-
tion of ALB and OPN immunolabel intensity versus cell number demonstrated relative increases in marker
intensity not correlated with cell number (Figure A.5). In agreement with bulk experiments, ALB and OPN
label intensity showed stratification by TGFβ1 treatment while the variation within each soluble treatment
condition reflected the impact of ECM composition (Figure 2.5A). We further quantified the percentage of
cells positive for ALB and OPN following either untreated (TGFβ1−) or treated (TGFβ1+) differentiation
conditions. These data demonstrate a large variation of ALB+ cell percentage by ECM and regardless of
TGFβ1 treatment, indicating that ECM composition can play a role in regulating ALB expression (Fig-
ure A.6). However, the profile of OPN+ cell percentage was more substantially influenced by TGFβ1
treatment with ECM composition having a less pronounced effect on OPN expression within the soluble
treatment conditions (Figure A.6). Regarding specific ECM components, fibronectin and laminin (and ar-
rayed conditions containing either) were highly represented in the conditions with the highest percentage of
ALB+ cells while collagen IV was predominant in conditions with lower percentages of ALB+ cells. These
observations were further confirmed by main and interaction effects from full factorial multiple regression
analysis (Figure A.7). From this large-scale dataset, we have selected five arrayed conditions to illustrate the
single-cell quantification capabilities and distinct profiles observed. Micrographs of these arrayed conditions
not only confirm summary measure conclusions but also exhibit distinct cellular populations stratified in par-
ticular by OPN (Figure 2.5B). Single-cell quantification highlights the observed variance in both cell count
(histogram height) and ALB or OPN label intensity (Figure 2.5C). In particular, we observed normal-like
(ALB for 3•4 in TGFβ1−), Poissonian (ALB for F in TGFβ1−), uniform (OPN for F in TGFβ1+), and
bimodal distributions (OPN for L•1•3 in TGFβ1+).
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2.4.4 Notch ligand microarrays demonstrate cell-extrinsic and cell-intrinsic
effects on progenitor fate
In order to systematically investigate the effect of distinct Notch ligands on liver progenitor fate specifi-
cation, we adapted the microarray platform to present Notch ligands. Specifically, we designed an array
containing Fc-recombinant JAG1, DLL1, and DLL4. Notch ligands are known to require clustering to func-
tion both in situ or when adsorbed to or deposited on a substrate (Bardot et al. 2005; Varnum-Finney,
L. Z. Wu, et al. 2000). We used Fc-recombinant Notch ligands pre-conjugated to Protein A/G at a molar
ratio of 1:6 (A/G:ligand) as a means of mediating clustering and retention in the hydrogel substrate and
improving cellular recognition. Immunolabeling of arrayed JAG1 and DLL1 showed increased signal and
a less diffuse pattern when conjugated with Protein A/G (Figure 2.6A). Arrayed Fc-recombinant, Protein
A/G-conjugated JAG1, DLL1, and DLL4 was functional, stimulating BMEL cells towards cholangiocytic
fates even in TGFβ1− conditions (Figure 2.6B). We subsequently expanded the array design to include all
five ECM proteins from the previous array experiments and also shRNA-infected cells. Using this array
design, we quantified the percentage of cells positive for ALB (Figure 2.6C) and OPN (Figure 2.6D) in the
absence of exogenous TGFβ1. Further, we additionally evaluated the effects of Notch ligands on ALB and
OPN following TGFβ1 treatment (Figure A.8). Collectively, these data further confirm the presence of
ECM-specific effects; for example, collagen IV was less conducive to fate specification in agreement with the
ECM-only experiments. In addition, extrinsic presentation of JAG1 resulted in a relative upregulation of
OPN only in select conditions (namely collagens I, III, and IV) while DLL1 and DLL4 consistently triggered
upregulation of OPN.
We further explored potential combinatorial effects of cell-intrinsic ligand expression by using the Notch
ligand arrays in combination with the shJag1 and shDll1 BMEL cells previously evaluated in the bulk and
co-culture experiments. These data show that shJag1 cells exhibited lower ALB and OPN expression (par-
tially dependent on ECM context) as well as a decrease in the effect of arrayed Notch ligands, suggesting
that the exogenous ligands cannot effectively compensate for the reduction in cell-intrinsic Jag1 expression
(Figures 2.6C–D). In contrast, shDll1 cells demonstrated a different effect in which both ALB and OPN in-
creased compared to control cells (Figures 2.6C–D). These conclusions were corroborated by the main effects
from multiple regression analysis (Figure A.9). In order to explore the potential presence of double-positive
(ALB+/OPN+) cells, we further utilized the single-cell quantification data produced from this set of arrays
to plot OPN label intensity versus ALB label intensity (Figure 2.7A). These contour-density plots illustrate
the combined effects of arrayed ligands and cell-based ligand knockdown. Most notably, these data demon-
strate the presence of ALB+/OPN+ cells, which were primarily present following Dll1 knockdown with
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an increased frequency in combination with exogenously-presented Notch ligand. This imaging cytometry-
based quantification was correlated with cell morphologies observed in immunofluorescence micrographs
(Figure 2.7B).
2.5 Discussion
In order to examine the complex regulatory mechanisms governing stem and progenitor fate specification,
methods that enable the systematic perturbation of microenvironmental signals are required. In these
studies, we have developed and applied a cohort of strategies to investigate the combined roles of TGFβ,
Notch, and ECM in liver progenitor bipotential differentiation. A schematic representation of our overall
approach and findings is illustrated in Figure 2.8. Taken together, our results confirm that liver progenitor
differentiation is influenced by both Jag1 and TGFβ1, and we further illustrate numerous combinatorial
effects of the Notch and TGFβ signaling pathways. In particular, using a GFP+/GFP− co-culture approach,
we separated the cell-intrinsic and cell-extrinsic functions of Notch ligands and showed distinct roles for
Jag1 and Dll1 with shRNA knockdown. Additionally, we established ECM-specific effects using a cellular
microarray platform that further formed the basis for the fabrication of Notch ligand microarrays. Exogenous
presentation of Protein A/G-conjugated Fc-recombinant Notch ligands (JAG1, DLL1, and DLL4) in this
microarray platform induced cholangiocytic differentiation and further produced ALB+/OPN+ double-
positive cells when combined with Dll1 knockdown.
Both Notch and TGFβ have been demonstrated to be involved in the differentiation of cholangiocytes
and the formation of bile ducts (Clotman, Jacquemin, et al. 2005; Zong et al. 2009). Transcriptional pro-
filing of HBC-3 murine liver progenitors has previously revealed upregulation of family members from both
of these pathways during cholangiocytic specification (Ader et al. 2006). Here, we demonstrate not only
direct signaling effects but also inter-pathway feedback, as evidenced by the higher TGFβ1 threshold for
cholangiocytic specification with GSI X treatment (Figure 2.1C), the upregulation of Dll1, Dll4, and Jag1
mRNA transcripts by TGFβ1 (Figure 2.2A), and downregulation of Jag1 by inhibitors of both Notch and
TGFβ (Figure 2.2C). These observations are consistent with studies of other tissues in which Jag1 was
upregulated by TGFβ through protein-protein interactions between SMAD3 and the Notch intracellular
domain (Blokzijl et al. 2003; Zavadil et al. 2004). Moreover, this suggests the known periportal gradient of
TGFβ may also serve to upregulate JAG1 and other Notch pathway members during ductal plate pattern-
ing. Data regarding Jag1, Dll1, and other Notch ligands must be synthesized with the known behaviors and
functions of Notch receptors. In particular, Ortica et al. (2014) recently showed that Notch2 and Notch4
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maintain progenitor state in BMEL cells whereas Notch3 was associated with a hepatocytic morphology.
Cell type-specific (conditional) inducible mouse models show that Notch2 (but not Notch1 ) is indispensable
for cholangiocytic differentiation and furthermore coordinates patterning of the ductular network (Falix et al.
2014; Geisler et al. 2008; Jeliazkova et al. 2013).
Notch pathway activity in the liver is highly sensitive to dosing and spatial localization of both receptor
and ligand (Hofmann et al. 2010; Kodama et al. 2004; Loomes et al. 2007). This interplay is further under-
scored by the observation that Jag1−/+;Notch2−/+ double heterozygous mice exhibit features of Alagille
syndrome (Lozier et al. 2008). In canonical Notch signaling, Notch ligands act as binding partners for the
Notch receptors, a cell-extrinsic mechanism through which transcriptional activity occurs in the receiving
(and not ligand-presenting) cell. Our co-culture data imply that Jag1 and Dll1 may work together through
a combination of cell-extrinsic and cell-intrinsic means in cholangiocyte specification. For instance, both the
shDll1GFP+ (shJag1GFP−) and shJag1GFP+ (shJag1GFP−) conditions exhibited similar reductions in Opn
expression compared to conditions exhibiting only extrinsic knockdown: controlGFP+ (shJag1GFP−) and
controlGFP+ (shDll1GFP−). Consistent with this trend, the shJag1GFP+ (shDll1GFP−) condition exhibited
a moderate reduction of Opn, though not statistically significant (P=0.118). Taken together, these data are
suggestive of potential overlaps in function and mechanism for Jag1 and Dll1, specifically for cholangiocyte
differentiation.
Notably, both exogenous (cell-extrinsic) presentation of DLL1 as well as Dll1 knockdown elicited increases
in cholangiocytic specification in the Notch ligand arrays, in the absence of exogenous TGFβ (Figure 2.6). It
is possible that the observed cell-intrinsic effects are due to ligand intracellular domain signaling. Specifically,
the Notch ligand intracellular domain is cleaved in the same manner as Notch receptors and is furthermore
capable of nuclear translocation (LaVoie and Selkoe 2003; Six et al. 2003). The intracellular domain of DLL1
in particular is known to modulate SMAD-dependent transcription (Bordonaro et al. 2011; Hiratochi et al.
2007). Further, these results are suggestive of the possibility that DLL1 expression may influence either
Notch receptor expression or Notch signaling activity, effects that are observed in numerous contexts of
lateral inhibition (Alamo et al. 2011; Bray 2006; Shimojo et al. 2008) but have not previously been reported
for liver differentiation and bile duct formation. The additional functionality of DLL4 may indicate some
further redundancy with DLL1 which would require simultaneous knockdown of both ligands for further
investigation.
In our ECM arrays, fibronectin and laminin were the most conducive to fate specification, particularly
in TGFβ1−, while collagen IV was less conducive (Figures A.6 and A.7), providing evidence that liver
progenitor differentiation integrates ECM cues. Laminin and collagen IV are both main components of
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the basement membrane while fibronectin is largely expressed in the mesenchyme surrounding the portal
vein (Martinez-Hernandez and Amenta 1993). Our observations are in general agreement with past studies:
Tanimizu, Miyajima, and Mostov (2007) showed induction of biliary cyst formation by laminin but not
collagen IV while Yanai et al. (2008) observed 220-fold induction of Ck19 by the combination of collagen I
and fibronectin (cf., <20-fold for collagen I alone). Tanimizu, Kikkawa, et al. (2012) further demonstrated
that α1-containing laminin is sufficient for cholangiocytic fate specification while α5-containing laminin is
necessary for bile duct formation. As our formulation of laminin contained multiple subchains, future studies
could delineate functional roles for each subchain in both co-cultures and arrays. In addition, based on the
variations in cell number (and the corresponding size of the cell islands on the array) that we observed on
distinct ECM conditions, future efforts could aim to exploit the microarray platform to directly examine
potential synergistic or antagonistic interactions between ECM composition and cell–cell contacts during
differentiation. Furthermore, one limitation of the cell microarray platform is the difficulty in evaluating
numerous phenotypic markers simultaneously. Our array results presented here focused on the expression of
ALB and OPN as characteristic markers of hepatocytic and cholangiocytic fates, respectively. Future efforts
could build on these results by scaling-up relevant conditions and performing broader analyses of phenotypic
marker expression and signaling pathway activation within distinct microenvironments.
Recent studies of liver progenitor differentiation and bile duct morphogenesis have revealed important
details regarding the spatiotemporal dynamics of Notch signaling in the liver. Zong et al. (2009) demonstrated
that Notch plays a role in differentiation, in addition to morphogenesis, and further found that Notch activity
precedes differentiation of the first layer of the ductal plate. Additionally, Hofmann et al. (2010) showed
JAG1 in the portal mesenchyme controls ductal plate patterning but not fate specification. Our data are
consistent with a model of differentiation and early ductal plate formation that integrates feedback from
multiple Notch ligands (namely Jag1 and Dll1 ) expressed on progenitor cells. It is possible that both JAG1
in the mesenchyme and TGFβ induce JAG1 in progenitors as part of the specification process, consistent
with lateral induction (Eddison et al. 2000; Timmerman et al. 2004).
In summary, our study highlights the importance of context-dependent Notch and TGFβ signaling as
well as the integration of microenvironmental cues (namely ECM proteins) in liver progenitor differentia-
tion. The effect of specific receptor-ligand interactions remains uncertain but could be investigated through
presentation of Notch receptors in arrays or genetic manipulation, as Ortica et al. (2014) demonstrate. Ad-
ditionally, although studies of the liver transcriptome show Dll1 is detectable but not highly expressed (Yu
et al. 2010), more sensitive methods may be required if expression is cell type-dependent, as our data suggest.
Last, the observation of cholangiocytic differentiation localized at the periphery of cell islands in microarrays
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(Figure 2.6B) is suggestive of currently-undefined spatial localization mechanisms and underlying signaling
gradients that could be systematically explored through future studies utilizing the microarray platform.
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Figure 2.1: Liver progenitors differentiate into hepatocytes and cholangiocytes via TGFβ and Notch.
(A)Micrographs of BMEL progenitor cells cultured under differentiation conditions (TGFβ1±). BMEL cells
in TGFβ1+ were cholangiocytic (ALB−/OPN+) while those in TGFβ1− were hepatocytic (ALB+/OPN−).
Scale bars are 50 µm. (B) qRT-PCR analysis of Alb and Opn mRNA transcripts in BMEL cells treated
with increasing doses of TGFβ1. Student’s t-tests were performed against 0 ng/ml for each concentration
of TGFβ1 with P-values indicated for P<0.05 (*). (C) qRT-PCR analysis of Alb, Opn, and Sox9 mRNA
transcripts in BMEL cells treated with TGFβ1, γ-secretase inhibitor X (5 µM, GSI X), or SB-431542 (10
µM). For the DMSO treatment, Student’s t-tests were performed against 0 ng/ml for each concentration of
TGFβ1 with P-values indicated for P<0.05 (*). For the GSI X and SB-431542 treatments, Student’s t-tests
were performed against equal TGFβ1 concentrations in the DMSO treatment with P-values indicated for
P<0.05 (ˆ). Numeric callouts show y-axis values (not P-values). Data presented as mean ± s.e.m. with
n=3. Log2 errors are relative.
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Figure 2.2: Jag1 and TGFβ1 coordinate cholangiocytic fate specification. (A) qRT-PCR analysis of
Dll1, Dll4, Jag1, and Jag2 mRNA transcripts in BMEL cells under basal (growth) and differentiation
(TGFβ1±) conditions. Student’s t-tests were performed against basal for TGFβ1±. (B) Representative
immunoblot against JAG1 in BMEL cells under differentiation conditions (TGFβ1±). Cells were further
treated with an equivalent volume of vehicle (DMSO), GSI X (5 µM, GSI), or SB-431542 (10µM, SB).
Molecular weight markers shown in kDa (left) and β-actin control at 45 kDa (bottom). (C) Quantification of
JAG1 immunoblots described in Figure 2.2B. Student’s t-tests were performed against DMSO for TGFβ1±.
(D) qRT-PCR analysis of Alb and Opn mRNA transcripts in BMEL cells infected with lentiviral shRNA
constructs against a non-target sequence (control), Dll1 (shDll1), and Jag1 (shJag1). For shDll1 and shJag1,
Student’s t-tests were performed against the same treatment condition (TGFβ1±) in control cells. Numeric
callouts show y-axis values (not P-values). Data presented as mean ± s.e.m. with n≥3. P-values indicated
for P<0.05 (*). See also Figures A.2 and A.3.
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AB
Figure 2.3: GFP+/GFP− co-cultures confirm distinct roles for Jag1 and Dll1. (A) Schematic of
GFP+/GFP− co-culture experiment. GFP+ cells were generated using a GFP adenovirus and co-cultured
at a 1:50 ratio with GFP− cells under differentiation conditions (TGFβ1±). GFP+ cells were collected
after 72 h of culture by flow sorting for downstream RNA isolation and qRT-PCR analysis. (B) qRT-PCR
analysis of Alb, Opn, and Sox9 mRNA transcripts in GFP+ cells from co-cultures of every GFP+/GFP−
combination of control-, shDll1-, or shJag1-infected BMEL cells. Results were normalized to expression in
cultures grown under basal conditions in parallel with co-cultures. For each gene, Student’s t-tests were
performed against controlGFP+ (controlGFP−) for every combination of GFP− and GFP+ cells. P<0.05
indicated separately for TGFβ1− (*) and TGFβ1+ (ˆ). Numeric callouts show y-axis values (not P-values).
Data presented as mean ± s.e.m. with n≥3. See also Figure A.4.
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Figure 2.4: Cellular microarrays enable studies of combinatorial microenvironmental regulation.
(A) Schematic of a cellular microarray experiment. Biomolecules and ECM proteins are patterned on a
polyacrylamide hydrogel substrate using contact printing. Cells seeded on arrays adhere only to the pat-
terned regions and are exposed to the deposited biomolecules and any experiment-specific soluble factors,
fixed at endpoint, immunolabeled, imaged, and analyzed. (B) Analytical pipeline for cellular microarrays.
Individual cells on islands are automatically identified by nuclear stain (DAPI) and associated with inten-
sities in other channels, resulting in both single-cell and summary quantifications (e.g., percentage of cells
positive for a marker) of results by deposited biomolecule and soluble factor treatment. Scale bars are 100
µm. (C) Experimental pipeline for cellular microarrays. BMEL cells are seeded for 2 h on arrays (sufficient
to populate each patterned region), cultured under differentiation conditions (TGFβ1±) for 72 h, fixed, and
labeled for nuclei, ALB, and OPN. Arrays shown are 18×4.5 mm (40×8 spots).
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Figure 2.5: Microenvironmental regulation of liver progenitor differentiation by ECM proteins. (A) Scatter
plot of ALB intensity against OPN intensity by TGFβ1 treatment. Each point represents a single arrayed
ECM protein combination. (B) Immunofluorescence micrographs of each ECM condition in Figure 2.5B.
Scale bar is 50 µm. (C) Single-cell histograms of ALB and OPN label intensity for selected ECM proteins
by TGFβ1 treatment. Data presented as mean ± s.e.m. with n=3. Abbreviations: 1=collagen I, 3=collagen
III, 4=collagen IV, F=fibronectin, L=laminin. Combinations denoted by “•”, e.g., “1•3•4” denotes an ECM
combination containing collagen I, III, and IV. See also Figures A.5, A.6, and A.7.
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Figure 2.6: Arrayed Notch ligands drive cholangiocytic fate specification. (A) Immunolabeling of arrayed
Fc-recombinant JAG1 and DLL1. Scale bar is 50 µm. (B) Immunofluorescence micrograph showing BMEL
cells in TGFβ1−. Arrowhead shows spatial specificity of cholangiocytic (OPN+) differentiation at the edge
of the island surrounding an OPN− core. Scale bar is 150 µm. (C) ALB quantification of shRNA-infected
BMEL cells in TGFβ1− on five ECM proteins. (D) OPN quantification of shRNA-infected BMEL cells in
TGFβ1− on five ECM proteins. Break in y-axis applies only to bar for JAG1/laminin/shDll1 condition.
Data presented as mean ± s.e.m. with n≥3. Hypothesis testing in Figures 2.6C and 2.6D was performed as
follows: For control cells, Student’s t-tests were performed against IgG for each arrayed Notch ligand within
each ECM condition with P-values indicated for P<0.05 (*). For shDll1 and shJag1 cells, Student’s t-tests
were performed against the corresponding arrayed Notch ligand for control cells, again within each ECM
condition with P-values indicated for P<0.05 (ˆ). See also Figures A.8 and A.9.
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Figure 2.7: Imaging cytometry of Notch ligand arrays. (A) Contour maps showing imaging cytometry
of shRNA-infected BMEL cells responding to Notch ligands on collagen III. Dotted lines show cutoffs de-
termining cell positivity for both ALB (x-axis) and OPN (y-axis). (B) Immunofluorescence micrographs
showing varying response to Notch ligand by shRNA-infected BMEL cells. Scale bar is 150 µm.
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Figure 2.8: Schematic summary of approach and findings. Cellular microarrays enable controlled studies of
the combined effects of microenvironmental signals, including TGFβ, Notch, and ECM. Analysis of BMEL
cell differentiation within cellular microarrays and complementary co-culture formats is further suggestive
of the following roles for distinct Notch ligands: TGFβ1 and cell-extrinsic Notch ligands (JAG1 and DLL1)
cooperate to induce cholangiocytic fate; cell-intrinsic Dll1 plays a role in the suppression of hepatocytic fate
in response to TGFβ1; and cell-intrinsic Dll1 inhibits the generation of double-positive (ALB+/OPN+)
cells during differentiation.
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Chapter 3
Substrate stiffness and matrix
composition coordinately control the
differentiation of liver progenitor cells∗
3.1 Abstract
Recent approaches have utilized microfabricated platforms to examine combinations of microenvironmental
signals that regulate stem and progenitor cell differentiation. However, the majority of these efforts have fo-
cused on the biochemical properties of extracellular matrix (ECM) or soluble factors without simultaneously
exploring the biomechanical effects of cell–substrate interactions. To address this need, we combined a high-
throughput approach for the analysis of combinatorial ECM cues with substrates of modular stiffness and
traction force microscopy. This integrated approach enabled the characterization of cell-generated traction
stress and phenotypic expression in response to ECM cues. We investigated the impact of substrate stiffness
and ECM composition on the differentiation of bipotential mouse embryonic liver (BMEL) progenitor cells.
We observed that hepatocyte differentiation was primarily regulated by ECM composition, and cholangio-
cyte differentiation was cooperatively influenced by ECM proteins and stiffness properties. In particular,
stiffness-mediated cholangiocyte differentiation was observed for cells cultured on fibronectin, while colla-
gen IV promoted differentiation independent of substrate stiffness. We demonstrated the influence of cell
contractility and traction stress in early cholangiocyte specification and further uncovered the roles of ERK
and ROCK in this differentiation process. Overall, these findings illustrate the involvement of biomechanical
signals in liver progenitor differentiation. Further, this approach could enable investigations for a broad
range of cell types and ECM proteins, providing an integrated platform for evaluating the combinatorial
effects of biochemical and biophysical signals in cell differentiation.
3.2 Introduction
Liver progenitor cells are the bipotential precursors to hepatocytes, the functional parenchymal cells of the
liver, and cholangiocytes, which form the bile duct epithelium. During development, these cells receive
∗This work was previously published by Elsevier (Amsterdam) in the journal Biomaterials (Kourouklis et al. 2016) and is
reproduced here with the permission of the publisher.
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numerous signals from the microenvironment directing their differentiation toward either fate. For example,
it is known that a gradient of TGFβ signaling localizes cholangiocyte differentiation to the periportal region
(Clotman, Jacquemin, et al. 2005; Clotman and Lemaigre 2006). Further activity by the Notch ligand JAG1
and receptor NOTCH2 is necessary for the formation of mature intrahepatic bile ducts (Hofmann et al. 2010;
Jeliazkova et al. 2013; Tchorz et al. 2009; Zong et al. 2009). Concurrently, interactions between β1-integrins
and the extracellular matrix (ECM) proteins collagen I and laminin have been demonstrated to influence
both cholangiocyte differentiation and morphogenesis (Tanimizu, Kikkawa, et al. 2012; Tanimizu, Miyajima,
et al. 2007; Yanai et al. 2008). We have recently studied the mechanisms by which progenitor differentiation
is simultaneously regulated by these pathways, illustrating cooperative interactions between the TGFβ and
Notch pathways establishing a role for ECM proteins (Kaylan et al. 2016). While the importance of these
biochemical signals in liver progenitor cell fate decisions has been investigated in detail, the role of mechanical
cues is considerably less-defined for this cell type.
Recent studies have demonstrated the importance of ECM stiffness in liver pathology (e.g., cirrhosis)
(Friedman 2010; Georges et al. 2007; Wells 2008) and further highlight the causative rather than consequen-
tial role of ECM stiffness in the development of the fibrotic disease (Kai et al. 2016). In other tissue contexts,
mechanical signals and associated mechanotransduction have been broadly implicated in the regulation of
stem and progenitor cell differentiation (Discher, Mooney, et al. 2009; Ivanovska et al. 2015; Trappmann
and Chen 2013). Studies of mesenchymal stem cell differentiation in particular have yielded a wealth of
approaches for elucidating fundamental mechanobiology (Kshitiz et al. 2012; MacQueen et al. 2013; Vo-
gel and Sheetz 2006), including protein patterning (R. A. Desai et al. 2011; Kilian et al. 2010; McBeath
et al. 2004; Reilly and A. J. Engler 2010), modular elastic substrates (A. J. Engler et al. 2006; A. Engler
et al. 2004), and mechanical and biochemical gradient generation (Guvendiren and Burdick 2012; Legant
et al. 2009; Rape et al. 2015; Tse and A. J. Engler 2011). Despite the important information provided by
these efforts, the complexity and less defined nature of the hepatic microenvironment requires the develop-
ment of approaches to efficiently examine large sets of combinatorial ECM signals while maintaining select
features of in vivo mechanobiology. Previous studies aimed at deconstructing combinatorial effects have
exploited the fabrication of cellular microarrays of ECM proteins on elastic substrates (Brafman, Minicis,
et al. 2009; Flaim, Chien, et al. 2005; Flaim, Teng, et al. 2008; Reticker-Flynn et al. 2012). In contrast with
the demonstrated ability of cell microarrays to examine the effects of combinatorial biochemical signaling by
ECM proteins, there have only been limited efforts to simultaneously investigate the role of the associated
biophysical signals.
Fundamental investigations into cell mechanotransduction mechanisms have highlighted the critical in-
54
teraction between the mechanical microenvironment and cell traction force. Cell traction force is generated
through a myosin-dependent contractile mechanism in response to the adhesion of membrane receptors on
ECM ligands and the subsequent activation of intracellular pathways (Vogel and Sheetz 2006). The magni-
tude of the generated stress is regularly correlated with the assembly of intracellular structures (Balaban et
al. 2001) and subsequent signaling pathway activation plays an important role in several biological functions
such as migration (Trepat et al. 2009) and differentiation (Wen et al. 2014). One of the most common meth-
ods for measuring traction force at the cell–ECM interface is the technique termed traction force microscopy
(TFM) (Butler et al. 2002; Style et al. 2014; Tang et al. 2014; J. H.-C. Wang and Lin 2007). However,
there have not been previous demonstrations of using TFM or other methods of traction measurement with
cellular microarrays.
In this report, we demonstrate an approach for the integration of cell microarrays with substrates of
modular mechanical characteristics and TFM. We illustrate the unique capability of this strategy to support
the systematic investigation of the combined effects of ECM composition and substrate stiffness on cell
traction force and differentiation. Our studies reveal previously unidentified characteristics of liver progenitor
differentiation which could have important implications in the understanding of liver morphogenesis and
disease.
3.3 Methods
3.3.1 Cell culture
We utilized BMEL 9A1 cells between passages 28 and 37. These cells were cultured as previously described
(Strick-Marchand and Weiss 2002). Briefly, cells were seeded on tissue culture plastic coated with collagen
I (0.5 mg/ml) and subsequently cultured under controlled environmental conditions (37°C and 5% CO2).
Treatment with trypsin-EDTA (0.25% v/v) for ≤10 min was used to detach cells for subculturing. Basal
media for expansion consisted of RPMI 1640 + GlutaMAX (Life Technologies, 61870-127) with fetal bovine
serum (10% v/v, FBS), penicillin/streptomycin (1% v/v, P/S), human recombinant insulin (10 µg/ml,
Life Technologies, 12585-014), IGF-2 (30 ng/ml, PeproTech, 100-12), and EGF (50 ng/ml, PeproTech,
AF-100-15). Differentiation media consisted of Advanced RPMI 1640 (Life Technologies, 12633-012) with
FBS (2% v/v), P/S (0.5% v/v), l-glutamine (1% v/v), and minimum non-essential amino acids (1% v/v,
Life Technologies, 11140-050). During differentiation experiments, cells were seeded on arrays at ≥500E3
cells/slide for phenotypic assessment, 200E3 cells/dish in 35 mm glass-bottom Petri dishes for TFM, and
2.5E6 cells/slide for PA substrates conjugated with ECM using sulfo-SANPAH. Cells were allowed to adhere
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to ECM for at least 2 h before addition of experiment-specific treatments.
3.3.2 Growth factor and drug treatments
All growth factors and drugs were prepared and reconstituted according to the instructions of the man-
ufacturers: TGFβ1 (R&D Systems, 240-B-002), 5 µg/ml in 4 mM HCl with 0.2% (w/v) bovine serum
albumin; (–)-blebbistatin (Cayman Chemical, 13013), 1 mg/ml in dimethyl sulfoxide (DMSO); Y-27632
(Enzo Life Sciences, 270-333-M005), 5 mg/ml in deionized water (dH2O); NSC23766 (Tocris Biosciences,
2161), 10 mg/ml in dH2O; FR180204 (Sigma-Aldrich, SML0320), 10 mg/ml in DMSO; SP600125, 10 mg/ml
in DMSO. For hepatocyte differentiation (TGFβ1−), cells were cultured in differentiation media for 72 h.
For cholangiocyte differentiation (TGFβ1+), cells were cultured in differentiation media with TGFβ1 (1.5
ng/ml) for 24 h. Drugs were added to differentiation media at the following concentrations: (–)-blebbistatin,
25 µM; Y-27632, 10 µM; NSC23766, 10 µM; FR180204, 10 µM; SP600125, 10 µM.
3.3.3 Preparation of polyacrylamide hydrogels
Polyacrylamide (PA) hydrogels were prepared following previous protocols (Aratyn-Schaus et al. 2010;
Reticker-Flynn et al. 2012; Tse and A. J. Engler 2010). Briefly, 25×75 mm glass microscope slides were
washed with 0.25% v/v Triton X-100 in dH2O and placed on an orbital shaker for 30 min. After rinsing with
dH2O, slides were immersed in acetone and placed on the shaker for 30 min. The acetone wash was followed
by immersion in methanol and another 30 min on the shaker. The slides were then washed with 0.05 N
NaOH for 1 h, rinsed with dH2O, air-dried, and placed on a hot plate at 110°C until dry. For silanization,
the cleaned slides were immersed in 2% v/v 3-(trimethoxysilyl)propyl methacrylate in ethanol and placed
on the shaker for 30 min. The silanized slides were washed with ethanol on the shaker for 5 min, air-dried,
and again placed on the hot plate at 110°C until dry. For fabrication of hydrogels with specific elastic
moduli, three prepolymer solutions with different acrylamide/bis-acrylamide percentage (w/v) ratios were
prepared to achieve elastic moduli of 4 kPa (4% acrylamide, 0.4% bis-acrylamide), 13 kPa (6% acrylamide,
0.45% bis-acrylamide), and 30 kPa (8% acrylamide, 0.55% bis-acrylamide) and similar porosity (Wen et al.
2014). Each of these prepolymer solutions were mixed with Irgacure 2959 (BASF, Corp.) solution (20%
w/v in methanol) at a final volumetric ratio of 9:1 (prepolymer:Irgacure). This working solution was then
deposited onto slides (100 µl/slide) and covered with 22×60 mm cover glasses. The sandwiched working
solution was transferred to a UV oven and exposed to 365 nm UV A for 10 min (240 mJ). After removing
the cover glasses, the slides were immersed in dH2O at room temperature for 3 d in order to remove excess
reagents from the hydrogel substrates. Before microarray fabrication, hydrogel substrates were thoroughly
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dehydrated on a hot plate for ≥15 min at 50°C.
3.3.4 Microarray fabrication
We fabricated microarrays as previously described (Brafman, Chien, et al. 2012; Flaim, Chien, et al. 2005;
Underhill et al. 2009). Briefly, ECM proteins were mixed with an equal volume of 2× ECM protein buffer
(38% v/v glycerol in dH2O, 16.4 mg/ml sodium acetate, 3.72 mg/ml EDTA, 0.5% v/v Triton X-100, 80
ul glacial acetic acid, pH=4.8) and loaded into a 384-well V-bottom microplate. The final concentration
of total ECM protein in each combination was 250 µg/ml; two-way combinations contained 125 µg/ml of
each individual ECM protein. We utilized the following ECM proteins in our studies: collagen I (rat tail,
EMD Millipore, 08-115), collagen III (human, EMD Millipore, CC054), collagen IV (human, EMD Millipore,
CC076), fibronectin (human plasma, Sigma-Aldrich, F2006), and laminin (mouse, EMD Millipore, CC095).
We additionally used 70 kDa dextran-rhodamine (2.5 mg/ml, Life Technologies, D-1841) as a marker for
later array analysis. An automated benchtop microarrayer (OmniGrid Micro, Digilab) was loaded with
SMP3 Stealth microarray pins (ArrayIt) and used to transfer biomolecules from the 384-well microplate to
the PA hydrogel substrate. This process produced arrayed domains approximately 150 µm in diameter. We
stored fabricated arrays at room temperature and 65% RH overnight and then sterilized the next morning
with 30 min UV C and immersion in 1× phosphate buffered saline (PBS) supplemented with 1% v/v P/S.
Cells were seeded on arrays immediately after sterilization per the section above.
3.3.5 Conjugation of ECM to PA hydrogels
We equilibrated sulfo-SANPAH (25 mg/ml in DMSO, G-Biosciences, 82022-840) to ambient temperature
and immediately diluted to 1.04 mg/ml with 0.1 M HEPES buffer. We distributed 600 µl of this solution
on PA substrates fabricated on 25×75 mm glass microscope slides (see above) and exposed substrates to
UV light (300–460 nm) for 20 min. Substrates were subsequently washed with 0.1 M HEPES buffer for 5
min with agitation, after which we repeated the above steps twice more. After drying, we distributed 200 µl
fibronectin (40 µg/ml in 0.1 M HEPES buffer) or 200 µl collagen IV (40 µg/ml in 0.1 M HEPES buffer) on
each substrate and incubated at 4°C overnight. We sterilized substrates with 30 min UV C in 1× phosphate
buffered saline (PBS) supplemented with 1% v/v P/S.
3.3.6 Traction force microscopy
For the TFM experiments, we adjusted our protocol in order to fabricate the PA hydrogels in glass-bottom
35 mm Petri dishes (Cell E&G, GBD00002-200) rather than on 25×75 mm microscope slides. This enabled
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us to perform TFM on live cells at 37°C and 5% CO2. To measure the cell-generated forces, we added 1 µm
far-red fluorescent beads (Life Technologies, F-8816) to the working solution at a final concentration of 0.2%
v/v (J. H.-C. Wang and Lin 2007; N. Wang et al. 2002) and fabricated hydrogels with embedded beads by
exposure to 365 nm UV A for 10 min. We subsequently completed the hydrogel and array fabrication proto-
cols as described above and seeded cells on the arrays. After completion of experiment-specific treatments,
the arrays were transferred to an incubated (37°C and 5% CO2) Axiovert 200M microscope (Carl Zeiss, Inc.).
The microscope was used to capture phase contrast and far-red fluorescent micrographs to record cellular
position and morphology along with bead displacement before and after treatment with sodium dodecyl
sulfate (1% v/v in 1× PBS). The captured images were analyzed in MATLAB using a previously-developed
script to extract the traction stress and contractile moment (Butler et al. 2002; N. Wang et al. 2002). All
plots of traction stress and contractile moment show root mean square values.
3.3.7 Immunocytochemistry and imaging
Cells were treated with brefeldin A (10 µg/ml, R&D Systems, 1231/5) for 2 h and subsequently fixed in
paraformaldehyde (4% w/v in 1× PBS) for 15 min. Fixed samples were permeabilized with Triton X-100
(0.25% v/v in 1× PBS) for 10 min and incubated in blocking buffer (5% v/v donkey serum in 1× PBS) for 1
h at room temperature. We incubated samples for 1 h at room temperature with one or more of the following
primary antibodies diluted in blocking buffer: mouse anti-ALB (1/50 from stock, R&D Systems, MAB 1455)
and goat anti-OPN (1/60 from stock, R&D Systems, AF808). We next incubated samples for 1 h at room
temperature with one or more of the following secondary antibodies diluted in blocking buffer: DyLight
550-conjugated donkey anti-mouse IgG (1/50 from stock, Abcam, ab98767) and DyLight 488-conjugated
donkey anti-goat IgG (1/50 from stock, Abcam, ab96935). Samples were mounted in Fluoromount G with
DAPI (Southern Biotech, 0100-20) and imaged the next day using an Axiovert 200M microscope (Carl Zeiss,
Inc.) and associated Zen Pro software. In order to capture entire arrays as one image for later analyses, we
utilized the tiling feature of Zen Pro.
3.3.8 Immunoblotting
Cell lysates were collected using ice-cold RIPA lysis buffer (Thermo Scientific, 89900) with a protease in-
hibitor cocktail (Thermo Scientific, 78425) and phosphatase inhibitor cocktail (Thermo Scientific, 78428)
per the manufacturer’s instructions. Samples were immediately pulse sonicated 3×10 s and centrifuged at
14,000×g for 15 min at 4°C to remove cell debris. A BCA protein assay (Thermo Scientific, 23225) was
performed in 96-well microplates per the manufacturer’s instructions to determine total protein concentra-
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tions. Isodiluted samples were further diluted in 4× Laemmli sample buffer and 2-mercaptoethanol (50 mM),
denatured at 95 °C for 5 min, and loaded into a pre-cast 4–20% polyacrylamide gel (Bio-Rad, 567-1093) at
15 µg/well. Gels were run in 1× tris/glycine/SDS at 200 V and 33–43 mA for 45 min. Transfer to 0.45
µm PVDF membranes (EMD Millipore, IPVH00010) occurred in 1× tris/glycine and methanol (20% v/v)
at 100 V using plate electrodes for 30 min, after which membranes were placed in a blocking solution of
non-fat dry milk (5% w/v) in wash buffer (1× tris-buffered saline and 0.05% w/v Tween-20) for 1 h with
agitation. Membranes were subsequently incubated overnight on an orbital shaker at 4°C with BSA (5%
w/v in wash buffer) and rabbit anti-CK19 monoclonal antibody (1/10,000 from stock, Abcam, ab52625)
or rabbit anti-phospho-ERK1/ERK2 (p44/42) (1/1,000 from stock, Cell Signaling, 9101S). After 3×10 min
rinses with wash buffer, the membrane was incubated for 1 h at room temperature with a solution of HRP-
linked anti-rabbit IgG (1/3,000 dilution from stock, Cell Signaling, 7074S) in wash buffer with non-fat dry
milk (5% w/v). Membranes were subsequently rinsed 6×5 min with wash buffer, incubated for 5 min with
chemiluminescent substrate (Thermo Scientific, 34080), and imaged (ChemiDoc XRS Imaging System, Bio-
Rad). To confirm equal protein loading, membranes were treated with stripping buffer (Thermo Scientific,
21059) and labeled with monoclonal rabbit anti-β-actin (1/1,000 from stock, Cell Signaling, 4970S) using
the same protocol. Membranes labeled with anti-p-ERK were blocked and incubated with secondary in BSA
(5% w/v) in wash buffer to prevent non-specific binding to phosphoproteins in non-fat milk. Protein content
was quantified with NIH ImageJ (Schneider et al. 2012).
3.3.9 Array analysis
Images of arrays were converted to individual 8-bit TIFF files per channel (e.g., red) by ImageJ and Fiji
(Schindelin et al. 2012; Schneider et al. 2012). Image size was reduced to ≤100 MB by binning to re-
duce memory requirements during computational analysis. CellProfiler’s IdentifyPrimaryObjects and
IdentifySecondaryObjects modules were used to identify nuclei and immunolabeled regions, respectively
(Kamentsky et al. 2011). The MeasureObjectIntensity module was used to quantify single-cell immunola-
bel intensity. The location of arrayed conditions within each image was automatically determined relative to
manually-located dextran-rhodamine markers. In order to account for drift between experiments, quantile
normalization was applied by biological replicate to the output of MeasureObjectIntensity. The percent-
age of cells positive for each marker was calculated by defining a cutoff 2 s.d. above the mean of a negative
treatment.
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3.3.10 Statistical analysis
Three biological replicates were performed for each experiment unless otherwise noted. For array studies,
4–6 slides (2 slides per biological replicate) totaling 40–60 islands/condition were analyzed unless otherwise
noted. All data presented as mean ± s.e.m. We performed two-tailed, two-sample Student’s t-tests with
unequal variance for pairwise comparisons. Multiple regression analyses were performed in R using the
base lm function. For each model, we confirmed homoscedasticity, normal distribution of residuals, and the
absence of leveraged outliers using residual-fit, Q-Q, and scale-location plots. The unstandardized regression
coefficient (β), which is reflective of the contrast (i.e., mean change) between two categorical variables,
and associated P-value are provided for tests of specific hypotheses within a regression. For tests of overall
regression significance, we evaluated the R2 value, F -statistic, and P-value. For all hypothesis testing,
P<0.05 was considered significant.
3.4 Results
Our overall goal in these studies was to ascertain the collective impact of both substrate stiffness and ECM
composition on liver cell fate decisions. To do so, we fabricated cellular microarrays on PA substrates
of different elastic moduli (Figure 3.1A) and subsequently cultured progenitor cells on the arrayed ECM
combinations. At endpoint, we either assessed phenotypic marker expression (Figure 3.1B) or performed
TFM to measure traction stress (Figure 3.1C). We were additionally able to assay response to chemical
inhibition of intracellular signaling pathways in either format. In this work, we utilized bipotential mouse
embryonic liver (BMEL) progenitor cells, which express markers of hepatocyte function when cultured at
high-density or in aggregates (Strick-Marchand and Weiss 2002). BMEL cells are additionally capable of
expressing cholangiocyte markers in Matrigel cultures or when treated with TGFβ1 (Antoniou et al. 2009;
Strick-Marchand, Morosan, et al. 2004; Strick-Marchand and Weiss 2002), the latter of which we used in
these studies to initiate cholangiocyte differentiation. For the cell microarray studies, we utilized albumin
(ALB) and osteopontin (OPN) as representative markers for hepatocyte and cholangiocyte differentiation,
respectively. We have previously correlated expression of ALB with hepatocyte markers (Hnf4a, Cebpa) and
OPN with cholangiocyte markers (Sox9, Ggt1 ) markers for BMEL cells within defined microenvironments
(Kaylan et al. 2016).
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3.4.1 Liver progenitor differentiation is influenced by both matrix
composition and substrate stiffness
We characterized differentiation of BMEL progenitor cells on ECM-arrayed PA substrates of elastic moduli
4 kPa, 13 kPa, and 30 kPa. We selected this range of stiffness for these studies as it has been previously
demonstrated to be relevant for regulating the differentiation trajectories of stem cells in other tissue contexts
(Ivanovska et al. 2015). Although normal liver tissue has been shown to exhibit stiffness near 150 Pa
(S. S. Desai et al. 2016), the local stiffness near sites of progenitor differentiation within the developing
liver has not been clearly determined. Further, alterations of stiffness within the 1–10 kPa range have
been shown to influence the phenotypic characteristics of liver portal fibroblasts and mature cholangiocytes
(Komatsu et al. 2010; Li et al. 2007). Arrays fabricated on these distinct substrates contained all two-
factor combinations of collagen I (C1), collagen III (C3), collagen IV (C4), fibronectin (FN), and laminin
(LN). After allowing cell adhesion for 2 h, we induced differentiation of cells on the ECM arrays toward the
hepatocyte (low-serum differentiation medium) or cholangiocyte (low-serum differentiation medium with 1.5
ng/ml of TGFβ1) lineages and evaluated early (24 h and 72 h) upregulation of differentiation markers.
Under hepatocyte induction conditions, cells exhibited an overall upregulation of ALB (Figure 3.2A), with
a number of the ECM compositions supporting percentages of ALB+ cells >40% at 72 h (Figure 3.2B).
Interestingly, the C4 condition, as well as 2-factor combinations containing C4, exhibited a substantial
reduction in the percentage of ALB+ cells (Figure 3.2B). Despite this reduction in ALB expression, cells
cultured in the absence of TGFβ1 did not exhibit significant cholangiocyte differentiation regardless of
ECM composition (Figure B.1A). Regression analysis suggested a modest overall reduction in ALB+ cell
percentage on 4 kPa versus 30 kPa (Table B.1), though many ECM conditions supported equal or slightly
greater ALB+ cell percentages on 4 kPa substrates. However, during hepatocyte differentiation, total cell
number was influenced by substrate stiffness, with cell number per ECM domain significantly reduced on
the 4 kPa arrays across numerous ECM conditions (Figure B.2). Collectively, these results suggest that,
within the range tested, substrate stiffness does not exhibit a major effect on hepatocyte differentiation
but may influence cell survival or adhesion during the differentiation process. Further, ECM composition,
particularly the presence of C4, has a significant effect on hepatocyte differentiation of liver progenitor cells.
In parallel, we evaluated the effects of ECM and stiffness on cholangiocyte differentiation. We observed
that 24 h of TGFβ1 treatment was sufficient to substantially upregulate OPN. Specifically, cells in these
arrays were ALB− and OPN+ (Figure 3.2C) and further demonstrated reduced percentages of OPN+ cells
on 4 kPa substrates compared to 30 kPa on some ECM combinations (Figure 3.2D). Regression analysis
confirmed a significant reduction in OPN+ cell percentage on 4 kPa substrates (β=−24.1%, P<0.001)
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(Table B.1). The effect of ECM composition on OPN+ cell percentage between 30 kPa and 13 kPa substrates
was less pronounced (β=−8.88%, P=0.027). Cells in arrays treated with TGFβ1 did not substantially
express ALB regardless of ECM composition (Figure B.1B). In order to ascertain the effects of individual
ECM proteins, we performed separate regressions on data from the 30 kPa and 4 kPa substrates (Table B.2).
Regression of the 30 kPa substrate data showed that different ECM combinations did not account for most
variability in OPN+ cell percentage (adjusted R2=0.135, F[4, 55]=3.30, P=0.0170). Regression of the 4 kPa
substrate data, however, had a greater R2 and was highly significant (adjusted R2=0.420, F[4, 40]=8.97,
P<0.001) and showed that combinations containing C4 had the greatest OPN+ cell percentage (β=40.8%,
P<0.001). Although not statistically significant, combinations containing C1 also had a greater OPN+ cell
percentage (β=16.6%, P=0.129) compared to other ECM proteins on 4 kPa substrates. C3, LN, and FN did
not support differentiation as effectively as C4 and C1 on 4 kPa substrates. We selected C1, C4, FN, and all
two-factor combinations therein for further analysis. Examination of OPN+ cell percentages for these ECM
combinations from the TGFβ1+ arrays in Figure 3.2 recapitulated the results of our regression analyses: In
particular, C4 sustained cholangiocyte differentiation on 4 kPa substrates while FN does not (Figure 3.3A).
C1 exhibited an effect intermediate between C4 and FN. Fluorescent micrographs of the C1, C4, and FN
arrayed conditions were consistent with these quantitative results (Figure 3.3B).
Based on the cell microarray results, we scaled-up select conditions using chemical conjugation of individ-
ual ECM conditions to entire PA gel substrates and isolated bulk mRNA and protein for additional marker
analysis. Following treatment with TGFβ1, cells cultured on C4 exhibited greater expression of CK19 com-
pared to cells on FN (Figures 3C and 3D). CK19 is a cholangiocyte marker shared with progenitor cells,
and (consistent with the OPN data) the most substantial difference between the effects of C4 and FN on
CK19 expression was observed on 4 kPa substrates. In addition, we investigated the potential influence of
ECM composition and stiffness on the expression of cell–cell and cell–matrix adhesion molecules. Notably,
mRNA expression of E-cadherin (Cdh1 ), N-cadherin (Cdh2 ), and integrin β1 (Itgb1 ) was not significantly
affected by substrate stiffness (Figure B.3). ECM composition appeared to exhibit some influence, however,
with the presence of FN leading to increased mRNA expression for N-cadherin and integrin β1. Integrin αν
exhibited a distinct mRNA expression profile with similar expression between C4 and FN conditions on 30
kPa substrates but relatively reduced expression on C4 compared to FN on 4 kPa substrates (Figure B.3).
Due to their previously-recognized involvement in substrate stiffness sensing (Ingber 2006; Riento and Ridley
2003; Riveline et al. 2001), we further examined mRNA expression of the kinases ROCK1 and RAC1. Rock1
mRNA expression was relatively increased on C4 and FN 30 kPa substrates while Rac1 mRNA expression
was not influenced by composition or stiffness. In subsequent experiments (described below), we explored
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the functional role of these kinases in progenitor differentiation within the array format.
3.4.2 Cell contractility and traction stress in cholangiocyte differentiation
Cell contractility has been demonstrated to be a critical component of mechanostransduction pathways
underlying cellular responses to substrate stiffness (Ingber 2006; Vogel and Sheetz 2006; Wozniak and Chen
2009). The selective reduction in cholangiocyte differentiation on soft substrates suggested the potential
involvement of cell contractility in this differentiation process. To investigate this hypothesis, we treated cells
with (–)-blebbistatin, an inhibitor of myosin II contractility, and observed a relative decrease in OPN+ cell
percentage across each of the substrate stiffnesses (Figure 3.4A). We did not observe significant changes in cell
numbers resulting from (–)-blebbistatin treatment in these cholangiocyte differentiation arrays (Figure B.4),
indicating that the effect of blebbistatin on OPN expression was not due to an off-target effect on cell
survival or proliferation. These results suggest that myosin II contractility is necessary for cholangiocyte
differentiation independent of ECM composition and substrate stiffness.
We next sought to better understand the underlying biophysical mechanisms resulting in divergent cholan-
giocyte differentiation on C1, C4, and FN. We used TFM to examine both cell–substrate and cell–cell in-
teractions during cholangiocyte differentiation in TGFβ1+ arrays. Specifically, we measured the traction
stress, which is representative of interactions between the monolayer of BMEL cells on each arrayed ECM
domain and the underlying PA hydrogel substrate. Interestingly, cell monolayers on C4 generated greater
traction stress on 4 kPa substrates compared to 30 kPa (P<0.001) (Figures 3.4B and 3.4C). In contrast, the
traction stresses on C1 and FN were reduced on 4 kPa substrates compared to 30 kPa. Only FN, however,
demonstrated significant differences between the 4 kPa and 30 kPa substrates (P<0.001) (Figure 3.4C).
Therefore, ECM composition determines the magnitude of cell-generated traction stress in response to sub-
strate stiffness. In addition, cell monolayers on C1-C4 and C4-FN generated greater traction stress on 4
kPa substrates compared to 30 kPa. This result is in accordance with the effects of C4 on traction stress,
indicating that C4 functionality supersedes that of C1 and FN alone. Unlike C1 and FN alone, C1-FN
demonstrated greater traction stress on 4 kPa substrates compared to 30 kPa (P<0.001).
As part of the traction force analyses, we further calculated the contractile moment, which has been
previously utilized as a measure that reflects the strength of cell–cell interactions (Krishnan et al. 2011;
N. Wang et al. 2002). These measurements illustrate that the contractile moment declined on 4 kPa gels
for all ECM proteins presented individually as well as the C1-C4 combination (Figure B.5), and the most
pronounced relative reduction was observed for the FN domains. Therefore, for these ECM conditions,
reductions in substrate stiffness were correlated with reductions in the contractile moment. However, for
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cells on C1-FN and C4-FN, a different trend was observed, in which the distinct substrate stiffnesses did not
influence contractile moment in a statistically-significant manner.
Our TFM results indicate that within the context of cholangiocyte differentiation conditions (TGFβ1+),
C4 supports cell traction stress on both 30 kPa and 4 kPa substrates. This effect was different than what
we observed on FN, which exhibited dependence on the stiffness of the substrate. As a comparison, we
additionally investigated cell traction stress on both C4 and FN in hepatocyte differentiation conditions
(TGFβ1−) (Figure B.6). In contrast to the results observed for cholangiocyte differentiation, traction stress
was similarly reduced on 4 kPa versus 30 kPa substrates for both C4 and FN. These data suggest that the
dependence of cell traction stress on ECM composition or stiffness is further regulated by the differentiation
conditions, namely the presence of TGFβ1.
3.4.3 Effects of signaling pathway inhibitors on differentiation and cell
traction stress
We next aimed to explore the mechanisms by which ECM characteristics and cell traction stress regulate
cholangiocyte differentiation of progenitor cells. Within the microarray format, we induced cholangiocyte
differentiaton (TGFβ1+) and further treated the microarrays with a panel of signaling inhibitors or vehicle
control (DMSO). Specifically, among the factors tested were inhibitors against extracellular-signal-regulated
kinase (ERK), which modulates mitogen-activated protein kinase (MAPK) signaling through ECM–integrin
interactions (Aplin et al. 2001; Lai et al. 2001), and Rho-associated protein kinase (ROCK), which can
increase myosin II activity by phosphorylation (Amano et al. 1996). Treatment with an inhibitor of
ERK (FR180204) reduced OPN+ cell percentages for all ECM combinations on 30 kPa substrates (Fig-
ures 3.5A and 3.5B). Regression analysis confirmed that FR180204 reduced OPN+ cell percentages on 30
kPa (β=−29.5%, P<0.001) but not 4 kPa substrates (β=−4.78%, P=0.354) (Table B.3). In contrast, treat-
ment with an inhibitor of ROCK (Y-27632) increased OPN+ cell percentages (Figures 3.5A and 3.5B).
These results were corroborated by regression analysis, which indicated increases in OPN+ cell percentage
on both 30 kPa (β=16.3%, P<0.001) and 4 kPa (β=26.8%, P<0.001) substrates for treatment with Y-27632
(Table B.3). Notably, we observed statistically significant increases in OPN+ cell percentage for C1 and FN
but not C4 on both 30 kPa and 4 kPa substrates (Figure 3.5A).
Additionally, we used inhibitors against RAC1, a Rho family GTPase, and c-Jun N-terminal kinase (JNK)
(Figure B.7). RAC1 frequently opposes ROCK-mediated actin-myosin contractility (Sahai and Marshall
2002; El-Sibai et al. 2008) while JNK transduces integrin-mediated MAPK signaling, like ERK (Barr and
Bogoyevitch 2001; Johnson and Lapadat 2002). Treatment with an inhibitor of RAC1 (NSC23766) increased
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OPN+ cell percentages on 4 kPa substrates (β=38.9%, P<0.001) but not 30 kPa substrates (β=5.37%,
P=0.265) (Table B.3). Treatment with an inhibitor of JNK (SP600125) increased OPN+ cell percentages on
4 kPa substrates (β=12.8%, P=0.0265) but decreased them on 30 kPa substrates (β=−10.7%, P=0.0275)
(Table B.3). We did not observe toxicity due to any of the drug treatments and observed comparable, if not
greater, cells/island for the drug treatments in comparison to the DMSO control (Figure B.8).
Due to the intriguing increase in cholangiocyte differentiation following ROCK inhibition, particularly
on 4 kPa substrates, we hypothesized that ROCK inhibition would alter cell traction stress. Thus, we
examined cell-generated contractility and traction stress using TFM within the cell microarray together
with pharmacological inhibition of ROCK by Y-27632 (Figure 3.6). We found ROCK inhibition reduced
traction stress on both 4 kPa and 30 kPa substrates for all ECM combinations except FN (Figures 3.6A
and 3.6C). For 30 kPa substrates with FN, Y-27632 treatment was statistically indistinguishable from the
DMSO control. For 4 kPa substrates with FN, however, the traction stress increased with Y-27632 treatment
(P<0.001). These characteristic effects are displayed in representative heat maps of the traction stress for
C4 and FN on both 30 kPa (Figure 3.6B) and 4 kPa (Figure 3.6D) substrates. In addition, we calculated
the contractile moment and observed decreases for 30 kPa substrates with Y-27632 treatment for all ECM
combinations, including FN (Figure B.9A). For 4 kPa substrates, the contractile moment decreased with
Y-27632 treatment for C1, C4, and C1-FN and increased for FN and C4-FN (Figure B.9B).
Based on our finding that ERK inhibition significantly reduced cholangiocyte differentiation within the
arrays, we further investigated the role of ERK in the differentiation process. Using scaled-up substrates
containing chemically conjugated C4 or FN, we examined the activation of ERK signaling through the
immunoblot assessment of phosphorylated ERK1 and ERK2 (p-ERK). Following induction of cholangiocyte
differentiation (TGFβ1+), p-ERK levels were slightly increased at 24 h relative to basal levels exhibited
by undifferentiated BMEL cells (Figures 3.7A and 3.7C), and then decreased relative to basal at 72 h
(Figure 3.7B and 3.7C). This increase at 24 h was observed for C4 on both 30 kPa and 4 kPa substrates. For
the FN conditions, cells on 4 kPa substrates exhibited a modest reduction in p-ERK levels compared to cells
on 30 kPa at the 24 h time point. These data are suggestive of a stiffness dependence of p-ERK activation on
FN, a result consistent with the cholangiocyte differentiation for that ECM condition. In addition, we further
investigated the potential influence of ERK inhibition on cell traction stress. Utilizing cell microarrays on
30 kPa substrates, we performed TFM analysis and measured the effect of the ERK inhibitor (FR180204)
on cell traction on domains containing both C4 and FN. Notably, at 24 h of cholangiocyte differentiation,
ERK inhibition did not significantly alter cell traction stress on either of the ECM conditions (Figures 3.7D
and 3.7E), indicating that ERK signaling is not an upstream regulator of the observed cell traction at
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that time point. Taken together, these data suggest that ERK signaling is likely one of the mechanisms
sensing ECM composition and stiffness in these cells and may act downstream of cell traction stress in the
mechanoregulation of cholangiocyte differentiation.
3.5 Discussion
Stem cell differentiation is regulated by features of the local microenvironment such as mechanical feedback
(Discher, Janmey, et al. 2005; A. J. Engler et al. 2006), protein composition (Frantz et al. 2010), and soluble
factor presentation (Discher, Mooney, et al. 2009; Park et al. 2011). Previous studies extensively investigated
the effects of select ECM proteins on cellular responses but the complexity of the multi-component ECM
(Trappmann and Chen 2013) requires the development of new strategies to further unveil the role of ECM
biomechanics in cellular functionality. Similarly, the stiffness of the liver microenvironment has been shown
to play a regulatory role in the function of mature hepatocytes (S. S. Desai et al. 2016; Wells 2008). These
biomechanical effects have been associated with the activation of specific signaling pathways (e.g., ERK)
(Klein et al. 2009; Rosenfeldt and Grinnell 2000) and are correlated with growth factor presentation (Li et
al. 2007). Although healthy liver consists of relatively soft tissue with stiffness measuring from 150–600 Pa
(S. S. Desai et al. 2016; Georges et al. 2007), local stiffness has been shown to be greater near the periportal
region (S. S. Desai et al. 2016), where cholangiocyte differentiation and bile duct morphogenesis occur during
liver development. In addition, liver stiffness can substantially increase during liver fibrosis and cirrhosis to
≥20 kPa (Venkatesh and Ehman 2014; Yeh et al. 2002; Yin et al. 2007). Such conditions result from chronic
liver injury that is often associated with ductular reactions within the adult liver consisting of proliferative
cells exhibiting progenitor markers (Gouw et al. 2011; Roskams et al. 2004). This suggests that progenitor
differentiation may occur within the context of stiffening microenvironments in disease settings. Collectively,
despite the potential role of ECM stiffness in liver progenitor differentiation, there have not been extensive
studies to analyze this subject.
To assess potential cooperative effects of the biochemical and biophysical properties of ECM, we inte-
grated cell microarrays with PA hydrogels exhibiting a range of stiffness. Using this approach, we found that
liver progenitor cells commit toward a cholangiocyte phenotype on higher stiffness substrates. However, the
effects of substrate stiffness on cholangiocyte differentiation varied upon the type of ECM protein arrayed
over the elastic substrates. We have schematically summarized these overall findings in Figure 3.8. In partic-
ular, liver progenitor differentiation was sensitive to substrate stiffness on FN, likely due to force-dependent
unfolding (Baneyx et al. 2002; Smith et al. 2007) that enhances integrin α5β1-mediated adhesion through
66
the presence of the synergy peptide (e.g., PHSRN) (Friedland et al. 2009). In contrast with FN, presenta-
tion of C4 blunted stiffness-mediated cholangiocyte differentiation. This could be due to the formation of
a mechanically robust network of C4 (Yurchenco and Ruben 1987) or the C4-induced activation of α1β1
integrins that have been previously shown to mitigate stiffness sensing (Eble et al. 1993; Louis et al. 2007).
Notably, hepatocyte differentiation was substantially less affected by stiffness. However, ECM composition
did influence the expression of ALB, in particular, the presence of C4 reduced the expression of ALB relative
to other ECM conditions. Together with the low expression of OPN on C4 under hepatocyte differentiation
conditions, we hypothesize that the presence of C4 may maintain an undifferentiated progenitor phenotype,
a mechanism that could be systematically explored in future studies utilizing the cell microarray platform.
In addition, based on recent reports examining hepatocyte functionality (S. S. Desai et al. 2016), it is possi-
ble that hepatocyte differentiation of progenitor cells may be most significantly influenced by alterations in
stiffness below 1 kPa. Future efforts could aim to adapt the microarray platform to support high-throughput
investigations at this range of stiffness.
Our results demonstrate that the effects of different ECM proteins on cholangiocyte differentiation were
consistent with the generated traction stress. Indeed, for FN and less profoundly for C1, cells generated
significantly greater traction on stiffer substrates. In contrast, cells on C4 exhibited similar traction stress
on both stiff and soft substrates. Therefore, the magnitude of traction stress connects ECM composition
to the degree of cholangiocyte differentiation. Furthermore, actin-myosin contractility represents a critical
cytoplasmic mechanism by which cells generate mechanical stress to sense and respond to their local mi-
croenvironment. In the cellular microarrays, inhibiting myosin II with (–)-blebbistatin diminished the effects
of stiffness on cholangiocyte differentiation for every ECM composition, connecting actin-myosin contrac-
tility with cholangiocyte differentiation. Based on the TFM analysis, we also calculated a measure termed
the contractile moment, which has been shown to be characteristic of the degree of intercellular traction
at the cell–cell interface (Krishnan et al. 2011; N. Wang et al. 2002). Interestingly, the contractile moment
positively correlated with substrate stiffness for the presentation of individual proteins (e.g., C1, C4, or FN).
In contrast, the presentation of ECM pairs supported stiffness-independent generation of traction stress and
contractile moment. These results are suggestive of important interactions between cell–ECM and cell–cell
signaling, which are further supported by the intriguing results observed following inhibition of ROCK and
RAC1.
Since ROCK and RAC1 are known to promote cell contractility through myosin II phosphorylation and
actin polymerization (Sit and Manser 2011), respectively, we examined their contribution to cholangiocyte
differentiation. Interestingly, inhibition of ROCK (and RAC1) substantially increased cholangiocyte dif-
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ferentiation on soft substrates. However, ROCK inhibition primarily reduced cell traction stress with the
notable exception being FN, for which ROCK inhibition increased cell traction on 4 kPa substrates. Based
on the previously demonstrated roles of ROCK and RAC1 in the destabilization of cell–cell adhesions within
defined treatment contexts (Frasa et al. 2010; Sahai and Marshall 2002), we hypothesize that ROCK and
RAC1 inhibition within the cell microarray format may enhance cell–cell interactions and therefore promote
cholangiocyte differentiation in a manner that is not dependent on cell–ECM traction. Consequently, the
treatment of progenitor cells with ROCK and RAC1 inhibitors facilitated cholangiocyte lineage specification
independent of substrate stiffness. Building on our results presented here, the additional incorporation of
techniques for directly measuring cell–cell traction forces, such as fluorescence resonance energy transfer
(FRET)-based molecular tension sensors (Borghi et al. 2012; Kim et al. 2015) into the array format could
provide critical insights into potential cooperative interactions with intercellular adhesion signaling.
The ECM proteins presented in the cellular arrays (e.g., C1, C4 and FN) have been shown to support β1
integrin-mediated ERK signaling (Giancotti 2000), whose phosphorylation has been previously correlated
with stiffness-mediated differentiation in mature hepatocytes (Schrader et al. 2011). Here, the pharmaco-
logical inhibition of ERK significantly reduced cholangiocyte differentiation, particularly on stiff substrates.
Furthermore, TFM showed that ERK inhibition had negligible effects on traction stress, suggesting that
ERK activation is downstream of contractility. Moreover, the effects of stiffness on cholangiocyte differenti-
ation coincided with the increased expression of phosphorylated ERK at 24 h which subsequently decreases
by 72 h following differentiation induction. For FN, this increase in ERK phosphorylation was primarily
observed on stiff substrates with the soft substrates exhibiting a level of phosphorylation below basal un-
differentiated cells. In contrast, C4 presentation led to the highest observed levels of phosphorylated ERK
at the 24 h time point. These characteristics of ERK activation are consistent with the stiffness effects on
differentiation and traction stress identified for FN and C4. Collectively, these findings provide insight into
the mechanisms that regulate cholangiocyte differentiation in response to combinatorial ECM cues. Despite
the apparent roles of ERK and ROCK in the early stages of cholangiocyte specification, future experiments
will be required in order to decouple their distinct contributions to liver progenitor differentiation.
3.6 Conclusions
We have examined how biomechanical cues and ECM proteins coordinately regulate the differentiation of
liver progenitor cells. We combined cell microarrays on substrates of tunable stiffness with TFM in order
to simultaneously assess phenotype and cell-generated traction stress. Cholangiocyte differentiation was
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dependent on both the type of ECM protein presented and the stiffness of the substrate. We showed that
actin-myosin contractility controls cholangiocyte differentiation independent of ECM composition and stiff-
ness. We further demonstrated the involvement of ERK signaling in cholangiocyte differentiation, though
ERK inhibition did not directly affect traction stress generation. Overall, we have described an integrated
approach to examine the mechanisms by which combinatorial biochemical and biomechanical ECM cues
control cell fate. This strategy provides significant insight into cell–ECM interactions during progenitor
differentiation and can facilitate numerous future efforts examining the mechanisms underlying liver devel-
opment and disease.
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3.7 Figures
Figure 3.1: An integrated platform for correlating fate processes with both biochemical and biophysical
parameters. (A) ECM combinations were arrayed on a PA hydrogel substrate, enabling simultaneous control
of ECM composition and PA modulus. (B) Cells cultured on ECM arrays were assessed for phenotypic
marker expression. (C) Cells on PA substrates doped with fluorescent beads, enabling measurement of
cell-generated forces on ECM arrays. Scale bars are 50 µm.
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Figure 3.2: Cell microarray-based analysis of the effects of ECM composition and substrate modulus on
liver progenitor differentiation. (A) Representative arrays on 30 kPa and 4 kPa substrates after 72 h of
differentiation without TGFβ1 labeled for nuclei (DAPI), ALB, and OPN. (B) Quantification of TGFβ1−
arrays for ALB+ cell percentage. (C) Representative arrays on 30 kPa and 4 kPa substrates after 24 h of
differentiation with TGFβ1 (1.5 ng/ml) labeled for nuclei (DAPI), ALB, and OPN. (D) Quantification of
TGFβ1+ arrays for OPN+ cell percentage. Arrays in (A) and (C) are 4.5×9.0 mm (10×20 islands) and
each island is approximately 150 µm in diameter. Data presented as mean ± s.e.m. with n=2 and 40 total
islands per condition. See also Figures B.1 and B.2 as well as Tables B.1 and B.2.
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Figure 3.3: Cholangiocyte differentiation is dependent on both ECM composition and substrate stiffness.
(A) Selected ECM combinations from TGFβ1+ arrays highlighting differential response to stiffness between
C4 and FN. Student’s t-tests were performed against 30 kPa for each ECM combination. (B) Representative
micrographs of the C1, C4, and FN arrayed conditions on 30 kPa and 4 kPa substrates labeled for nuclei
(DAPI), ALB, and OPN. (C) Representative immunoblots of cells cultured for 24 h with TGFβ1 (1.5 ng/ml)
on 30 kPa and 4 kPa substrates conjugated with C4 and FN using sulfo-SANPAH. (D) Quantification
of CK19 immunoblot data normalized by β-actin. Student’s t-tests were performed against 30 kPa C4
substrates. Data presented as mean ± s.e.m. with n=2 and 40 total islands per condition in arrays and n=3
for sulfo-SANPAH experiments. P-values indicated for P<0.05 (*), P<0.01 (**), and P<0.001 (***). Scale
bars are 50 µm. See also Figure B.3.
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Figure 3.4: Cell-generated traction stress integrates cues from both substrate stiffness and ECM com-
position. (A) Selected ECM combinations in TGFβ1+ arrays treated with DMSO (vehicle control) and
(–)-blebbistatin (25 µM). Student’s t-tests were performed against DMSO for each ECM combination on
each stiffness. (B) Representative phase contrast micrographs and heat maps of traction stress for C4 and
FN in TGFβ1+ arrays. (C) Quantification of root mean square values of traction stress in TGFβ1+ arrays.
Student’s t-tests were performed against 30 kPa for each ECM combination. Data presented as mean ±
s.e.m. with n=3 and 20–50 total islands per condition. P-values indicated for P<0.05 (*), P<0.01 (**), and
P<0.001 (***). Scale bars are 50 µm. See also Figures B.4, B.5, and B.6.
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Figure 3.5: Treatment of cell microarrays with signaling pathway inhibitors. (A) Quantification of OPN+
cell percentage on selected ECM combinations in TGFβ1+ arrays treated with inhibitors against ERK
(FR180204, 10 µM) and ROCK (Y-27632, 10 µM). Student’s t-tests were performed against DMSO for
each treatment within each ECM combination. (B) Representative fluorescent micrographs of C4 and FN
conditions labeled for nuclei (DAPI) and OPN. Data presented as mean ± s.e.m. with n=3 and 60 total
islands per condition. P-values indicated for P<0.05 (*), P<0.01 (**), and P<0.001 (***). Scale bars are
50 µm. See also Figures B.7 and B.8 and Table B.3.
74
Figure 3.6: Evaluation of cell traction stress in the context of ROCK inhibition. Traction stress generated
in TGFβ1+ arrays on 30 kPa (A) and 4 kPa (C) substrates with DMSO (vehicle control) and an inhibitor
of ROCK (Y-27623, 10 µM). Representative phase contrast micrographs and heat maps of traction stress for
30 kPa (B) and 4 kPa (D) substrates. Student’s t-tests were performed against DMSO within each ECM
combination. Data presented as mean ± s.e.m. with n=3 and approximately 20 total islands per condition.
P-values indicated for P<0.05 (*), P<0.01 (**), and P<0.001 (***). See also Figure B.9.
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Figure 3.7: Assessment of ERK signaling and effects on cell traction. Representative immunoblots for cells
differentiated with TGFβ1 (1.5 ng/ml) for 24 h (A)) and 72 h (B) on 30 kPa and 4 kPa substrates conjugated
with C4 and FN using sulfo-SANPAH. (C) Quantification of p-ERK immunoblot data normalized by β-actin
and basal controls. (D) Traction stress generated in TGFβ1+ arrays on 30 kPa substrates treated with
DMSO (vehicle control) and an inhibitor of ERK (FR180204, 10 µM). (E) Representative phase contrast
micrographs and heat maps of traction stress for C4 and FN. Data presented as mean ± s.e.m. with n=3
and 20–25 total islands per condition in arrays. Scale bars are 50 µm.
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Figure 3.8: Schematic summary of overall findings. Both C4 and FN support cholangiocyte differentiation
of liver progenitors on stiff substrates while only C4 does so on soft substrates. Differentiation on stiff C4
and FN substrates is dependent on myosin II contractility and ERK signaling and is further associated with
high traction stresses. In contrast, soft FN substrates are associated with low traction stress and result
in reduced cholangiocyte differentiation. Inhibition of either ROCK or RAC1 increases cholangiocyte fate
specification on soft FN substrates.
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Chapter 4
Notch signaling coordinates with cell
contractility to drive biliary
differentiation of liver progenitor cells∗
4.1 Abstract
The progenitor cells of the developing liver are capable of differentiating toward both hepatocyte and biliary
epithelial cell fates. In addition to the established role of TGFβ and Notch signaling in this fate specifi-
cation process, there is increasing evidence that liver progenitors are sensitive to mechanical cues in their
microenvironment. Here, we utilized microarrayed patterns of the extracellular matrix protein collagen I
together with the Notch ligands JAG1, DLL1, and DLL4 to provide a controlled biochemical and biome-
chanical microenvironment for progenitor cells. In these patterns, we observed biliary differentiation at the
periphery upon presentation with Notch ligand. Further characterization confirmed peripheral expression of
the biliary markers OPN, SOX9, and CK19 and central expression of the hepatic markers ALB and HNF4A.
Localized differentiation toward both fates was found to be sensitive to changes in substrate stiffness: hepatic
differentiation occurred preferentially on soft (E ∼ 4 kPa) substrates while biliary differentiation increased
on stiff (E ∼ 30 kPa) substrates. In situ hybridization of arrayed patterns revealed peripheral localization of
mRNA for the Notch ligands Jag1 and Dll1 as well as the receptor Notch2. Parallel measurements obtained
by traction force microscopy and corroborated by finite element modeling showed substantial stresses at
the periphery, coincident with maximal biliary differentiation. We investigated the impact of downstream
signaling events in a series of inhibition studies, showing that peripheral biliary differentiation is dependent
on Notch, TGFβ, and myosin-mediated cell contractility and further antagonized by ERK. We have there-
fore delineated distinct sets of biomechanical cues which coordinate with Notch signaling to guide the fate
specification of liver progenitors toward both hepatocyte and biliary epithelial cell fates.
∗This chapter is currently in preparation as a manuscript for submission to a peer-reviewed journal.
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4.2 Introduction
The cells which populate the hepatic diverticulum during development and later serve as the source of liver
parenchyma are termed bipotential progenitor cells, or hepatoblasts, as they are capable of differentiating
toward both hepatocytic and biliary epithelial cell fates. While differentiation of liver progenitors toward
a hepatocytic fate is guided chiefly by signaling through Wnt, HGF, and FGF (Berg et al. 2007; Micsenyi
et al. 2004; Schmidt et al. 1995), biliary fate is specified by Notch and TGFβ signaling (Clotman, Jacquemin,
et al. 2005; Clotman and Lemaigre 2006; Kodama et al. 2004; Zong et al. 2009). Specifically, a gradient
of TGFβ activity caused in part by expression of TGFβR2 and TGFβR3 in the periportal region leads to
differentiation of progenitors toward a biliary epithelial fate (Antoniou et al. 2009; Clotman, Jacquemin,
et al. 2005). Mutations in the receptor NOTCH2 or ligand JAG1 are associated with bile duct paucity and
cholestasis in patients with Alagille syndrome (L. Li et al. 1997; McDaniell et al. 2006; Oda et al. 1997). By
deletion of the Notch effector Rbpj, Zong et al. (2009) showed that Notch is necessary for both biliary cell
fate and tubulogenesis.
Thus, the progenitor cells of the developing liver integrate a diverse set of biochemical cues during fate
specification. Yet several recent lines of evidence suggest that liver progenitor cells are influenced not only
by biochemical cues but also biophysical parameters in their microenvironment. For example, we recently
determined that biliary differentiation is coordinated by both substrate stiffness and extracellular matrix
(ECM) composition (Kourouklis et al. 2016). Others have focused on the role of YAP, which is known
to act directly as a mechanosensor (Dupont et al. 2011), and associated repression by Hippo-associated
kinases LATS1 and LATS2 (Camargo et al. 2007; Yimlamai et al. 2014). This is particularly interesting
in the context of liver progenitor fate specification because YAP has been shown to regulate both Notch
signaling and biliary fate through direct binding of its nuclear co-factor TEAD (Yimlamai et al. 2014),
though others have presented evidence that TGFβ, and not Notch, is downstream of YAP in the context of
biliary differentiation (D.-H. Lee et al. 2016). Thus, the potential link between mechanical sensing, through
either YAP or other means, and the fate specification of liver progenitor cells has not yet been fully defined.
Toward this end, we utilize here microarrayed patterns of ECM co-printed with Notch ligands to pro-
vide a controlled biochemical and biomechanical environment for liver progenitor cell differentiation. We
characterize spatially-localized differentiation of these progenitor cells toward biliary fates at the periphery
of patterns and hepatocyte fates near the center of patterns. This process of localized differentiation is
dependent on both Notch and TGFβ signaling and is further sensitive to substrate stiffness. Traction force
microscopy (TFM) was used to measure cell-generated forces, indicating high stresses co-incident with pe-
ripheral biliary differentiation. Finally, we determined that peripheral biliary differentiation of progenitors
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was dependent on myosin-mediated contractility and oppositional with ERK signaling.
4.3 Methods
4.3.1 Cell culture
We utilized bipotential mouse embryonic liver (BMEL) 9A1 cells between passages 30 and 36. These cells
were cultured as previously described (Strick-Marchand and Weiss 2002). Briefly, cells were seeded on tissue
culture plastic coated with collagen I (0.5 mg/ml) and subsequently cultured under controlled environmental
conditions (37°C and 5% CO2). Treatment with trypsin-EDTA (0.25% v/v) for ≤10 min was used to
detach cells for subculturing. Basal media for expansion consisted of RPMI 1640 with fetal bovine serum
(10% v/v, FBS), penicillin/streptomycin (1% v/v, P/S), l-glutamine (1% v/v), human recombinant insulin
(10 µg/ml, Life Technologies, 12585-014), IGF-2 (30 ng/ml, PeproTech, 100-12), and EGF (50 ng/ml,
PeproTech, AF-100-15). Differentiation media consisted of Advanced RPMI 1640 (Life Technologies, 12633-
012) with FBS (2% v/v), P/S (0.5% v/v), l-glutamine (1% v/v), and minimum non-essential amino acids
(1% v/v, Life Technologies, 11140-050). During differentiation experiments, cells were seeded on arrays at
1E6 cells/slide (immunocytochemistry) and 500E3 cells/dish (TFM). Cells were allowed to adhere to arrays
for 2 h before addition before 2× washes with differentiation media and subsequent addition of experiment-
specific treatments. All growth factors and drugs used in these experiments were prepared and reconstituted
according to the instructions of the manufacturers; see Table C.1.
4.3.2 Preparation of polyacrylamide hydrogels
Polyacrylamide (PA) hydrogels were prepared following previous protocols (Aratyn-Schaus et al. 2010; Tse
and Engler 2010; Wen et al. 2014). Briefly, 25×75 mm glass microscope slides were washed with 0.25% v/v
Triton X-100 in dH2O and placed on an orbital shaker for 30 min. After rinsing with dH2O, slides were
immersed in acetone and placed on the shaker for 30 min. The acetone wash was followed by immersion
in methanol and another 30 min on the shaker. The slides were then washed with 0.2 N NaOH for 1 h,
rinsed with dH2O, air-dried, and placed on a hot plate at 110°C until dry. For silanization, the cleaned slides
were immersed in 2% v/v 3-(trimethoxysilyl)propyl methacrylate in ethanol and placed on the shaker for 30
min. The silanized slides were washed with ethanol on the shaker for 5 min, air-dried, and again placed on
the hot plate at 110°C until dry. For fabrication of hydrogels with specific elastic moduli, two prepolymer
solutions with different acrylamide/bis-acrylamide percentage (w/v) ratios were prepared to achieve elastic
moduli of 4 kPa (4% acrylamide, 0.4% bis-acrylamide) and 30 kPa (8% acrylamide, 0.55% bis-acrylamide)
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with similar porosity (Wen et al. 2014). Each of these prepolymer solutions were mixed with Irgacure 2959
(BASF, Corp.) solution (20% w/v in methanol) at a final volumetric ratio of 9:1 (prepolymer:Irgacure). This
working solution was then deposited onto slides (100 µl/slide) and covered with 22×60 mm cover glasses.
The sandwiched working solution was transferred to a UV oven and exposed to 365 nm UV A for 10 min
(240E3 µJ). After removing the cover glasses, the slides were immersed in dH2O at room temperature for 3
d in order to remove excess reagents from the hydrogel substrates. Before microarray fabrication, hydrogel
substrates were thoroughly dehydrated on a hot plate for ≥15 min at 50°C.
4.3.3 Microarray fabrication
Microarrays were fabricated as described previously (Brafman et al. 2012; Flaim et al. 2005; Kaylan, Er-
milova, et al. 2016). Biomolecules for arraying were diluted in 2× growth factor buffer (38% v/v glycerol
in 1× PBS, 10.55 mg/ml sodium acetate, 3.72 mg/ml EDTA, 10 mg/ml CHAPS) and loaded in a 384-well
V-bottom microplate. Collagen I (rat tail, EMD Millipore, 08-115) was prepared at a final concentration
of 500 µg/ml. Fc-recombinant Notch ligand solutions were prepared at a final concentration of 104 µg/ml
and included: Fc-JAG1 (R&D Systems, 599-JG-100), Fc-DLL1 (R&D Systems, 5026-DL-050), and Fc-DLL4
(Adipogen, AG-40A-0145-C050). All Notch ligand conditions were pre-conjugated with Protein A/G (Life
Technologies, 21186) at a minimum 1:6 molar ratio (A/G:ligand) before arraying. Human IgG (104 µg/ml
final, R&D Systems, 1-001-A) was arrayed as a control in experiments involving Notch ligands. A robotic
benchtop microarrayer (OmniGrid Micro, Digilab) loaded with SMPC Stealth microarray pins (ArrayIt) was
used to transfer biomolecules from source plate to polyacrylamide hydrogel substrate, producing ∼600 µm
diameter arrayed domains. Fabricated arrays were stored at room temperature and 65% RH overnight and
left to dry under ambient conditions in the dark. Prior to cell culture, the arrays were sterilized with 30 min
UVC while immersed in 1× PBS supplemented with 1% (v/v) P/S, after which cells were seeded on arrays
as described above.
4.3.4 Immunocytochemistry and imaging
Samples were fixed in paraformaldehyde (4% w/v in 1× PBS) for 15 min. Samples intended for labeling of
secreted proteins (namely ALB and OPN) were treated with brefeldin A (10 µg/ml, R&D Systems, 1231/5)
for 2 h prior to fixation. Fixed samples were permeabilized with Triton X-100 (0.25% v/v in 1× PBS) for
10 min and incubated in blocking buffer (5% v/v donkey serum and 0.1% v/v Triton X-100 in 1× PBS) for
1 h at room temperature. We incubated samples for 1 h at room temperature or overnight at 4°C with one
or two of the primary antibodies listed in Table C.2 diluted in blocking buffer. The next day, we incubated
88
samples for 1 h at room temperature with one or two of the following secondary antibodies diluted in blocking
buffer: DyLight 488-conjugated donkey anti-rabbit IgG (1/50 from stock, Abcam, ab96919), DyLight 550-
conjugated donkey anti-mouse IgG (1/50 from stock, Abcam, ab98767), and DyLight 488-conjugated donkey
anti-goat IgG (1/50 from stock, Abcam, ab96935). Samples were mounted in Fluoromount G with DAPI
(Southern Biotech, 0100-20) and imaged no earlier than the day after mounting using an Axiovert 200M
microscope (Carl Zeiss, Inc.) and associated Zen Pro software. In order to capture entire arrays as one
image for later analyses, we utilized the tiling feature of Zen Pro.
4.3.5 In situ hybridization and imaging
We performed in situ hybridization similarly to previously-described protocols (Aujla et al. 2015; Biehl and
Raetzman 2015). Samples were fixed in paraformaldehyde (4% w/v in 1× PBS) for 10 min, permeabilized
with 0.3% Triton X-100 in 1× PBS for 15 min, and digested with Proteinase K (0.1 µg/ml) for 15 min at 37°C.
Afterwards, samples were acetylated, pre-hybridized, and incubated in hybridization solution with linearized,
digoxigenin-labeled probes for Jag1, Dll1, Notch1, Notch2, or Hes1 (Lori T. Raetzman and Matthew J. Biehl,
Molecular and Integrative Physiology) at 55°C. Prior to initiation of hybridization, probes were denatured for
3 min at 95°C. After overnight incubation, samples were washed in 50% 0.5× formamide solution, washed
in 0.5× sodium citrate, and blocked (10% heat-inactivated sheep serum, 2% bovine serum albumin and
0.1% Triton X-100 in tris-buffered saline). Following blocking, slides were incubated with anti-digoxigenin
antibody (see Table C.2) diluted in blocking buffer for 1 h. Next, samples were washed with tris-buffered
saline of increasing alkalinity (pH=7.5, 9.5) and incubated overnight in NBT/BCIP developing solution
(Roche, 11 681 451 001). Samples were subsequently fixed with paraformaldehyde (4% w/v in 1× PBS for
10 min), mounted in Fluoromount G with DAPI (Southern Biotech, 0100-20), and imaged similarly to the
immunofluorescently-labeled samples described above.
4.3.6 Traction force microscopy and finite element analyses
For the TFM experiments, we adjusted our protocol in order to fabricate the PA hydrogels in glass-bottom
35 mm Petri dishes (Cell E&G, GBD00002-200) rather than on 25×75 mm microscope slides. This enabled
us to perform TFM on live cells at 37°C and 5% CO2. To measure the cell-generated forces, we added 1
µm far-red fluorescent beads (0.2% v/v, Life Technologies, F-8816) to the working solution (J. H.-C. Wang
and J.-S. Lin 2007; N. Wang et al. 2002) and fabricated hydrogels with embedded beads by exposure to
365 nm UV A for 10 min. We subsequently completed the hydrogel and array fabrication protocols as
described above and seeded cells on the arrays. After completion of experiment-specific treatments, the
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arrays were transferred to an incubated (37°C and 5% CO2) Axiovert 200M microscope (Carl Zeiss, Inc.).
The microscope was used to capture phase contrast and far-red fluorescent micrographs to record cellular
position and morphology along with bead displacement before and after treatment with sodium dodecyl
sulfate (1% v/v in 1× PBS). The captured images were analyzed in MATLAB using a custom version of
a previously-published script to extract the traction stress and contractile moment (Butler et al. 2002; N.
Wang et al. 2002). See Kaylan, Kourouklis, et al. (2017) for a more detailed description.
Theoretical stress profiles were obtained by construction of a 3D finite element model of the patterned cell
monolayer as described (Nelson et al. 2005) using previously-defined parameter values (Folkman and Moscona
1978; Ohshima and Nerem 1990). Briefly, a two-layer model containing an active top layer (patterned cells)
and passage bottom layer (substrate) was constructed. Contractility was induced in the active layer by
temperature reduction, yielding isotropic thermal strain and associated stresses.
4.3.7 Image processing and analysis of microarrays
Images of entire arrays were converted to individual 8-bit TIFF files per channel (i.e., red, green, blue, and
gray) by Fiji (ImageJ version 1.51n) (Schindelin et al. 2012; Schneider et al. 2012). Image size was reduced to
∼50 megapixels/channel by binning to reduce memory requirements during computational analysis. The Ide
ntifyPrimaryObjects and IdentifySecondaryObjects modules of CellProfiler (version 2.2.0) (Kamentsky
et al. 2011) were used to identify nuclei for cell counts and regions marked by fluorescence or enzyme
activity, respectively. The MeasureObjectIntensity module was used to quantify single-cell intensity for
both immunofluorescence and in situ hybridization. The location of arrayed conditions within each image
was automatically determined relative to manually-located dextran-rhodamine markers. The centroid of
each island was calculated and used to assign a radial distance to each cell for analyses of spatial localization
within arrayed patterns.
4.4 Results
4.4.1 Patterned liver progenitors exhibit spatially-localized differentiation
We had previously observed peripheral expression of the biliary marker OPN in liver progenitors on arrayed
patterns containing both ECM proteins and Notch ligands (Kaylan, Ermilova, et al. 2016). In order to better
characterize the expression profile of these peripheral cells vs. those more centrally-located, we fabricated
arrays of patterns (∼600 µm diameter) containing the ECM protein collagen I paired with either control
IgG or Fc-recombinant Notch ligands (DLL1, DLL4, JAG1). These ligands were pre-conjugated to Protein
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A/G so as to increase ligand functionality by clustering and orientation as previously described (Kaylan,
Ermilova, et al. 2016). BMEL progenitor cells, which are capable of assuming a hepatocytic or biliary fate
(Strick-Marchand and Weiss 2002), were seeded on these Notch ligand arrays and cultured under differen-
tiation conditions for t = 72 h, at which point we immunolabeled for OPN and the hepatocytic marker
ALB. In agreement with our previous experiments, we observed cells expressing OPN at the periphery of
patterns while those expressing ALB were located centrally (Figure 4.1A). Counts of cells positive for OPN
confirmed peaks near 300 µm from the pattern center (Figure 4.1B). Also in agreement with our previous
experiments, peripheral expression of OPN increased with the presentation of Notch ligands, particularly
DLL4 (Figure 4.1B). Counts of cells positive for ALB, however, indicated primarily central localization and
further did not suggest responsiveness to ligand (Figure 4.1C).
Next, we generated probability density functions to compare the localization of OPN+ to ALB+ cells
(Figure C.1). We observed that these two populations of cells are largely exclusive and, specifically, that
there is a comparatively low probability of an ALB+ cell appearing in the outer 50 µm of the patterns, where
most OPN+ cells are located. We also evaluated expression of another biliary marker, CK19, and found
localized expression at the periphery (Figure C.2). To further generalize our conclusions, we immunolabeled
arrayed patterns for a biliary transcription factor, SOX9, as well as a hepatocytic transcription factor HNF4A
(Figure 4.1D). In agreement with our data for OPN and ALB, we observed peripheral expression of SOX9
and central expression of HNF4A. Prompted by previous experiments which showed that liver progenitor
differentiation is sensitive to substrate stiffness (Kourouklis et al. 2016), we also evaluated expression of SOX9
and HNF4A on soft (4 kPa) rather than stiff (30 kPa) substrates, observing abrogation of SOX9 expression
and an increase in HNF4A expression (Figure 4.1D). Quantification of immunolabel intensity for SOX9
and HNF4A on both soft and stiff substrates confirmed our qualitative observations (Figure 4.1E). We also
considered whether the localization of the immunolabels might be related to an artifact of the array format.
Evaluation of the expression of the liver progenitor marker EpCAM and cell–cell adhesion molecules CDH1
(E-cadherin) and CDH2 (N-cadherin) with the same secondary antibodies utilized for our other experiments
showed largely uniform patterns, supporting the fidelity of previous observations of differentiation gradients.
4.4.2 Notch and TGFβ signaling are necessary for localized differentiation
Previous studies have delineated a role for both TGFβ and Notch in liver progenitor differentiation (Clotman,
Jacquemin, et al. 2005; Clotman and Lemaigre 2006; Zong et al. 2009) and we have previously examined
interactions between these two pathways (Kaylan, Ermilova, et al. 2016). To determine if these signaling
pathways are both required for the generation of biliary cells at the periphery of the arrayed patterns, we
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treated cells with inhibitors of Notch (γ-secretase inhibitor X, GSI) and TGFβ (SB-431542, SB), observing
that both are required for peripheral expression of OPN (Figure 4.2A). We further observed that the efficacy
of DLL4 toward inducing peripheral OPN expression is blunted on soft (4 kPa) vs. stiff (30 kPa) substrates
(Figure 4.2A). In contrast, expression of SOX9 and HNF4A upon treatment with SB-431542 is only subtly
different (Figure 4.2B). Presentation of DLL4 appears to induce sporadic central expression of SOX9, an
effect which is not seen in patterns treated with SB-431542. Closer examination shows that cells positive
for SOX9 in the vehicle control (DMSO) condition are not observed in the SB-431542 condition and are
further replaced by cells positive for HNF4A (Figure 4.2C). Somewhat counter-intuitively, central HNF4A
is reduced with inhibition of TGFβ signaling by SB-431542 (Figure 4.2C).
We next used in situ hybridization in order to better understand the expression of Notch family members
in these patterns. To do so, we validated several probes against Notch family members including Jag1, Dll1,
Notch1, Notch2, and Hes1 (Figure C.4). When used to localize mRNA in arrayed patterns fabricated
on stiff (30 kPa) substrates, we observed peripheral localization of Jag1, Dll1, and Notch2 (Figure 4.3).
Presentation of the ligand DLL4 induced rearrangement of this expression pattern, specifically causing an
increase in centrally-located cells expressing mRNA for each gene. On soft (4 kPa) substrates, we found
greater contrast in mRNA expression between peripheral and central cells but no longer observed ligand-
induced central expression (Figure 4.3).
4.4.3 Mechanotransduction pathways guide peripheral biliary fate
Given the known inducement of mechanical stresses at the corners and edges of geometric shapes (Kilian et
al. 2010; Nelson et al. 2005) and the potential of stress evolved in this manner to affect cell fate processes (J.
Lee et al. 2015; Ruiz and C. S. Chen 2008), we hypothesized that traction stress gradients are involved in the
spatially-localized differentiation of liver progenitor cells in arrayed patterns. A finite element model (FEM)
constructed using previous approaches (Nelson et al. 2005) indicated peak stress at the edge of circular
patterns of the same diameter as those we produced by arraying (∼600 µm). We validated this theoretical
prediction by using TFM of BMEL progenitor cells (Figure 4.4A). Direct comparisons of dimensionless stress
as a function of radius further confirmed that the FEM values were in agreement with the TFMmeasurements
(Figure 4.4B). Root mean square (RMS) values of stress across entire patterns indicated relatively greater
values on stiff compared to soft substrates (Figure 4.4C). Additionally, RMS values appeared to decrease
over time for both stiff and soft substrates. We did not observe changes in RMS values of stress triggered by
Notch ligand presentation (Figure 4.4C), which suggests that engagement with arrayed Notch ligand does
not trigger substantial rearrangement of cell–substrate contacts. TFM measurements of cells treated with
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GSI, however, indicated a reduction in RMS values by inhibition of Notch signaling independent of presented
ligand (Figure C.5).
To ascertain the potential role of cellular mechanotransduction in localized differentiation of liver progen-
itors, we treated cells on arrayed patterns with a set of inhibitors for ERK (FR180204), myosin II ATPases
(blebbistatin), actin polymerization (nocodazole), and ROCK (Y-27632) (Figure 4.5). We continued to
observe “patches” of SOX9 among the centrally-located cells positive for HNF4A, particularly upon pre-
sentation of Notch ligand. Interestingly, inhibition of ERK by FR180204 increased overall SOX9 signal as
well as repsonsiveness to ligand presentation. Treatment with blebbistatin, however, abrogated both SOX9
and HNF4A expression as well as responsiveness to ligand. Qualitatively, neither nocodazole or Y-27632
affected the expression of SOX9 or HNF4A. Last, given recent works describing the role of YAP and Hippo
signaling in liver physiology (Lu et al. 2015; Yimlamai et al. 2014), we evaluated the effect of activating
YAP using L-α-lysophosphatidic acid (LPA) (Figure C.6), which is thought to promote nuclear localization
and downstream transcriptional activity through G-protein coupled receptor signaling (Miller et al. 2012;
F.-X. Yu et al. 2012). We observed reduction in cells positive for HNF4A, in potential agreement with
antagonistic mechanisms between HNF4A and YAP (Cai et al. 2016). HNF4A expression was restored in
centrally-located cells upon inhibition of YAP–TEAD interactions by verteporfin (W.-S. Chen et al. 2015)
but not GSI (Figure C.6).
4.5 Discussion
Here, we utilized microarrayed patterns of ECM co-presented with Notch ligands to provide a biochemically-
and biophysically-defined microenvironment for liver progenitor differentiation. In these patterns, we ob-
served spatially-localized differentiation of progenitors toward biliary fates peripherally and hepatocytic fates
centrally (Figure 4.1). Other groups have made similar observations using both 2D and 3D engineered sys-
tems in the context of both mesenchymal and induced pluripotent stem cells (J. Lee et al. 2015; Z. Ma
et al. 2015; Ruiz and C. S. Chen 2008). In these other contexts, pathways related to both cell contractility,
such as RhoA and ROCK, and cell–cell adaptor proteins, such as E-cadherin were both implicated. Here we
show that myosin-mediated contractility is necessary for localization of differentiation, similar to Z. Ma et al.
(2015), though we do not demonstrate further dependence on ROCK. We have, however, observed increased
number and penetration of cells positive for OPN upon induction with a constitutively-active RhoAL63 and
have further demonstrated that Notch signaling is necessary for this to occur (data not shown). Along
these lines, ongoing work is focused on determining if induction of contractility by RhoAL63 is sufficient to
93
induce expression of Notch ligand or receptor. Further dependence on cell–cell signaling could be determined
through selective inhibition of cadherin by functional antibody or by knockdown of individual Notch ligands.
We further demonstrated dependence of peripheral biliary differentiation on both Notch and TGFβ
(Figure 4.2). Although largely in agreement with known mechanisms of differentiation, the reduction in
HNF4A upon inhibition of TGFβ is difficult to reconcile with these mechanisms. D.-H. Lee et al. (2016)
show cross-talk between YAP and TGFβ but it is not clear if TGFβ can directly regulate HNF4A or other
hepatic factors through autocrine signaling. Additionally, the exact nature of the link between peripheral
traction stress (Figure 4.4) and progenitor fate remains unclear. Although we have shown blebbistatin
inhibits both fates by reducing myosin II-related contractility, Y-27632 is supportive of differentiation despite
similarly reducing contractility, an observation we’ve previously made in the context of TGFβ-induced
differentiation of liver progenitors (Kourouklis et al. 2016). The role of ERK is similarly unexpected as we
had previously shown it was necessary for biliary differentation upon stimulation with TGFβ (Kourouklis et
al. 2016). It is also interesting that we did not observe effects on differentiation by activating YAP signaling.
Immunolabeling for YAP1 in patterns indicated cytoplasmic localization (data not shown), due potentially
to the high density of cultures in arrayed patterns coupled with the density-dependent activity of YAP (B.
Zhao et al. 2007). Last, it is not possible from our experiments to completely deconvolve order of cause
and effect. Specifically, it is unclear whether stress leads to differentiation or whether the differentiating
cells are, for example, inherently more contractile. In the case of TFM of GSI-treated cells (Figure C.5), for
example, the implied mechanism could be either that cells cannot generate stress without direct interactions
with Notch pathway members or merely that the cells fail to differentiate without Notch and therefore do
not become contractile.
In summary, we have characterized the differentiation of liver progenitors in arrayed patterns toward both
hepatocytic and biliary fates. We found that biliary differentiation occurs preferentially at the periphery
of patterns while hepatocytic differentiation, in contrast, occurs centrally. Spatially-localized differentiation
of progenitors was modulated by Notch, TGFβ, and ERK signaling as well as myosin-mediated cell con-
tractility and substrate stiffness. Measurements of cell-generated forces using TFM and simulations using
FEM indicated peak stresses co-incident with peripheral biliary differentiation. We have thus demonstrated
the distinct, inter-related roles of biochemical and biomechanical signaling in guiding liver progenitor fate
specification.
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4.6 Figures
Figure 4.1: Localized differentiation of liver progenitors in arrayed patterns. (A) Immunolabeling of
BMEL cells for the biliary marker OPN and hepatocyte marker ALB on arrayed collagen I patterns with
control IgG or Fc-recombinant Notch ligands DLL1, DLL4, and JAG1. (B) Quantification of distribution of
OPN-positive cell counts as a function of radial distance from the centroid of each island. (C) Quantification
of distribution of ALB-positive cell counts as a function of radial distance from the centroid of each island.
(D) Immunolabeling of BMEL cells for the biliary transcription factor SOX9 and hepatocyte transcription
factor HNF4A on substrates of elastic moduli 30 kPa and 4 kPa. (E) Quantification of SOX9 intensity as
a function of radial distance from the centroid of each island on substrates of elastic moduli 30 kPa and 4
kPa. Scale bars indicate 150 µm. See also Figures C.1, C.2, and C.3.
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Figure 4.2: Peripheral biliary differentiation is dependent on Notch and TGFβ signaling as well as substrate
stiffness. (A) Immunolabeling of BMEL cells for OPN on Notch ligand arrays fabricated on 30 kPa and 4
kPa substrates. These cells were treated with inhibitors of Notch signaling (γ-secretase inhibitor X, GSI,
5 µM) and TGFβ (SB-431542, SB, 10 µM); otherwise, cells were treated with vehicle control (DMSO).
(B) Immunolabeling of BMEL cells for SOX9 and HNF4A on 30 kPa substrates treated with vehicle control
(DMSO) or SB-431542. (C) Insets of images of control IgG in (B) showing differential localization of SOX9
and HNF4A with SB-431542 treatment. Scale bars indicate 150 µm.
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Figure 4.3: Notch family members are expressed at the periphery of arrayed patterns. In situ hybridization
of arrayed patterns on 30 kPa and 4 kPa substrates presenting control IgG or Fc-recombinant DLL4. Probes
were against the Notch ligands Jag1 and Dll1 and the receptor Notch2. Scale bar indicates 150 µm. Data
courtesy of Ian C. Berg. See also Figure C.4.
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Figure 4.4: Liver progenitors in arrayed patterns generate traction stress gradients. (A) Simulated FEM
and measured TFM profiles of arrayed patterns. Scale bars indicate 200 µm. (B) Stress as a function
of radius for both FEM and TFM. Variables were made dimensionless by normalization to peak values.
(C) Root mean square (RMS) stress values in as a function of time, substrate stiffness, and presented
ligand. Data presented as mean ± s.e.m. See also Figure C.5.
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Figure 4.5: Progenitor differentiation in arrayed patterns is modulated by ERK and cell contractility.
Liver progenitors on control IgG or Fc-recombinant DLL4 treated with vehicle control (DMSO) or inhibitors
of ERK signaling (FR180204, 10 µM), myosin II ATPases (blebbistatin, 25 µM), actin polymerization
(nocodazole, 500 nM), and ROCK (Y-27632, 10 µM). See also Figure C.6.
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Chapter 5
Mapping lung tumor cell drug responses
as a function of matrix context and
genotype using cell microarrays∗
5.1 Abstract
Carcinoma progression is influenced by interactions between epithelial tumor cells and components of their
microenvironment. In particular, cell–extracellular matrix (ECM) interactions are known to drive tumor
growth, metastatic potential, and sensitivity or resistance to therapy. Yet the intrinsic complexity of ECM
composition within the tumor microenvironment remains a barrier to comprehensive investigation of these
interactions. We present here a high-throughput cell microarray-based approach to study the impact of
defined combinations of ECM proteins on tumor cell drug responses. Using this approach, we quantitatively
evaluated the effects of 55 different ECM environments representing all single and two-factor combinations
of 10 ECM proteins on the responses of lung adenocarcinoma cells to a selection of cancer-relevant small
molecule drugs. This drug panel consisted of an alkylating agent and five receptor tyrosine kinase inhibitors.
We further determined that expression of the neuroendocrine transcription factor ASCL1, which has been
previously associated with poor patient outcome when co-expressed with the RET oncogene, altered cell
responses to drugs and modulated cleavage of the pro-apoptotic protein caspase-3 depending on ECM con-
text. Our results suggest that co-expression of specific ECM proteins with known genetic drivers in lung
adenocarcinoma may impact therapeutic efficacy. Furthermore, this approach could be utilized to define
the molecular mechanisms by which cell–matrix interactions drive drug resistance through integration with
clinical cell samples and genomics data.
5.2 Introduction
Systemic therapy for advanced lung adenocarcinoma consists primarily of platinum-based agents or targeted
therapies against known driver mutations (Reck, Heigener, et al. 2013; Reck, Popat, et al. 2014). Clinical
∗This work was previously published by the Royal Society of Chemistry (Cambridge, United Kingdom) in the journal
Integrative Biology (Kaylan et al. 2016) and is reproduced here per the terms of the publisher’s standard license to publish
(http://www.rsc.org/journals-books-databases/journal-authors-reviewers/licences-copyright-permissions/).
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outcomes using both approaches have improved over the last decade due specifically to the selective inclusion
of bevazicumab in chemotherapeutic treatment regimens (Reck, Pawel, et al. 2009; Soria et al. 2013) as well
as the use of precision therapies to treat tumors with EGFR mutations (Maemondo et al. 2010; Paez et al.
2004; Zhou et al. 2011) or the EML4–ALK fusion gene (Shaw et al. 2009; Soda et al. 2007). There remains,
however, a pressing need to identify mechanisms which contribute to drug sensitivity or resistance due to
poor overall patient survival and both innate and acquired resistance (Doebele et al. 2012; Kobayashi et al.
2005; Pao et al. 2005; Sequist et al. 2011; Shaw et al. 2009). Further, such mechanisms are likely to be specific
to certain histopathological classes and genotypes as many driver mutations confer the ability to resist cell
death through deregulation of apoptosis and activation of pro-survival signaling (Dean et al. 2005; Holohan
et al. 2013), Of particular relevance to the current work is the recent delineation of a neuroendocrine-like
subtype of lung cancer which co-expresses ASCL1 and RET and has been associated with reduced patient
survival, increased tumor cell proliferation, and expression of anti-apoptotic proteins (Augustyn et al. 2014;
Kosari et al. 2014). In addition to genomic drivers, it is well-established that extracellular matrix (ECM)
proteins can regulate drug resistance via interactions with integrins and other cell-surface receptors (Bissell
et al. 2005; Pickup et al. 2014). These interactions have previously been shown to suppress cell death and
promote survival through downstream regulation of P53 (Lewis et al. 2002), BCL2 (Frisch et al. 1996), RAC
(Zahir et al. 2003), NFκB (Weaver et al. 2002; Zahir et al. 2003), receptor tyrosine kinases (RTKs) (Sethi
et al. 1999), EGFR (Reginato et al. 2003), and PI3K (Pontiggia et al. 2012) among other mechanisms.
Recent studies examining the role of cell–matrix interactions in lung cancer progression have elucidated
the roles of fibronectin and galectins in fibrosis (Mackinnon et al. 2012) and metastasis (Reticker-Flynn and
Bhatia 2015; Reticker-Flynn, Malta, et al. 2012), β1-integrins in resistance to chemotherapeutic treatment
(Hodkinson et al. 2007; Sethi et al. 1999), Matrigel in RB -mediated tumor suppression (Kratzke et al. 1993),
and matrix-derived cues in epithelial–mesenchymal transition (Gibbons et al. 2009; Gill et al. 2012; Shah
et al. 2012). These efforts illustrate the varied, interconnected functions of ECM proteins in the lung cancer
microenvironment, and are suggestive of interactions between microenvironmental factors and cell-intrinsic
genetic programs. Existing engineered approaches provide powerful means by which to investigate these
phenomena (Gibbons et al. 2009; Gill et al. 2012; Loessner et al. 2010). The use of three-dimensional
(3D) culture systems containing scaffolding from both natural and synthetic sources have been particularly
productive towards understanding ECM-mediated drug resistance in cancers of the breast (Weaver et al.
2002), ovaries (Loessner et al. 2010; Yang and Zhao 2011), and pancreas (Dangi-Garimella et al. 2011).
Although these approaches are well-designed to deliver mechanistic insights, they often lack the throughput
to fully investigate the combinatorial impact of both matrix composition and intrinsic genetic programs on
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tumor cell behavior.
Here, we demonstrate a combinatorial ECM microarray platform for mapping tumor cell drug responses
as a function of matrix context. We elucidate differential cell responses due not only to ECM presentation
but also the expression of the neuroendocrine transcription factor ASCL1 and further link drug resistance to
reduced cleavage of caspase-3, a pro-apoptotic protein. Thus, this platform enables not only high-throughput
investigations of the mechanistic role of ECM in drug responses but also the identification of genotype-specific
microenvironmental factors that drive tumor progression.
5.3 Methods
5.3.1 Cell culture and drug treatments
We utilized A549 lung adenocarcinoma cells between passages 6 and 13. A549 culture media consisted of
F-12K nutrient mixture supplemented with 10% v/v fetal bovine serum and 1% v/v penicillin/streptomycin
solution. Cells were cultured on tissue culture plastic in controlled environmental conditions (37°C and 5%
CO2). Treatment with trypsin (0.25% v/v) for ≤10 min was used to detach cells for subculturing. A549-
ASCL1 cells were generated by infection with a lentiviral vector and subsequently selected with blasticidin
(10 µg/ml) until the passage before each experiment. Cells were seeded on arrays at 500E3 cells/slide and
allowed to adhere for 2 h, at which point slides were washed twice with media. This 2 h cell seeding process
was empirically established based on sufficient cell adhesion and near-confluent cell domains on the arrays
at this time point. Drug treatments were added immediately after washing at the following concentrations,
unless otherwise noted: cabozantinib (4 µM), cisplatin (5 µM), nilotinib (5 µM), gefitinib (4 µM), sunitinib
(2 µM), vandetanib (1 µM). Our vehicle control was the highest concentration of dimethyl sulfoxide (DMSO)
required by any drug treatment within each experiment (usually ≤0.05% v/v and no more than 1% v/v).
Last, cultures for experiments examining proliferation were treated with 5-bromo-2’-deoxyuridine (BrdU, 30
µg/ml) for 2 h prior to fixation (see below).
5.3.2 Preparation of polyacrylamide hydrogel substrates
Polyacrylamide hydrogel substrates were prepared following previous protocols (Brafman et al. 2012; Flaim
et al. 2005; Kourouklis et al. 2016; Underhill et al. 2009). Briefly, 25×75 mm glass microscope slides were
washed with 0.25% v/v Triton X-100 in distilled water (dH2O) and placed on an orbital shaker for 30 min.
After rinsing with dH2O, slides were immersed in acetone and placed on the shaker for 30 min. The acetone
wash was followed by immersion in methanol and another 30 min on the shaker. The slides were then washed
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with 0.05 N NaOH for 1 h, rinsed with dH2O, air-dried, and placed on a hot plate at 110°C until dry. For
silanization, the cleaned slides were immersed in 2% v/v 3-(trimethoxysilyl)propyl methacrylate in ethanol
and placed on the shaker for 30 min. The silanized slides were washed with ethanol on the shaker for 5
min, air-dried, and again placed on the hot plate at 110°C until dry. We prepared a prepolymer solution of
10.55% w/v acrylamide and 0.55% w/v bis-acrylamide, which was subsequently mixed with Irgacure 2959
(BASF Corp.) solution (20% w/v in methanol) at a volumetric ratio of 9:1 (prepolymer:Irgacure). This
working solution was then deposited onto silanized slides (100 µl/slide) and covered with 22×60 mm cover
glasses. The sandwiched working solution was transferred to a UV oven and exposed to 365 nm UV A for
10 min. After removing the cover glasses, the slides were immersed in dH2O at room temperature for 3 days
in order to remove excess reagents from the hydrogel substrates. Before microarray fabrication, hydrogel
substrates were thoroughly dehydrated on a hot plate for ≥15 min at 50°C.
5.3.3 Fabrication of microarrays
Microarrays were fabricated as previously described (Brafman et al. 2012; Flaim et al. 2005; Kourouklis et al.
2016; Underhill et al. 2009). Briefly, ECM proteins were mixed with an equal volume of 2× ECM protein
buffer (38% v/v glycerol in dH2O, 16.4 mg/ml sodium acetate, 3.72 mg/ml ethylenediaminetetraacetic acid,
0.5% v/v Triton X-100, 80 ul glacial acetic acid, pH=4.8) and loaded into a 384-well V-bottom microplate.
The final concentration of total ECM protein in each combination was 250 µg/ml; two-factor combinations
contained 125 µg/ml of each individual ECM protein. We utilized the following ECM proteins in our
studies: collagen I (rat tail, EMD Millipore, 08-115), collagen III (human, EMD Millipore, CC054), collagen
IV (human, EMD Millipore, CC076), fibronectin (human plasma, Sigma-Aldrich, F2006), galectin-3 (human,
R&D Systems, 1154-GA-050/CF), galectin-8 (human, R&D Systems, 1305-GA-050/CF), laminin (mouse,
EMD Millipore, CC095), osteopontin (human, R&D Systems, 1433-OP-050/CF), tenascin-C (human, R&D
Systems, 3358-TC-050), and tenascin-R (human, R&D Systems, 3865-TR-050). We additionally used 70 kDa
dextran-rhodamine (2.5 mg/ml, Life Technologies, D-1841) as a marker to facilitate microarray analysis. An
automated benchtop microarrayer (OmniGrid Micro, Digilab) was loaded with SMP3 Stealth microarray
pins (ArrayIt) and used to transfer biomolecules from the 384-well microplate to polyacrylamide hydrogel
substrates. We stored fabricated arrays at room temperature and 65% RH overnight and then sterilized the
next morning with 30 min UV C and immersion in phosphate-buffered saline supplemented with 1% v/v
penicillin/streptomycin. Cells were seeded on arrays immediately after sterilization per the section above.
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5.3.4 Immunofluorescence and imaging
Cells were fixed in freshly-prepared paraformaldehyde (4% w/v) for 15 min and permeabilized with Triton
X-100 (0.25% v/v) for 10 min. Alternatively, BrdU samples were fixed in 70% cold ethanol for 5 min and
permeabilized with HCl (1.5 M) for 30 min at room temperature. For labeling with antibody, samples were
incubated in blocking buffer (5% v/v donkey serum) for 1 h at room temperature and subsequently labeled
with rabbit anti-cleaved caspase-3 (1/50 from stock, Cell Signaling Technology, 9664S) or mouse anti-BrdU
(1/350 from stock, Cell Signaling Technology, 5292S) for 1 h at room temperature. We next incubated
samples for 1 h at room temperature with DyLight 488-conjugated donkey anti-rabbit IgG (1/50 from stock,
Abcam, ab96919) or DyLight 550-conjugated donkey anti-mouse IgG (1/50 from stock, Abcam, ab98767).
Samples were mounted in Fluoromount G with DAPI (Southern Biotech, 0100-20) and imaged using an
Axiovert 200M microscope (Carl Zeiss, Inc.) and associated Zen Pro software. In order to capture entire
arrays as one image for later analyses, we utilized the tiling feature of Zen Pro.
5.3.5 Image processing and analysis of microarrays
Images of entire arrays were converted to individual 8-bit TIFF files per channel (e.g., red) by Fiji (Im-
ageJ version 1.51a) (Schindelin et al. 2012; Schneider et al. 2012). Image size was reduced to ∼29–
32 megapixels/channel by binning to reduce memory requirements during computational analysis. The
IdentifyPrimaryObjects and IdentifySecondaryObjects modules of CellProfiler (version 2.1.1) (Ka-
mentsky et al. 2011) were used to identify nuclei for cell counts (for calculating cells/island and percentage
of control) and immunolabeled regions, respectively. The MeasureObjectIntensity module was used to
quantify single-cell intensity for the cleaved caspase-3 and BrdU immunolabels. The location of arrayed
conditions within each image was automatically determined relative to manually-located dextran-rhodamine
markers. In order to account for drift between experiments, quantile normalization was applied by biological
replicate to the output of MeasureObjectIntensity. See Appendix D for a detailed description of the
microarray analysis pipeline.
5.3.6 Statistical analysis
We performed 4–5 biological replicates for all experiments totaling 80–100 islands per arrayed condition.
Each biological replicate consisted of 2 slides with 20 total islands per arrayed condition unless otherwise
noted. Multiple regression analyses and principal components analyses were performed in R using the base
lm() and princomp() functions, respectively (R Core Team 2016). For each regression model, we confirmed
homoscedasticity, normal distribution of residuals, and the absence of leveraged outliers using residual-
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fit, Q-Q, and scale-location plots. Relative importance of regression coefficients were calculated using the
boot.relimp() and booteval.relimp() functions from the relaimpo R package (Groemping 2006). Five-
parameter logistic fits for dose-response curves were generated using the nplr() function from the nplr R
package. Boxplots show median and not mean values. Upper and lower boxplot hinges represent the limits
of the first and third quartiles, respectively, while the upper and lower whiskers represent ±1.58 × IQR
and are roughly equivalent to the 95% CI. We used an unpaired Wilcoxon rank sum test for all two-sample
comparisons. For all hypothesis testing, P<0.05 was considered significant.
5.4 Results
In order to ascertain the combinatorial impact of ECM on lung tumor cell drug responses, we designed an
ECM array containing all 55 single and two-factor combinations of collagen I (C1), collagen III (C3), collagen
IV (C4), fibronectin (FN), galectin-3 (G3), galectin-8 (G8), laminin (LN), osteopontin (OP), tenascin-C
(TC), and tenascin-R (TR) (Figure 5.1A). These ECM proteins were selected either for their ubiquity in
vivo and central role in cell–matrix interactions, or specifically for their known involvement in modulating
tumor drug responses (Naba, Clauser, Hoersch, et al. 2011). We initially examined the effect of ECM
composition on the adhesion and proliferation of A549 lung adenocarcinoma (A549-WT) cells. After an
initial cell seeding period of 2 h and subsequent 2 days of culture on ECM arrays, the number of A549-
WT cell numbers per array island (i.e., cells/island) varied depending on ECM condition (Figure 5.1B).
Regression analysis showed that C1 (β=0.952, P<0.001), C4 (β=0.868, P<0.001), C3 (β=0.397, P<0.001),
and G8 (β=0.263, P=0.009) were the main ECM proteins mediating adhesion as measured by cells/island
(Figure D.1, Table D.1). Conversely, inclusion of TC in an ECM condition did not mediate adhesion
(β=−0.164, P=0.108). These trends were also apparent in direct comparisons of cells/island for ECM
conditions with and without C1, G8, and TC (Figure 5.1C). Further, we directly evaluated proliferation as
a function of ECM condition using immunofluorescence for BrdU (Figure D.2). Regression analysis showed
that the percentage of BrdU-positive cells was not a strong function of any one ECM protein (data not
shown). Correlation analysis by ECM condition using Pearson’s product-moment correlation established
a small negative correlation between cells/island and the percentage of BrdU-positive cells (r=−0.077,
P=0.026), suggesting that cell density on each island is a factor determining proliferative activity.
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5.4.1 Tumor cell drug response dependent on matrix context
We next selected six drugs for which to assay A549 cell responses as a function of ECM condition. Im-
mediately following the initial cell seeding period of 2 h, we treated arrays with anti-tumor drugs over 2
days of culture and quantified cells/island for each ECM condition as a measure of cell viability. These
drugs included cabozantinib (a c-Met and VEGFR2 inhibitor), cisplatin (an alkylating agent), nilotinib (a
BCR-ABL, c-Kit, and PDGFR inhibitor), gefitinib (an EGFR inhibitor), sunitinib (a broad-spectrum RTK
inhibitor), and vandetanib (an EGFR and RET inhibitor). Further, we selected concentrations for each drug
at the IC50 previously determined for A549-WT cells cultured on standard tissue culture plastic (data not
shown). The overall responses of A549-WT cells on ECM arrays to each drug as a percentage of untreated
controls cultured in parallel (see definition in Supplemental Methods) was similar and ranged from 68.5%
of control for vandetanib to 50.6% of control for cabozantinib (Figure 5.2A and Table D.3). For each drug
treatment, we observed a broad range of differential responses based on ECM condition (Figure 5.2B). In
order to better understand the impact of specific ECM conditions across all drugs, we performed principal
components analysis (PCA) (Figure 5.2C). Principal components 1 and 2 together explained 70.4% of vari-
ance and represented overall response and drug-specific response, respectively (Figure D.3) for each ECM
condition (Figure 5.2C). Specifically, principal component 2 defined ECM conditions for which cells were
responsive only to Group 1 (cabozantinib, cisplatin, nilotinib) or only to Group 2 (gefitinib, sunitinib, vande-
tanib). Data from four ECM conditions at the extremes of both principal components 1 and 2 corroborated
our interpretation of both principal components (Figure 5.2D). For principal component 1, cells on TR-OP
were overall sensitive to drug treatment while cells on C1-TR were overall resistant. In contrast, for principal
component 2, cells on G3-G8 were solely resistant to Group 1 drugs while cells on FN were solely resistant
to Group 2 drugs.
We selected cisplatin and sunitinib as representative drugs from Group 1 and Group 2, respectively.
Regressions within the cisplatin and sunitinib treatments showed that different ECM proteins mediated cell
survival (Figure 5.3A and Table D.3). For cisplatin, C4 was most supportive of cell survival (β=0.7604,
P<0.001) while FN was not supportive of cell survival (β=0.173, P=0.378). For sunitinib, C1 was most
supportive of cell survival (β=0.489, P=0.00879) while TC was least supportive of cell survival (β=−0.370,
P=0.0618). Interestingly, FN switched from least supportive in cisplatin to second-most supportive in
sunitinib (Figure 5.3A), in agreement with the previous PCA analysis (Figures 5.2C and 5.2D). These results
were further supported by the relative importance of each ECM in response to treatment with both cisplatin
and sunitinib (Figure D.4). Specifically, G8 (23.5%), C4 (21.4%), and FN (14.4%) explained the largest
percentage of R2 for the cisplatin treatment while C1 (24.3%), TC (16.1%), and FN (13.7%) explained the
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largest percentage of R2 for the sunitinib treatment (Figure D.4). Representative micrographs of conditions
treated with cisplatin (Figure 5.3B) and sunitinib (Figure 5.3C) further confirmed the results of both the
PCA and regression analysis.
5.4.2 Interaction effects between ECM proteins modulate drug response
Due to differing responses to cisplatin and sunitinib on FN, we focused on potential interaction effects
between FN and other ECM proteins in these treatments. For cisplatin treatment, we observed that FN-
containing ECM conditions with C4 or G8 exhibited greater survival than FN alone (Figure 5.4A), in
agreement with the results of the regression analysis (Figure 5.3A). Conversely, the addition of TC did not
reduce cell survival on FN. Representative micrographs of FN-G8, FN, and FN-TC confirmed these trends
(Figure 5.4B). In contrast, we observed that cells treated with sunitinib on FN-containing ECM conditions
were mostly resistant with the exception of FN-LN (Figures 5.4C and 5.4D). Interaction effects for G8- and
C4-containing conditions treated with cisplatin as well as C1- and TC-containing conditions treated with
sunitinib were again in agreement with the earlier PCA and regression analysis (Figure D.5).
In order to better characterize ECM-specific drug responses, we fabricated additional ECM arrays con-
taining a focused set of ECM combinations and controls identified from above studies, and performed dose-
response curve analysis. Our earlier data suggested that G8 and G8-TC would be sensitive while G8-OP
would be resistant (Figure 5.3, Figure D.5). Dose-response curve analysis (Figure 5.5A) and representative
micrographs (Figure 5.5B) confirmed these predictions. Similarly, our data suggested that the addition of
G8 and OP to FN would be sufficient to induce resistance to cisplatin treatment, predictions which were
also confirmed by dose-response analysis (Figure 5.5C) and representative micrographs (Figure 5.5D). Using
the same approach for sunitinib, we confirmed predictions that cells on C1, C1-LN, FN, and FN-OP are
resistant while those on G3 and G8 are sensitive (Figure D.7).
5.4.3 ASCL1 expression mediates matrix-dependent drug response and
apoptotic activation
Next, to establish whether ASCL1 expression mediates drug response on specific ECM conditions, we gen-
erated an ASCL1 -expressing A549 variant (A549-ASCL1) using lentiviral transfection. Overall responses of
A549-ASCL1 cells on ECM were similar those of A549-WT cells to cabozantinib, cisplatin, nilotinib, gefi-
tinib, sunitinib, and vandetanib (Figure D.7). We compared A549-ASCL1 to A549-WT responses on specific
ECM conditions using unpaired Wilcoxon rank sum tests and observed that A549-ASCL1 cells responded
differently depending on matrix context (Figure 5.6A). As an alternative means of comparing A549-ASCL1
111
responses to A549-WT responses, we plotted P-values against the ratio of A549-ASCL1/A549-WT responses,
a visualization which similarly identified ECM conditions within each drug treatment with significant dif-
ferences between cell types (Figure D.8). To better illustrate these trends, we selectively plotted ECM
conditions for which we observed extreme A549-ASCL1/A549-WT ratios and P<0.05 (Figure 5.6B). PCA
further delineated ECM conditions conducive to sensitivity (e.g., C4) or resistance (e.g., FN-C3) depending
on ASCL1 expression (Figure D.9), findings that were further corroborated by dose-response analysis for
cisplatin (Figure D.10).
To establish a mechanistic basis for differing drug responses in A549-ASCL1 cells versus A549-WT cells,
we evaluated cleavage of caspase-3 (a key pro-apoptotic protein) on select ECM conditions after treatment
with sunitinib. These ECM conditions represented the full range of responses including WT resistant (i.e.,
FN-OP), ASCL1 resistant (i.e., C1 and FN-C3), and genotype insensitive (i.e., C4) (Figure 5.7A). Single-
cell imaging cytometry analysis of C1 and FN-C3 confirmed that A549-ASCL1 cells were less susceptible
to cleaved caspase-3-mediated apoptosis in response to treatment with sunitinib (Figure 5.7B). In contrast,
expression of cleaved caspase-3 in both A549-WT and A549-ASCL1 cells was similar on C4 while FN-
OP elicited high expression in A549-ASCL1 cells and not A549-WT cells. Representative micrographs
of cleaved caspase-3 staining within these ECM conditions were consistent with the overall trends observed
(Figure 5.7C). These data suggest that ECM composition and ASCL1 expression can cooperatively modulate
the induction of caspase-3-mediated apoptosis in response to sunitinib treatment.
5.5 Discussion
The six drugs we utilized here are approved for clinical use (cisplatin and gefitinib), currently undergoing
clinical trials (cabozantinib), or otherwise targeted against known genetic drivers of lung adenocarcinoma
progression (sunitinib, vandetanib, and nilotinib) and are thus of broad clinical relevance. Interestingly, we
observed drug-specific responses in WT cells, as evidenced by classification into two separate groups based
on ECM-specific response (Figure 5.2) as well as the reversal on some ECM conditions of responses to Group
1 and Group 2 drugs (Figures 5.2 and 5.3). In agreement with our identification of C4 as most conducive to
resistance to cisplatin treatment (Figure 5.3), Sethi et al. (1999) previously showed resistance to platinum-
based agents in small cell lung cancer cells cultured on C4, an effect caused by activation of RTK signaling
by β1-integrins. We also observed, however, that FN-containing ECM conditions were least resistant to
treatment with cisplatin yet most resistant to treatment to sunitinib. These divergent effects are possibly
due to preferential interactions with integrins by each ECM protein or drug mechanism of action — cisplatin
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is an alkylating agent and sunitinib is a multi-targeted RTK inhibitor specific primarily to PDGFR and
VEGFR. It is also of note that TC (and TR, to a lesser extent) did not mediate resistance to either cisplatin
or sunitinib despite its known expression and tumorigenic function in the microenvironment of most solid
tumors (F. S. Jones and P. L. Jones 2000; Sethi et al. 1999). Our data thus suggest that the role of TC in lung
adenocarcinoma progression may be more closely linked to its other roles in angiogenesis, immunosuppression,
or metastasis (Chiquet-Ehrismann et al. 2014; Holst 2008; Orend and Chiquet-Ehrismann 2006).
Given the variety of ECM proteins present in the in vivo tumor microenvironment, interaction effects
between ECM proteins are another potential factor regulating drug response. Some previous studies have
shown that combinations of ECM proteins generate unanticipated outcomes, e.g., Reticker-Flynn and Bha-
tia (2015) and Reticker-Flynn, Malta, et al. (2012) found that pairing G3 or G8 with FN enables lung
adenocarcinoma metastasis through interactions with α3β1-integrins. Our findings outline a separate role
for G8 outside of metastasis as a driver of drug resistance to cisplatin (Figures 5.3 and 5.4). We also found
strong interaction effects with FN in this study, observing that FN mediates sensitivity to treatment with
Group 1 drugs (e.g., cisplatin) and resistance to treatment with Group 2 drugs (e.g., sunitinib) (Figures 5.3
and 5.4). Previous studies of FN have implicated several mechanisms modulating drug response, including
p27Kip1, PI3K/AKT, and MAPK/ERK (Hazlehurst et al. 2000; Pontiggia et al. 2012). The role of OP in
particular is also of interest due to its presence in non-small cell lung cancers, an observation correlated with
shorter overall and disease-free survival (Chambers et al. 1996; Donati et al. 2005). Our findings suggest
OP-correlated reduction in patient survival may be related to activation of anti-apoptotic programs within
tumor cells by combinatorial interactions with ECM proteins.
Expression of the transcription factor ASCL1 is known to be involved in the tumorigenesis of adeno-
carcinomas with neuroendocrine features (Linnoila et al. 2000). Kosari et al. (2014) specifically found that
co-expression with RET was associated with shorter overall survival and further linked ASCL1 expression
to cell proliferation, motility, and activity of the JAK/STAT pathway. Interestingly, Augustyn et al. (2014)
found that BCL2 is a conserved ASCL1 target, providing another potential mechanism for drug resistance.
Our findings here suggest interplay between ASCL1 and ECM-associated associated drug response and fur-
ther that these effects work through regulation of the apoptotic machinery (Figure 5.7). It is also possible
that activation of the JAK/STAT pathway by ECM presentation plays a role in this context given prior
studies showing β1-integrin mediated reduction in apoptosis in mammary epithelium in particular (Pullan
et al. 1996; Robledo et al. 2005; Streuli et al. 1995; Yamashita et al. 2004).
Future efforts utilizing this platform could include primary tumor cells from animal or patient-derived
xenograft models as well as clinical transcriptomic and proteomic data. For example, additional mechanistic
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studies could be aimed at examining the processes underlying differential caspase-3 cleavage, or potential
regulation of other apoptotic machinery, within the distinct ECM domains. Specifically, these experiments
could include the assessment of integrin expression profiles and investigation of the functional roles of in-
tegrin subunits. In parallel to efforts aimed at inhibiting metastasis, therapeutics with integrin-blocking
functionalities may provide a means for enhancing cancer drug effects within ECM environments that would
otherwise promote resistance (Seguin et al. 2015). In addition, our results highlighting the combinatorial
influence of matrix proteins are supportive of a range of recent efforts to more broadly explore tumor matrix
expression at both the mRNA and protein level (Bergamaschi et al. 2008; Naba, Clauser, Lamar, et al.
2014). Further, given that our data show that interactions with the same microenvironmental factors lead
to different outcomes depending on ASCL1 expression (Figures 5.6 and 5.7), such efforts would be of use to
characterize genotype-specific expression of candidate microenvironmental markers of resistance and poten-
tially establish a new means of predicting resistance to drugs in specific subtypes of lung adenocarcinoma
and other cancers.
5.6 Conclusions
Tumor cell drug response is known to be influenced by both microenvironmental factors and genetics.
We have demonstrated here the use of a high-throughput ECM microarray approach to investigate the
combinatorial impact of both matrix context and expression of a driver gene on lung adenocarcinoma cell
drug response. Using this approach, we found that tumor cells responded differently depending on matrix
context and specifically identified ECM proteins that mediated resistance to the drugs cisplatin and sunitinib.
Furthermore, we observed that drug response and associated cleavage of the pro-apoptotic protein caspase-3
depended on both matrix context and expression of the neuroendocrine transcription factor ASCL1. In sum,
this approach represents an integrated means of simultaneously exploring regulation by ECM and known
genetic drivers in the context of drug sensitivity and resistance. This approach could be directed towards
defining the mechanisms by which cell–ECM interactions regulate drug response and tumor progression in
lung adenocarcinoma through the use of clinical samples and genomics data.
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5.7 Figures
Figure 5.1: Overview of array approach and cell adhesion to ECM. (A) Our overall approach utilized
31.5×4.5 mm arrays comprised of seven 4.5×4.5 mm subarrays. Each subarray contained 8 ECM conditions
totaling 55 single and two-factor combinations of 10 ECM proteins per array. (B) Combinatorial heat map
showing A549-WT cells/island after 2 days of culture as a function of all 55 ECM conditions. (C) Cells/island
after 2 days of culture for all 55 ECM conditions without (−) or with (+) the ECM proteins C1, G8, and
TC. See also Figure D.1 and Table D.1.
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Figure 5.2: Mapping drug responses as a function of ECM context. (A) A549-WT cell number as a
percentage of untreated controls on ECM arrays treated for 2 days with cabozantinib (4 µM), cisplatin (5
µM), nilotinib (5 µM), gefitinib (4 µM), sunitinib (2 µM), and vandetanib (1 µM). (B) Combinatorial heat
maps showing A549-WT percentage of control for each drug. Drugs are separated into Group 1 or Group 2
based on PCA described in (C) and Figure D.2. White boxes indicate conditions removed due to low adhesion
in controls. (C) PCA separating ECM conditions by sensitivity/resistance to either all drugs (principal
component 1) or to Group 1 or Group 2 (principal component 2). Callouts indicate representative ECM
conditions shown in (D). (D) Percentage of control for select ECM conditions identified in (C) validating
PCA. Error bars are s.e.m. See also Figure D.3 and Table D.2.
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Figure 5.3: Main effects of ECM for cisplatin and sunitinib treatments. (A) Standardized coefficients
from multiple regression analysis of the cisplatin and sunitinib treatments. Red arrows highlight switch in
rank of FN between cisplatin and sunitinib. Error bars are 95% CI. (B) Representative micrographs of
the highest-scoring (C4) and lowest-scoring (FN) ECM in the cisplatin regression labeled for nuclei (DAPI).
(C) Representative micrographs of the highest-scoring (C1) and the second-lowest scoring ECM (G3) in the
sunitinib regression labeled for nuclei (DAPI). TC was not shown due to poor adhesion in control. Scale
bars are 50 µm. See also Figure D.4 and Table D.3.
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Figure 5.4: Interaction effects with FN for cisplatin and sunitinib treatments. (A) Interaction effects as a
percentage of control for FN-containing ECM conditions treated with cisplatin (5 µM). (B) Representative
micrographs of data in (A) for FN-G8, FN, and FN-TC labeled for nuclei (DAPI). (C) Interaction effects as
a percentage of control for FN-containing ECM conditions treated with sunitinib (2 µM). (D) Representative
micrographs of data in (C) for FN-OP, FN, and FN-LN labeled for nuclei (DAPI). Error bars are s.e.m.
Scale bars are 50 µm. See also Figure D.5.
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Figure 5.5: Dose-response curves for select ECM conditions treated with cisplatin. (A) Dose-response
curves as a percentage of control for G8, G8-OP, and G8-TC treated with cisplatin at 0, 5, 20, 50, and 100
µM. (B) Representative micrographs of data in (A) labeled for nuclei (DAPI). (C) Dose-response curves
as a percentage of control for FN, FN-G8, and FN-OP treated with cisplatin at 0, 5, 20, 50, and 100 µM.
(D) Representative micrographs of data in (C) labeled for nuclei (DAPI). Dotted lines are 5-parameter
logistic fits. Scale bars are 75 µm. See also Figure D.6.
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Figure 5.6: ASCL1 -specific responses to drug treatment. (A) A549-WT percentage of control (x -axis)
against A549-ASCL1 percentage of control (y-axis). P-values from unpaired Wilcoxon rank sum tests com-
paring A549-WT and A549-ASCL1 drug responses are mapped to color. The red dashed line indicates the
axis along which A549-WT and A549-ASCL1 drug responses are identical. Callouts indicate ECM conditions
for which P<0.05. (B) Select ECM conditions from each drug treatment with P<0.05 (excluding FN-C3 in
cisplatin). Error bars are s.e.m. See also Figures D.8 and D.9.
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Figure 5.7: Imaging cytometry analysis of cleaved caspase-3. (A) A549-WT and A549-ASCL1 cell numbers
as a percentage of control on C1, C4, FN-C3, and FN-OP treated with 2 µM sunitinib. Error bars are s.e.m.
(B) Imaging cytometry analysis of cleaved caspase-3 expression in A549-WT and A549-ASCL1 cells on C1,
C4, FN-C3, and FN-OP. Peaks outlined by dotted lines show untreated controls; filled peaks show A549-WT
and A549-ASCL1 responses after treatment with 8 µM sunitinib. (C) Representative images of data in (A)
labeled for cleaved caspase-3 and nuclei (DAPI). Scale bars are 75 µm.
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Chapter 6
Conclusions
6.1 Specific contributions
In the sections below, I enumerate and frame the specific contributions of the previous chapters. These
contributions are split into three categories per the synthesis described in Section 1.5.
6.1.1 Design of combinatorial, multi-modal cell microarrays
Chapter 2: An extracellular matrix (ECM) array approach was combined with presentation of Fc-
conjugated Notch ligands JAG1, DLL1, and DLL4. In culturing these arrays with and without TGFβ,
we were able to delineate combinatorial cell–cell, cell–ECM, and cell–soluble factor regulation of liver
progenitor differentiation. Further, in utilizing cells in which endogenous expression of Notch ligand
was stably knocked down by lentiviral delivery of shRNA constructs, we were able to directly mea-
sure the distinct contributions of cell-extrinsic and cell-intrinsic ligand expression. This capability is
particularly important in light of the known differences in cell phenotype depending on relative expres-
sion of Notch ligand and receptor, thought to delineate signal-sending cells (which primarily express
ligand) from signal-receiving cells (which primarily express receptor) (Bray 2016). The fidelity of this
combinatorial array approach was validated by comparison with a GFP co-culture system in which
progenitor differentiation was measured after independent knockdown of endogenous ligand expression
in signal-sending (GFP−) or signal-receiving (GFP+) cells.
Chapters 3 and 4: ECM arrays on substrates of tunable elastic modulus were combined with traction
force microscopy (TFM), a method for directly measuring cell-generated forces. Doing so required the
design of a format in which arrays were fabricated on thin coverglass “viewing windows” in a 35 mm
Petri dish to accommodate the fluorescent microscopy techniques required for TFM—see Kaylan et al.
(2017) for a detailed description. Thus, this cell microarray platform was able to evaluate both cell
differentiation by standard immunofluorescence on microscope slides and biomechanical cell–substrate
interactions by TFM in Petri dishes. Further, the expression of mRNAs in arrayed domains was assayed
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using RNA in situ hybridization, a readout modality which allows for more sensitive detection and
localization than immunofluorescence.
Chapter 5: We designed an ECM array containing 55 different conditions representing all two-factor
combinations of 10 different ECM proteins. This combinatorial array was used with controlled genetic
expression of the lineage oncogene ASCL1 in lung tumor cells to define responses to a panel of clinically-
relevant drugs as a function of both matrix context and genotype.
6.1.2 Combinatorial mechanisms of liver progenitor cell fate specification
Chapter 2: Regulation of liver progenitor differentiation toward both hepatocyte and biliary fates was
found to be combinatorially regulated by Notch, TGFβ, and ECM. Specifically, we established not
only direct signaling effects but also inter-pathway feedback during differentiation toward a biliary
epithelial fate, observing a higher threshold for TGFβ with inhibition of Notch. We further observed
that TGFβ positively regulates expression of the Notch ligands Jag1, Dll1, and Dll4. Liver progenitors
cultured on ECM arrays exhibited responses dependent on the composition of their matrix. Arraying
Notch ligands together with ECM proteins showed that exogenous ligand is sufficient to induce biliary
differentiation while remaining dependent, however, on the composition of the co-presented ECM.
Knockdown of endogenous Notch ligands in cells on these arrays suggested that cell-intrinsic Dll1
inhibits differentiation toward both hepatocyte and biliary fates, a potentially cis-inhibitory mechanism
in contrast with the standard lateral induction associated with Jag1 in this context.
Chapter 3: We used ECM arrays on modular substrates to assess markers of TGFβ-driven biliary differen-
tiation and mechanotransduction through TFM measurements and small molecule inhibition. Analysis
of ECM arrays on soft (E ∼ 4 kPa) and stiff (E ∼ 30 kPa) substrates showed that stiff substrates were
more supportive of biliary fate. Interestingly, cells on ECM containing collagen IV were insensitive
to the inhibitory effect of stiffness and generated high traction stresses while those on ECM contain-
ing fibronectin were not and generated little traction stress. Differentiation was further found to be
dependent on myosin-linked contractility as well as signal transduction through ERK. Inhibition of
ROCK, however, was found to be sufficient to induce biliary fate regardless of substrate stiffness or
ECM composition. Thus, we provided evidence that liver progenitor fate is a cooperative function of
not only ECM context but also mechanotransduction through sensing of substrate stiffness.
Chapter 4: We had previously noted biliary differentiation localized to the periphery of arrayed patterns
of Notch ligands (see Chapter 2), suggestive of cooperation between Notch signaling and mechanotrans-
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duction. We further characterized this spatially-localized differentiation pattern, confirming peripheral
expression of several biliary markers (OPN, SOX9, and CK19) and central expression of hepatic mark-
ers (ALB and HNF4A). Localized differentiation toward both fates was found to be sensitive to changes
in substrate stiffness: hepatocytic differentiation occurred preferentially on soft (E ∼ 4 kPa) substrates
while cholangiocytic differentiation increased on stiff (E ∼ 30 kPa) substrates. Further, RNA in situ
hybridization of arrayed patterns revealed peripheral localization of mRNA for the Notch ligands Jag1
and Dll1 as well as the receptor Notch2. Parallel measurements obtained by TFM and corroborated
by finite element modeling suggested substantial stresses at the periphery, coincident with maximal
cholangiocytic differentiation. We investigated the impact of downstream signaling events in a series
of inhibition studies, showing that peripheral cholangiocytic differentiation is modulated by ERK and
cell contractility as well as Notch and TGFβ signaling. This study therefore delineates distinct sets of
biomechanical cues which coordinate with Notch to guide liver progenitor fate specification.
6.1.3 Mapping matrix regulation of lung tumor cell drug responses
Chapter 5: To address the lack of comprehensive data regarding the role of ECM in lung tumor cell
drug responses, we selected 10 ECM proteins known to modulate tumor drug responses and arrayed
all 55 associated two-factor combinations. Treatment with a clinically-relevant panel of six drugs
yielded responses which varied depending on both the matrix and drug utilized. Further, tumor
cells overexpressing the oncogene ASCL1 exhibited differential responses compared to WT cells, an
observation we linked to direct modulation of the cell apoptotic machinery via cleavage of caspase-3.
This work therefore demonstrates the usefulness of an ECM array platform toward investigations of
tumor cell drug responses.
6.2 Future perspectives
I have described here an advanced cell microarray platform capable of combinatorial presentation of mi-
croenvironmental cues and multi-modal readouts of biochemical and biomechanical state. This platform
was used productively toward the study of liver progenitor fate and lung tumor cell drug responses. There
remain several directions toward which this platform could be developed or otherwise applied:
Dynamic capabilities: There exist a variety of techniques by which the architecture and functionality of
hydrogels can be controlled over time—see Section 1.2.2 and Kirschner and Anseth (2013). However,
there have been limited efforts to make use of these techniques in the context of high-throughput
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array platforms. Doing so would more faithfully recapitulate time-dependent details of development
(e.g., morphogen gradients) as well as aspects of disease progression (e.g., stiffening in fibrosis, matrix
remodeling in cancer). Further, integration of these techniques would also allow for co-culture systems
to study interactions between different cell types over time, which is not possible using the current
system.
Computational models: Alan Turing’s last paper described a mathematical formulation of the factors,
termed “morphogens,” which drive biological pattern formation during development (Turing 1952). It
is immensely exciting that we now have not only detailed knowledge regarding the underlying genetics
of morphogenesis but also multi-scale computational models which describe the arc of tissue formation
through a molecular lens (Phillips et al. 2012). Many of the fine-grained predictions afforded by
these powerful computational models are especially well-suited to confirmation within the controlled
microenvironments of engineered systems. Similar models have been developed for contexts other than
development, notably mass transport and reaction–diffusion models of the tumor microenvironment.
Cell sources: The use of human induced pluripotent stem cells or mouse embryonic stem cells would
provide corroboration for some of the mechanisms of liver cell fate specification described here. With
respect to studies of tumor cell drug response, ECM arrays could serve to complement patient-derived
xenograft models by providing a systematic means for identifying microenvironmental targets of inter-
est. This objective would be facilitated by use of primary or post-xenograft cells together with panels
of drugs specific to the tumor of interest.
Animal models: Select questions raised by this dissertation regarding the distinct roles of the Notch lig-
ands and the role of cell contractility in biliary differentiation of progenitors may be most productively
pursued through the use of animal models. Both mouse and zebrafish models of liver development are
frequently-utilized (Goessling and Stainier 2016; Wang et al. 2017) and could be adapted to answer
the specific questions at hand. For example, a cell type-specific knockout, e.g., AFP-Cre for targeting
cells during the formation of the second ductal layer (Zong et al. 2009), could be used to determine
the potential roles of Dll1 expression at specific developmental stages. Similarly, inducement or ab-
rogation of contractility in the cells of the primordial bile duct might be achieved through the use of
conditional, targeted knockout of select components of the mechanotransduction cascade (e.g., RhoA,
ROCK, MLCK, mDia).
Different tissue contexts: Both the developing and mature liver contain a number other cell types,
namely endothelial cells, Kupffer macrophages, and stellate cells. There remains a need to better
130
characterize and identify the combinatorial microenvironmental determinants of the function of these
cells. Stellate cells, for instance, are thought to be key mediators of fibrotic disease (Wells 2005). Recent
efforts have reported thought-provoking links between activation capacity of stellate cells and the
mechanical microenvironment, as in the observation of blunted response to TGFβ on softer substrates
(Guvendiren et al. 2014).
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Appendix A
Supplemental Information for Chapter 2
A.1 Supplemental Methods
A.1.1 Multiple regression analyses
Multiple regression analysis was performed in R using the base lm function. Both main and interaction
effects were analyzed for the ECM arrays while only main effects were analyzed for the Notch ligand arrays.
For all models, we confirmed homoscedasticity, normal distribution of residuals around zero, and absence of
highly-influential outliers using residual-fit, Q-Q, and scale-location plots.
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A.2 Supplemental Figures
Figure A.1: Dose-response of Hnf4a and Sox9 to TGFβ1 treatment, related to Figure 2.1 Data presented
as mean ± s.e.m. with n=3. Student’s t-tests were performed against 0 ng/ml for each concentration of
TGFβ1 for Hnf4a and Sox9 separately. P-values indicated for P<0.10 (ˆ) and P<0.05 (*).
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Figure A.2: Analysis of GSI X and SB-431542 treatments, related to Figures 2.1 and 2.2. (A) qRT-PCR
analysis of mRNA transcripts of the Notch-related transcription factors Hes1 and Hey2 in BMEL cells
treated with increasing doses of TGFβ1. (B) qRT-PCR analysis of mRNA transcripts of the hepatocytic
transcription factor Cebpa and cholangiocytic marker Ggt1 in BMEL cells treated with increasing doses of
TGFβ1. (C) Quantification of β-actin protein expression (see Figures 2.2B and 2.2C) by immunoblot. Data
presented as mean ± s.e.m. with n≥2. In the DMSO treatment, Student’s t-tests were performed against 0
ng/ml for each concentration of TGFβ1 for each gene separately with P-values indicated for P<0.05 (*). In
the GSI X and SB-431542 treatments, Student’s t-tests were performed against the corresponding DMSO
treatment within each concentration of TGFβ1 with P-values indicated for P<0.05(ˆ).
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Figure A.3: Expression and morphology of knockdown BMEL cells, related to Figure 2.2. (A) Represen-
tative immunoblot showing knockdown of JAG1 in shJag1 cells. 1: BMEL cells untransduced by lentiviral
vector. 2: BMEL cells transduced with the control vector. 3: BMEL cells transduced with the shJag1 vector.
(B) Quantification of the JAG1 immunoblots described in Figure A.3A. Student’s t-tests were performed
against untransduced cells for control and shJag1 cells. (C) qRT-PCR analysis of Dll1 mRNA transcript
levels in control- and shDll1-infected BMEL cells. Student’s t-tests were performed against control cells
in each differentiation condition (TGFβ1±). (D) Phase contrast micrographs of control-, shJag1-, and
shDll1-infected BMEL cells. shJag1 and shDll1 cells exhibited differential morphology in TGFβ1+ indicat-
ing reduced capacity for transformation. Scale bars are 25 µm. Data presented as mean ± s.e.m. with n=3.
P-values indicated for P<0.05 (*).
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Figure A.4: GFP+/GFP− co-cultures, related to Figure 2.3. (A) Combined immunofluorescence and
phase contrast micrograph of GFP+/GFP− BMEL cells in TGFβ1- showing spatial separation of GFP+
cells. Scale bar is 200 µm. (B) Ratios of relative mRNA expression for Alb/Opn (hepatocytic/cholangiocytic)
and Opn/Sox9 normalized to control and log2-transformed. Data presented as means. Error bars were not
calculated for gene ratios.
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Figure A.5: DAPI quantification of ECM arrays, related to Figure 2.5. (A) Sum of the intensity of the
DAPI nuclear label (a proxy for cell count) on each ECM combination by treatment (TGFβ1±) showing
decrease in TGFβ1+ compared to TGFβ1-. (B) Scatter plot of mean ALB intensity against DAPI by
treatment (TGFβ1±). Each point represents a single arrayed ECM protein combination. (C) Scatter plot
of mean OPN intensity against DAPI by treatment (TGFβ1±). Each point represents a single arrayed ECM
protein combination. Data presented as mean ± s.e.m. with n=3. Abbreviations: 1=collagen I, 3=collagen
III, 4=collagen IV, F=fibronectin, L=laminin. Combinations denoted by “•”, e.g., “1•3•4” denotes an ECM
combination containing collagen I, III, and IV.
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Figure A.6: ALB and OPN quantification of ECM arrays, related to Figure 2.5. Quantification of mi-
croarrays of BMEL cells under differentiation conditions (TGFβ1±) on all 25 combinations of five ECM
proteins. Data presented as mean ± s.e.m. with n=3. Abbreviations: 1=collagen I, 3=collagen III, 4=colla-
gen IV, F=fibronectin, L=laminin. Combinations denoted by “•”, e.g., “1•3•4” denotes an ECM combination
containing collagen I, III, and IV.
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Figure A.7: Effects from multiple regression analysis of ECM arrays, related to Figure 2.5. Main and inter-
action effects extracted from full factorial multiple regression analysis of each combination of immunolabeled
protein (ALB and OPN by row) and treatment (TGFβ1± by column) in the ECM arrays. Abbreviations:
1=collagen I, 3=collagen III, 4=collagen IV, F=fibronectin, L=laminin. Interactions between factors are
denoted by “:”, e.g., “4:F” is the interaction effect of collagen IV and fibronectin. See Appendix A.1 for more
information.
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Figure A.8: Notch ligand arrays in TGFβ1+, related to Figure 2.6. (A) ALB quantification of shRNA-in-
fected BMEL cells in TGFβ1+ on five ECM proteins. (B) OPN quantification of shRNA-infected BMEL
cells in TGFβ1+ on five ECM proteins. Data presented as mean ± s.e.m. with n=3. For control cells,
Student’s t-tests were performed against IgG for each arrayed Notch ligand within each ECM condition with
P-values indicated for P<0.05 (*). For shDll1 and shJag1 cells, Student’s t-tests were performed against the
corresponding arrayed condition for control cells, again within each ECM condition with P-values indicated
for P<0.05 (ˆ). Numeric callouts show y-axis values (not P-values).
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Figure A.9: Effects from regression analysis of Notch ligand arrays, related to Figure 2.6. Main effects
from multiple regression analysis of each combination of immunolabeled protein (ALB and OPN by row)
and treatment condition (TGFβ1± by column) in the Notch ligand arrays. Collagen I, IgG, and non-target
shRNA-infected (i.e., control) cells served as the reference factors. See Appendix A.1 for more information.
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A.3 Supplemental Tables
Table A.1: shRNA target, clone, and sequence information.
Sigma Cat. # Target
GenBank Accession
TRC Clone ID Sequence (5’-to-3’)
SHC002H Non-mammalian sequences N/A CCGGCAACAAGATGAA
GAGCACCAACTCGAGT
TGGTGCTCTTCATCTTG
TTGTTTTT
SHCLNV NM_007865
(Mus musculus Dll1 )
TRCN0000028865 CGCGAGAAGGACGTTT
CTGTT
SHCLNV NM_013822
(Mus musculus Jag1 )
TRCN0000279260 GTGACGAAGCCACGTG
TAATA
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Table A.2: Primer pair sequences for qRT-PCR analysis.
Gene Symbol GenBank Accession Sequence (5’-to-3’)
Alb NM_009654.3 Forward: AAGCTGAGACCTTCACCTTCCACT
Reverse: CAGCTCAGCAAGAGCCGTTTGTTT
Cebpa NM_007678 Forward: AGCCAAGAAGTCGGTGGACAAGAA
Reverse: TGGTCAACTCCAGCACCTTCTGTT
Dll1 NM_007865.3 Forward: ACGGAGAAGGTTGCTCTGTGTTCT
Reverse: CACTCCCCTGGTTTGTCACAGTAT
Dll4 NM_019454 Forward: TTCGTCGTCAGGGACAAGAATAGC
Reverse: CACAGCAAGAGAGCCTTGGATGAT
Ggt1 NM_008116 Forward: TGAGGTTATCAATGCCCGTGAGGT
Reverse: TAACCACGGATTTCACCAGGGACA
Hes1 NM_008235 Forward: CAACACGACACCGGACAAACCAAA
Reverse: TGGAATGCCGGGAGCTATCTTTCT
Hey2 NM_013904 Forward: CTTGTGAGGAAACGACCTCCGAAA
Reverse: ACCTCATCACTGAGCTTGTAGCGT
Hprt1 NM_013556.2 Forward: GGAGTCCTGTTGATGTTGCCAGTA
Reverse: GGGACGCAGCAACTGACATTTCTA
Jag1 NM_013822.5 Forward: CCGTAATCGCATCGTACTGCCTTT
Reverse: ATTGCCGGCTAGGGTTTATCATGC
Jag2 NM_010588 Forward: TGGGACAATGACACCACTCCAGAT
Reverse: AGTTCTCATCACAGCGTACTCGGA
Sox9 NM_011448.4 Forward: ACGGAACAGACTCACATCTCTCCT
Reverse: TCGCTTCAGATCAACTTTGCCAGC
Spp1 (Opn) NM_009263.3 Forward: ACTACGACCATGAGATTGGCAGTG
Reverse: CTATAGGATCTGGGTGCAGGCTGTAAA
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Appendix B
Supplemental Information for Chapter 3
B.1 Supplemental Methods
B.1.1 Effect of beads on substrate modulus
The volume fraction of the fluorescent beads is vf = 0.002 for 30 kPa, 13 kPa, and 4 kPa polyacrylamide
hydrogel substrates. Using isostress composite theory, we calculated Ec, the composite modulus:
Ec =
EmEf
Emvf + Efvm
We found that the differences in elastic modulus between the composite (Ec) and the plain polyacrylamide
gel (Em) were negligible. Specifically, assuming an elastic modulus of 3 GPa for the beads, we calculated
Ec = 30.060, 13.026, 4.008 kPa. Due to the small differences between Ec and Em, we have assumed elastic
modulus values of Em for composite hydrogels containing beads.
B.1.2 RNA isolation and qRT-PCR analysis
Cell lysates were collected in TRIzol solution (Life Technologies, 15596-026) from which RNA was isolated
using phenol–chloroform extraction per the manufacturer’s instructions. Samples were subsequently digested
with DNAse (New England Biolabs, M0303S) at 37°C for 30 min and cleaned using an RNeasy Mini Kit
(Qiagen, 74104) per the manufacturer’s instructions. RNA concentration was obtained by UV spectroscopy
using a NanoDrop ND-1000 (Thermo Scientific); samples with a 260 nm/280 nm absorbance ratio <1.8 were
discarded. cDNA from isolated RNA (500 ng) was generated using the iScript cDNA synthesis kit (Bio-
Rad, 170-8891) and mixed with SsoAdvanced Universal SYBR Green Supermix (Bio-Rad, 1725272) with
pre-added primer pairs at a final concentration of 100 nM/primer, again per the manufacturer’s instructions.
Primer pairs for each gene of interest were designed using the NCBI’s Primer-BLAST (Ye et al. 2012) with
a target Tm of 60°C (see Table B.4 for GenBank accession numbers and sequences). Thermal cycling and
measurement of amplification curves were performed on a CFX Connect Real-Time PCR Detection System
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(Bio-Rad). Expression (i.e., 2−∆∆Ct analysis was performed in R using a custom script (R Core Team
2016). mRNA expression was calculated relative to Hprt1 and control samples.
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B.2 Supplemental Figures
Figure B.1: Additional OPN and ALB array quantifications, related to Figure 3.2. (A) Quantification of
TGFβ1− arrays on 30 kPa, 13 kPa, and 4 kPa substrates for OPN+ cell percentage. (B) Quantification
of TGFβ1+ arrays on 30 kPa, 13 kPa, and 4 kPa substrates for ALB+ cell percentage. Data presented as
mean ± s.e.m. with n=2 and 40 total islands per condition.
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Figure B.2: Cells/island for TGFβ1− (A) and TGFβ1+ (B) arrays on 30 kPa, 13 kPa, and 4 kPa
substrates. Data presented as mean ± s.e.m. with n=2 and 40 total islands per condition.
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Figure B.3: qRT-PCR analysis of genes related to mechanotransduction and cell–cell interactions, related
to Figure 3.3. Cells were cultured with TGFβ1 (1.5 ng/ml) on 30 kPa and 4 kPa substrates conjugated with
C1, C4, and FN using sulfo-SANPAH. Data normalized to basal controls (not shown) and presented as mean
± s.e.m. with n=2. Protein products: Rock1ÕROCK1; Rac1ÕRAC1; ItgavÕintegrin αν; Itgb1Õintegrin
β1; Cdh1ÕE-cadherin; Cdh2ÕN-cadherin.
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Figure B.4: Cells/island for DMSO- and (–)-blebbistatin-treated TGFβ1+ arrays on 30 kPa, 13 kPa, and
4 kPa substrates, related to Figure 3.4. Data presented as mean ± s.e.m. with n=2 and 40 total islands per
condition.
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Figure B.5: Contractile moment for TGFβ1+ arrays on 30 kPa and 4 kPa substrates, related to Figure 3.4.
Student’s t-tests were performed against 30 kPa substrates within each ECM combination. Data presented
as mean ± s.e.m. with n=3 and 20–50 total islands per condition. P-values indicated for P<0.05 (*), P<0.01
(**), and P<0.001 (***).
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Figure B.6: Traction stress for TGFβ1− arrays on 30 kPa and 4 kPa substrates after 24 h of differentiation,
related to Figure 3.4. Student’s t-tests were performed against 30 kPa substrates separately for C4 and FN.
Data presented as mean ± s.e.m. with n=2 and 8–10 total islands per condition. P-values indicated for
P<0.05 (*), P<0.01 (**), and P<0.001 (***).
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Figure B.7: Inhibition of RAC1 and JNK in TGFβ1+ arrays, related to Figure 3.5. (A) Quantification
of OPN+ cell percentage on 30 kPa and 4 kPa substrates treated with inhibitors against RAC1 (NSC23766,
10 µM) and JNK (SP600125, 10 µM). Student’s t-tests were performed against DMSO for each treatment
within each ECM combination. (B) Representative fluorescent micrographs of C4 and FN conditions labeled
for nuclei (DAPI) and OPN. DMSO micrographs were reproduced from Figure 3.5B to aid comparison. Data
presented as mean ± s.e.m. with n=3 and 60 total islands per condition. P-values indicated for P<0.05 (*),
P<0.01 (**), and P<0.001 (***). Scale bars are 50 µm.
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Figure B.8: Cells/island for TGFβ1+ arrays on 30 kPa and 4 kPa substrates treated with DMSO (vehicle
control), FR180204 (10 µM), Y-27632 (10 µM), NSC23766 (10 µM), and SP600125 (10 µM), related to
Figure 3.5. Data presented as mean ± s.e.m. with n=3 and 60 islands per condition.
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Figure B.9: Contractile moment for TGFβ1+ arrays on 30 kPa (A) and 4 kPa (B) substrates treated
with DMSO (vehicle control) and Y-27632 (10 µM). Student’s t-tests were performed against DMSO within
each ECM combination. Data presented as mean ± s.e.m. with n=3 and approximately 20 total islands per
condition. P-values indicated for P<0.05 (*), P<0.01 (**), and P<0.001 (***).
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B.3 Supplemental Tables
Table B.1: Regression to determine effect of substrate stiffness, related to Figure 3.2.
Dependent variable:
% cells positive for ALB % cells positive for OPN
TGFβ1− TGFβ1+
Constant 32.074*** (25.222, 38.925) 74.490*** (69.389, 79.590)
Stiffness: 13 kPa 0.361 (-9.288, 10.010) -8.879** (-16.670, -1.088)
Stiffness: 4 kPa -3.431 (-13.080, 6.218) -24.121*** (-31.912, -16.330)
Observations 179 150
R2 0.004 0.201
Adjusted R2 -0.007 0.190
Residual Std. Error 26.851 (df = 176) 20.157 (df = 147)
F -statistic 0.364 (df = 2; 176) 18.494*** (df = 2; 147)
Note: *p<0.1; **p<0.05; ***p<0.01
Regression against 30 kPa stiffness and DMSO
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Table B.2: Regression in TGFβ1+ to determine effect of ECM, related to Figure 3.2.
Dependent variable:
% cells positive for OPN
TGFβ1+
30 kPa 4 kPa
Constant 78.718*** (65.609, 91.826) 43.926*** (29.719, 58.133)
C1 3.141 (-16.222, 22.503) 16.608 (-4.377, 37.593)
C3 -22.159** (-41.521, -2.797) -14.257 (-35.242, 6.728)
C4 9.685 (-9.677, 29.047) 40.803*** (19.818, 61.788)
LN -11.807 (-31.169, 7.556) -10.941 (-31.926, 10.044)
FN
Observations 60 45
R2 0.194 0.473
Adjusted R2 0.135 0.420
Residual Std. Error 18.482 (df = 55) 17.347 (df = 40)
F -statistic 3.303** (df = 4; 55) 8.968*** (df = 4; 40)
Note: *p<0.1; **p<0.05; ***p<0.01
Regression against FN
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Table B.3: Regression to determine effect of treatments, related to Figure 3.5.
Dependent variable:
% cells positive for OPN
TGFβ1+
30 kPa 4 kPa
Constant 35.379*** (28.727, 42.032) 17.283*** (9.956, 24.611)
FR180204 -29.499*** (-38.907, -20.091) -4.781 (-14.851, 5.290)
Y-27632 16.272*** (6.864, 25.680) 26.845*** (16.775, 36.916)
NSC23766 5.367 (-4.041, 14.775) 38.903*** (28.832, 48.974)
SP600125 -10.669** (-20.077, -1.261) 12.794** (1.601, 23.987)
Observations 180 164
R2 0.375 0.398
Adjusted R2 0.361 0.383
Residual Std. Error 20.365 (df = 175) 21.149 (df = 159)
F -statistic 26.234*** (df = 4; 175) 26.277*** (df = 4; 159)
Note: *p<0.1; **p<0.05; ***p<0.01
Regression against DMSO
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Table B.4: Primer pair sequences for qRT-PCR analysis, related to Appendix B.1.
Gene Symbol GenBank Accession Sequence (5’-to-3’)
Cdh1 NM_009864.2 Forward: ATCCTGACCAGCAGTTCGTTGTTG
Reverse: AAAGGGTTCCTCGTTCTCCACTCT
Cdh2 NM_007664.4 Forward: AGCTCCTTGATCTCCCGTCTGTT
Reverse: TAACAAATAGCGGGCCTCGGAGT
Hprt1 NM_013556.2 Forward: GGAGTCCTGTTGATGTTGCCAGTA
Reverse: GGGACGCAGCAACTGACATTTCTA
Itgav NM_008402.3 Forward: AGCAGTGGGAGACTTCCAGACTAC
Reverse: TATGGCACTTCCAAACCTGGCAAA
Itgb1 NM_010578.2 Forward: GTGGCTCAAACCACTTAAGCCAAA
Reverse: CTGTTCTACTACCCACTCCCCACA
Rac1 NM_009007.2 Forward: GCTTTTCCCTTGTGAGTCCTGCAT
Reverse: AGGTGATGGGAGTCAGCTTCTTCT
Rock1 NM_009071.2 Forward: TGCCATGTTAAGTGCCACAGAGAC
Reverse: GACAAAGCCAGATGGTGGGTTCTT
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Appendix C
Supplemental Information for Chapter 4
C.1 Supplemental Figures
Figure C.1: Probability densities of ALB+ and OPN+ cell location in arrayed patterns, related to Fig-
ure 4.1. Note that densities are relative within each panel and should therefore not be compared across
panels.
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Figure C.2: CK19 is expressed by differentiating liver progenitors at the periphery of arrayed patterns,
related to Figure 4.1. Left, immunolabeling of liver progenitors on control IgG patterns fabricated on 30 kPa
substrates at t = 24 h of differentiation for the biliary marker CK19. Right, quantification of immunolabeling
for CK19 as a function of distance from island centroid. Scale bar is 150 µm.
163
Figure C.3: EpCAM, CDH1, and CDH2 do not exhibit localization in arrayed patterns, related to Fig-
ure 4.1. (A) Immunolabeling of BMEL cells on control IgG patterns fabricated on 30 kPa substrates at
t =24 h of differentiation. Cells were labeled for the progenitor marker EpCAM, CDH1 (E-cadherin), and
CDH2 (N-cadherin). Scale bar is 150 µm. (B) Quantification of immunolabeling for EpCAM, CDH1, and
CDH2 as a function of distance from island centroid.
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Figure C.4: Validation of in situ hybridization probes, related to Figure 4.3. BMEL cells were cultured on
collagen I-coated coverglasses for 24 h under basal conditions or 72 h under differentiation conditions with
TGFβ1 (1.5 ng/ml) and subsequently labeled using RNA in situ hybridization. Probes included the Notch
ligands Jag1, Dll1, receptors Notch1 and Notch2, and effector Hes1. Control samples were processed using
the described protocol without the addition of probes. Scale bar is 100 µm.
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Figure C.5: TFM of BMEL cells treated with GSI, related to Figure 4.4. Root mean square (RMS) traction
stresses are shown for BMEL cells cultured on Notch ligand arrays fabricated on 30 kPa substrates for t =72
and treated with vehicle control (DMSO) or GSI (10 µM). Data courtesy of Ian C. Berg.
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Figure C.6: Modulation of YAP activity in BMEL cells, related to Figure 4.5. Cells were cultured on
arrayed control IgG or Fc-conjugated DLL4 on 30 kPa substrates and treated with an activator of YAP
signaling (L-α-lysophosphatidic acid, LPA, 10 µM), an inhibitor of YAP–TEAD interactions (verteporfin,
500 nM), or GSI (10 µM). Scale bar is 150 µm.
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C.2 Supplemental Tables
Table C.1: List of growth factors and drugs.
Factor or drug Stock Target Manufacturer Catalog #
(–)-Blebbistatin 1 mg/ml 25 µM Cayman Chemical 13013
FR180204 10 mg/ml 10 µM Sigma-Aldrich SML0320
L-685,458 (GSI) 1 mM 5 µM Tocris 2627
L-α-lysophosphatidic acid (LPA) 1 mg/ml 10 µM Sigma-Aldrich L7260
Nocodazole 5 mg/ml 50 nM Sigma-Aldrich M1404
SB-431542 (SB) 10 mM 10 µM Sigma-Aldrich S4317
TGFβ1 5 µg/ml 1.5 ng/ml R&D Systems 240-B-002
Verteporfin 2 mg/ml 500 nM Sigma-Aldrich SML0534
Y-27632 5 mg/ml 10 µM Enzo Life Sciences 270-333-M005
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Table C.2: List of primary antibodies.
Antibody target Dilution Manufacturer Catalog #
ALB 1/100 Bethyl A90-134A
CK19 1/200 Abcam ab52625
Digoxigenin 1/500 Roche 11 093 274 910
HNF4A 1/200 Abcam ab41898
OPN (SPP1) 1/50 R&D Systems AF808
SOX9 1/200 EMD Millipore AB5535
YAP1 1/50 ProteinTech 13584-1-AP
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Appendix D
Supplemental Information for Chapter 5
D.1 Supplemental Methods
D.1.1 Analysis of microarrays
Following imaging of entire arrays, we applied the following analytical steps:
(A) Image processing in Fiji (ImageJ). Array images from each channel (i.e., blue, red, or green) were
converted from 32-bit TIFF images to 8-bit TIFF images in Fiji (ImageJ version 1.51a) (Schindelin
et al. 2012; Schneider et al. 2012) in order to reduce computational load during analysis. For similar
reasons, we applied 2×2 or 4×4 binning in Fiji to reduce image size from >500 megapixels to 29–32
megapixels per channel.
(B) Single-cell analysis in CellProfiler. Binned 8-bit TIFF images were analyzed in CellProfiler (version
2.1.1) (Kamentsky et al. 2011) using the following modules: IdentifyPrimaryObjects, IdentifyS
econdaryObjects, and MeasureObjectIntensity. IdentifyPrimaryObjects was used to identify
nuclei for cell counts while IdentifySecondaryObjects and MeasureObjectIntensity were used to
quantify immunolabel intensity, namely for assessment of proliferation by BrdU and apoptosis by
cleaved caspase-3. Single-cell data from all three modules were output as CSV files by channel for
downstream analysis.
(C) Statistical analysis in R. Before further analysis, we recorded pixel coordinates of dextran-rhodamine
markers for each array. Using single-cell CSV files from the previous step in conjunction with the
dextran-rhodamine coordinates and a transfer list defining the rows and columns of each ECM condi-
tion, we automatically assigned ECM conditions to the objects identified in CellProfiler. We manually
validated the results of this assignment with the associated images and corrected or otherwise discarded
data from arrays with poor signal-to-noise ratios or image artifacts. Using each biological replicate
(1–2 arrays with 10–20 islands per arrayed condition) as our fundamental statistical unit, we calculated
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the following measures in R (R Core Team 2016) for individual ECM conditions by treatment and cell
type:
(a) Cells/island. We calculated cells/island by dividing cell count by the known number of islands
per array and ECM condition: cells/island = cell count per array# of islands per array .
(b) Percentage of control. In order to accurately estimate the ECM-specific effect of drug treatment,
we first removed the following ECM conditions for which control cells/island was ≤3: C3-OP,
FN-G3, G3-TC, G3-TR, G8, LN-G3, OP, TC, TC-OP, TC-TR, and TR. For the remaining
ECM conditions, we calculated the percentage of control for each drug treatment: % of control
= 100 × cells/island (drug)cells/island (control) . This calculation was performed with respect to controls within each
biological replicate before pooling for later statistical analysis.
(c) Intensity. To account for drift between biological replicates, we calculated quantile normalized
intensity for labels (namely caspase-3 or BrdU) similarly to its application to oligonucleotide
microarrays (Amaratunga and Cabrera 2001). Specifically, single cell intensity observations per
channel were ranked within each biological replicate. We then calculated the mean of observations
at equal ranks across biological replicates and assigned that value to all observations of that rank.
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D.2 Supplemental Figures
Figure D.1: Main effects of ECM on A549-WT cells/island. (A) Standardized regression coefficients for
each ECM protein; larger coefficients were associated with greater cells/island. (B) Relative importance of
each ECM protein represented as a percentage of R2 of the regression in Table D.1. Error bars are 95% CI.
See also Figure 5.1 and Table D.1.
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Figure D.2: Analysis of A549-WT cell proliferation. (A) Combinatorial heat map showing A549-WT cell
proliferation as a function of all 55 ECM conditions. White boxes indicate conditions removed due to low
adhesion in controls. (B) Correlation of A549-WT cells/island with percentage of A549-WT cells positive
for BrdU.
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Figure D.3: PCA of A549-WT drug response. (A) Loadings for principal components 1 and 2. Principal
component 1 represents overall response to drug. Principal component 2 represents differential response to
drugs in Group 1 (cabozantinib, cisplatin, and nilotinib) and Group 2 (vandetanib, gefitinib, and nilotinib).
(B) Scree plot showing proportion of variance explained by each principal component. The first and second
principal components together explain 70.4% of variance. See also Figure 5.2.
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Figure D.4: Relative importance of ECM in A549-WT response to cisplatin and sunitinib. Relative
importance of each ECM in the cisplatin and sunitinib treatments. See also Figure 5.3 and Table D.3.
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Figure D.5: Interaction effects for select highly-ranked ECM proteins. (A) Interaction effects as a per-
centage of control for G8- and C4-containing ECM conditions treated with cisplatin (5 µM). (B) Interaction
effects as a percentage of control for C1- and TC-containing ECM conditions treated with sunitinib (2 µM).
Error bars are s.e.m. See also Figure 5.4.
176
Figure D.6: Dose-response curves for select ECM conditions treated with sunitinib. (A) Dose-response
curves as a percentage of control for cells on C1, G8, and LN-C1 treated with sunitinib at 0, 4, 8, 12,
and 20 µM. (B) Representative micrographs of data in (A) for C1 and G8 labeled for nuclei (DAPI).
(C) Dose-response curves as a percentage of control for cells on FN, FN-OP, and G3 treated with sunitinib
at 0, 4, 8, 12, and 20 µM. (D) Representative micrographs of data in (C) for FN and FN-OP labeled for
nuclei (DAPI). Scale bars are 75 µm.
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Figure D.7: Comparison of overall A549-WT and A549-ASCL1 drug response. Overall percentage of
control for A549-WT and A549-ASCL1 cells. See also Figure 5.6 and Figures D.8 and D.9.
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Figure D.8: ASCL1-specific responses to drug treatment. (A) Volcano plots showing the ratio of
A549-ASCL1 to A549-WT drug response (x-axis) against P-values from unpaired Wilcoxon rank sum tests
comparing A549-WT and A549-ASCL1 drug response (y-axis). Points above the red dashed line are P<0.05;
similarly, callouts indicate ECM conditions for which P<0.05. See (B) for detail of areas shaded in gray.
(B) Detail of areas shaded in gray in (A) showing ECM conditions treated with cisplatin and sunitinib for
which A549-ASCL1 cells were more resistant than A549-WT cells. See also Figures 5.6 and D.9.
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Figure D.9: PCA of WT-normalized A549-ASCL1 drug response as a function of ECM. (A) Loadings
for principal components 1 and 2. Principal component 1 represents overall WT-normalized response of
A549-ASCL1 cells to drug. Principal component 2 represents differential response to drugs in subsets of
Group 1 (cabozantinib and cisplatin) and Group 2 (vandetanib and nilotinib). (B) Scree plot showing
proportion of variance explained by each principal component. Principal components 1 and 2 together
explain 62.2% of variance. (C) PCA separates ECM conditions intoASCL1 -associated sensitivity/resistance.
(D) Select ECM conditions identified in (C) validating PCA. Error bars are s.e.m. See also Figures 5.6 and
D.8.
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Figure D.10: Dose-response analysis of C4 and FN-C3. (A) Dose-response curves as a percentage of
control for A549-WT and A549-ASCL1 cells on C4 and FN-C3 treated with cisplatin at 0, 5, 20, 50, and
100 µM. Dotted lines are 5-parameter logistic fits. (B) Representative micrographs for data in (A) labeled
for nuclei (DAPI). Scale bars are 75 µm. See also Figures 5.6 and D.8.
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D.3 Supplemental Tables
Table D.1: Regression against A549-WT cells/island by ECM. Regression model: A549-WT control
cells/island ∼ C1+C3+C4+FN+G3+G8+LN+OP+TC+TR. Calculated regression coefficients are stan-
dardized. See also Figures 5.1 and D.1.
Dependent variable:
Cells/island
Constant -0.450*** (-0.725, -0.175)
C1 0.952*** (0.753, 1.151)
C3 0.397*** (0.198, 0.596)
C4 0.868*** (0.669, 1.067)
FN 0.147 (-0.052, 0.346)
G3 -0.057 (-0.257, 0.143)
G8 0.263*** (0.065, 0.461)
LN 0.068 (-0.132, 0.268)
OP -0.052 (-0.251, 0.147)
TC -0.164 (-0.363, 0.036)
TR 0.022 (-0.179, 0.222)
Observations 923
R2 0.230
Adjusted R2 0.222
Residual Std. Error 0.882 (df = 912)
F -statistic 27.233*** (df = 10; 912)
Note: *p<0.1; **p<0.05; ***p<0.01
Values in parentheses are 95% CI
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Table D.2: Regression against A549-WT response by drug. Regression model: A549-WT % of control ∼
Treatment. Calculated regression coefficients are unstandardized. See also Figure 5.2.
Dependent variable:
% of control
Control 100.000*** (96.978, 103.022)
Cabozantinib -49.343*** (-53.658, -45.027)
Cisplatin -43.287*** (-47.684, -38.890)
Nilotinib -48.888*** (-53.224, -44.552)
Gefitinib -40.079*** (-44.454, -35.705)
Sunitinib -39.172*** (-43.558, -34.787)
Vandetanib -31.554*** (-35.960, -27.148)
Observations 2,915
R2 0.199
Adjusted R2 0.197
Residual Std. Error 32.634 (df = 2908)
F -statistic 120.098*** (df = 6; 2908)
Note: *p<0.1; **p<0.05; ***p<0.01
Values in parentheses are 95% CI
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Table D.3: Regression against A549-WT response by ECM for cisplatin and sunitinib. Regression model:
A549-WT control cells/island ∼ C1+C3+C4+FN+G3+G8+LN+OP+TC+TR for cisplatin and sunitinib
separately. Regression coefficients are standardized within each model. See also Figures 5.3 and D.4.
Dependent variable:
% of control
Cisplatin Sunitinib
Constant -0.977*** (-1.536, -0.418) -0.215 (-0.773, 0.343)
C1 0.478** (0.113, 0.843) 0.488*** (0.125, 0.851)
C3 0.557*** (0.182, 0.932) 0.279 (-0.093, 0.652)
C4 0.769*** (0.403, 1.136) 0.280 (-0.080, 0.640)
FN 0.173 (-0.211, 0.556) 0.420** (0.030, 0.809)
G3 0.559** (0.131, 0.988) -0.257 (-0.684, 0.170)
G8 0.766*** (0.413, 1.120) -0.177 (-0.522, 0.167)
LN 0.245 (-0.133, 0.624) 0.206 (-0.176, 0.587)
OP 0.669*** (0.300, 1.039) -0.089 (-0.456, 0.278)
TC 0.443** (0.057, 0.828) -0.370* (-0.756, 0.017)
TR 0.610*** (0.239, 0.982) -0.050 (-0.415, 0.316)
Observations 363 369
R2 0.107 0.114
Adjusted R2 0.081 0.090
Residual Std. Error 0.959 (df = 352) 0.954 (df = 358)
F -statistic 4.199*** (df = 10; 352) 4.626*** (df = 10; 358)
Note: *p<0.1; **p<0.05; ***p<0.01
Values in parentheses are 95% CI
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